Black Rock Coffee Bar, Inc. Reports Third Quarter 2026 Results

Total Revenue Growth of 29.7% Year Over Year in the Third Quarter

Same Store Sales Growth of 5.8% Year Over Year in the Third Quarter

Opened 11 New Stores in the Third Quarter

SCOTTSDALE, Ariz., Nov. 10, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, Inc. (Nasdaq: BRCB) (“Black Rock Coffee Bar” or the “Company”) today announced financial results for the third quarter ended September 30, 2026.

Third Quarter 2026 Highlights

  • Opened 11 new stores during the period
  • Total revenue of $66.8 million, up 29.7% compared to the prior year period
  • Same Store Sales Growth(1) of 5.8% compared to the prior year period
  • Income from operations of $2.8 million compared to a loss from operations of $6.4 million in the prior year period. In the third quarter of 2026, income (loss) from operations margin was 4.2%
  • Store-Level Profit(2) of $19.3 million as compared to $15.2 million in the prior year period. In the third quarter of 2026, Store-Level Profit Margin was 28.9%
  • Selling, general, and administrative (“SG&A”) expenses of $10.3 million, or 15.5% of total revenue, compared to $17.2 million, or 33.3% of total revenue, in the prior year period
  • Adjusted SG&A Expenses(2) of $8.9 million, or 13.4% of total revenue, compared to $6.9 million, or 13.3% of total revenue, in the prior year period
  • Net income grew 116.4% to $2.7 million, as compared to a net loss of $16.2 million in the prior year period
  • Adjusted EBITDA(2) grew 22.1% to $8.5 million, as compared to $6.9 million in the prior year period
  • Total store operating weeks(1) of 2,687, as compared to 2,108 in the prior year period

“We delivered another exceptional quarter, with revenue increasing 30% and adjusted EBITDA growing 22% year-over-year, reflecting the continued strength of our brand, customer engagement strategy and operating model. Same-store sales accelerated to 5.8%, or 16.6% on a two-year basis, marking our 15th consecutive quarter of positive same-store sales growth, while positive transaction growth reinforced our confidence in the resilience of consumer demand and the momentum we are building across the business. During the quarter, we opened 11 new stores and are now ahead of our development plan, increasing our full-year target to 40 new store openings. Further, we are reaffirming our full year revenue and adjusted EBITDA guidance based on our confidence in our plan for the remainder of the year. We are encouraged by the early success of initiatives including our menu innovation, expanded operating hours, and enhanced loyalty capabilities. We believe that these initiatives keep our menu fresh and exciting, give customers more reasons to visit throughout the day, and help deepen customer relationships and drive engagement over time. Combined with our strong development pipeline, growing leadership bench, and significant whitespace opportunity, we believe Black Rock remains well positioned to deliver sustainable long-term growth,” said Mark Davis, Chief Executive Officer.

Balance Sheet & Liquidity

As of September 30, 2026, Cash and cash equivalents totaled $13.6 million and total debt was $38.1 million, consisting of $22.5 million of borrowings under our credit facility, net of unamortized debt issuance costs, and $15.5 million of financing obligations related to certain reverse build-to-suit lease arrangements.

As of September 30, 2026, outstanding principal under the Company’s term loan facility was $19.5 million. The Company had $4.0 million outstanding under its $25 million revolving credit facility, leaving $21.0 million of remaining borrowing capacity as of September 30, 2026.

Full Year 2026 Outlook

The Company is updating its full year 2026 guidance to:

  • 40 new store openings
  • Total Revenue in the range of $255 to $257 million
  • Same Store Sales Growth in the mid-single digits
  • Adjusted EBITDA in the range of $34 to $35 million(3)
  • Capital Expenditures in the range of $47 to $48 million which include anticipated tenant improvement allowances
         

(1) Same Store Sales Growth and total store operating weeks are defined in the section “Key Performance Measures”.
(2) See “Non-GAAP Financial Measures” for a discussion of Store-Level Profit, Store-Level Profit Margin, Adjusted Selling, General, and Administrative Expenses, and Adjusted EBITDA and a reconciliation of each measure to its most directly comparable GAAP measure.
(3) A reconciliation of adjusted EBITDA outlook to GAAP net income is not available without unreasonable efforts due to the inherent difficulty in forecasting and quantifying with reasonable accuracy significant items required for the reconciliation, including equity-based compensation.
   

Conference Call and Webcast Information

Black Rock Coffee Bar will host a conference call on November 10, 2026, at 5:00 p.m. Eastern Time to discuss third quarter ended September 30, 2026 results. The conference call can be accessed live over the phone by dialing 1-877-704-4453 or for international callers, 1-201-389-0920. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13762671. The replay will be available until Tuesday, November 24, 2026. A live webcast of the conference call and related presentation materials will also be available in the investor relations section of Black Rock Coffee Bar’s website, ir.br.coffee.

About Black Rock Coffee Bar

Black Rock Coffee Bar is a high-growth operator of guest-centric, drive-thru coffee bars offering premium caffeinated beverages and an elevated in-store experience crafted by our engaging baristas. Black Rock Coffee Bar was founded in 2008 in Beaverton, Oregon. What started as a single 160 square foot coffee bar in 2008 is now one of the fastest growing beverage companies in the United States by revenue and the largest fully company-owned coffee retailer in the country, with more than 210 locations spanning seven states from the Pacific Northwest to Texas.

Forward-Looking Statements

This release contains a number of “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, Black Rock Coffee Bar’s strategy, future financial condition, sustainable long-term growth, future operations, projected costs, prospects, plans, objectives of management, the expected benefits of our strategic initiatives, our development pipeline, expected whitespace opportunity, and full year 2026 outlook, including new store openings, total revenue, same store sales growth, adjusted EBITDA, and capital expenditures. These statements are based on Black Rock Coffee Bar’s current expectations and beliefs, as well as a number of assumptions concerning future events. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “objective,” “seeks,” or “continue,” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Black Rock Coffee Bar’s control that could cause actual results to differ materially from the results discussed in the forward-looking statements, including our inability to successfully identify and secure appropriate sites and timely develop and expand our operations; our inability to protect our brand and reputation; our inability to secure, protect, and enforce our intellectual property rights; our dependence on a small number of suppliers and two roasting facilities; our dependence on third-party information technology systems and services; our and our vendors’ vulnerability to security breaches, including breaches that may impact confidential customer information; our expectations regarding our future operating and financial performance; the size of our addressable markets, market share, and market trends; our ability to compete in our industry; changes in consumer tastes and nutritional and dietary trends; our ability to effectively manage the continued growth of our workforce and operations; our inability to open profitable stores; our failure to generate projected same store sales growth; the sufficiency of our cash, cash equivalents, and investments to meet our liquidity needs; our dependence on long-term non-cancelable leases; our relationship with our employees and the status of our workers; the effects of seasonal trends on our results of operations; our vulnerability to global financial market conditions, including inflation and other macroeconomic factors, including, without limitation, due to the ongoing conflict in the Middle East; our ability to attract, retain, and motivate skilled personnel, including key members of our senior management; our vulnerability to adverse weather conditions in local or regional areas where our stores are located; our realization of any benefit from the Tax Receivable Agreements and our organizational structure; the increased expenses associated with being a public company; and those other risks described under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission (“SEC”) on March 4, 2026, our Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 filed with the SEC on August 12, 2026, as will be updated by our Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, once filed, and in our future reports to be filed with the SEC. Forward-looking statements contained in this release are made as of this date, and Black Rock Coffee Bar undertakes no duty to update such information except as required under applicable law.

Non-GAAP Financial Measures

This press release contains “non-GAAP financial measures” that are financial measures that either exclude or include amounts that are not excluded or included in the most directly comparable measures calculated and presented in accordance with accounting principles generally accepted in the United States (“GAAP”). Specifically, we make use of the non-GAAP financial measures “Adjusted EBITDA”, “Adjusted EBITDA Margin”, “Store-Level Profit”, “Store-Level Profit Margin”, “Adjusted Selling, General, and Administrative Expenses”, and “Adjusted Selling, General, and Administrative Expenses Margin”. We believe these non-GAAP financial measures assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our operating performance. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone provide. Please refer to the tables in this press release for a reconciliation of non-GAAP measures to the most directly comparable financial measure prepared in accordance with GAAP. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to the financial information prepared and presented in accordance with GAAP.

Store-Level Profit and Store-Level Profit Margin

Store-Level Profit represents store revenue in the specific period less beverage, food and packaging, labor and related expenses, occupancy and related expenses, and other store operating expenses, excluding depreciation and amortization and pre-opening costs in the period.

Store-Level Profit Margin represents Store-Level Profit as a percentage of store revenue. We use Store-Level Profit and Store-Level Profit Margin in our evaluation of the performance and profitability of each store.

We use Store-Level Profit and Store-Level Profit Margin to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, and to compare our performance against that of other peer companies using similar measures.

Adjusted EBITDA and Adjusted EBITDA Margin

Adjusted EBITDA is net income (loss) adjusted to exclude interest expense, net, income tax expense (benefit), and depreciation and amortization, further adjusted to exclude certain items that we do not consider indicative of our ongoing operating performance, including transaction costs associated with our initial public offering (“IPO”), capital restructuring costs, equity-based compensation, gain (loss) on the remeasurement of the liability related to the TRA, certain litigation defense costs, net and other non-core costs. Adjusted EBITDA Margin represents Adjusted EBITDA as a percentage of Total revenue.

We use Adjusted EBITDA and Adjusted EBITDA Margin to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, and to compare our performance against that of other peer companies using similar measures.

Adjusted Selling, General, and Administrative Expenses and Adjusted Selling, General, and Administrative Expenses Margin

Adjusted Selling, General, and Administrative Expenses is selling, general, and administrative expenses adjusted to exclude transaction costs, equity-based compensation, certain litigation defense costs, net and other costs. Adjusted Selling, General, and Administrative Expenses Margin represents Adjusted Selling, General, and Administrative Expenses as a percentage of Total revenue.

We use Adjusted Selling, General, and Administrative Expenses and Adjusted Selling, General, and Administrative Expenses Margin because it may provide a more meaningful comparison to prior periods and may be indicative of the level of such expenses to be incurred in future periods.

BLACK ROCK COFFEE BAR, INC.

Condensed Consolidated Statements of Operations (Unaudited)

(in thousands, except share and per share amounts)

         

  Three Months Ended
September 30,
  Nine Months Ended
September 30,
    2026       2025       2026       2025  
Store revenue $ 66,684     $ 51,410     $ 185,001     $ 146,520  
Other   71       58       207       162  
Total revenue   66,755       51,468       185,208       146,682  
Store operating costs and expenses (exclusive of depreciation and amortization presented separately below):              
Beverage, food and packaging costs   17,873       14,286       49,854       41,641  
Labor and related expenses   14,732       10,785       39,442       30,588  
Occupancy and related expenses   5,544       4,034       15,338       11,641  
Other store operating expenses   9,279       7,079       25,697       19,883  
Total store operating costs and expenses   47,428       36,184       130,331       103,753  
Selling, general and administrative expenses   10,340       17,158       29,387       31,898  
Depreciation and amortization   4,259       3,030       11,644       8,856  
Pre-opening costs   1,929       1,503       4,269       3,064  
Total operating expenses   63,956       57,875       175,631       147,571  
Income (loss) from operations   2,799       (6,407 )     9,577       (889 )
Interest expense, net   (685 )     (2,871 )     (1,632 )     (9,028 )
Other income (expense), net   (131 )     (6,866 )     (741 )     (7,950 )
Income (loss) before income taxes   1,983       (16,144 )     7,204       (17,867 )
Income tax expense (benefit)   (670 )     31       (466 )     253  
Net income (loss)   2,653       (16,175 )     7,670       (18,120 )
Less: Net loss attributable to Black Rock OpCo prior to the Transactions   —       (14,432 )     —       (16,377 )
Less: Net income (loss) attributable to noncontrolling interest   1,118       (1,031 )     4,539       (1,031 )
Net income (loss) attributable to Black Rock Coffee Bar, Inc. $ 1,535     $ (712 )   $ 3,131     $ (712 )
Net income (loss) per share of Class A common stock: (1)              
Basic $ 0.07     $ (0.05 )   $ 0.15     $ (0.05 )
Diluted $ 0.05     $ (0.05 )   $ 0.15     $ (0.05 )
Weighted-average shares of Class A common stock outstanding              
Basic   22,506,549       14,808,173       20,446,604       14,808,173  
Diluted   50,108,015       14,808,173       20,454,941       14,808,173  
               

(1) Basic and diluted net loss per share of Class A common stock is applicable only for the period subsequent to September 12, 2025, which is the period effective with and following the IPO and transactions related thereto.
   

BLACK ROCK COFFEE BAR, INC.

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands, except share data)

         

  September 30, 2026   December 31, 2025
ASSETS      
Current assets:      
Cash and cash equivalents $ 13,618   $ 28,406  
Receivables, net   5,708     3,450  
Inventories   3,618     2,898  
Prepaid expenses and deposits   4,671     5,363  
Total current assets   27,615     40,117  
Property and equipment, net   142,389     101,207  
Operating lease right-of-use assets, net   162,398     126,903  
Other assets   447     277  
Goodwill   9,360     9,360  
Deferred income tax asset   83,667     52,764  
Intangible assets, net   4,450     5,808  
Total assets $ 430,326   $ 336,436  
       
LIABILITIES AND SHAREHOLDERS’ EQUITY      
Current liabilities:      
Accounts payable   11,165     12,126  
Accrued expenses   10,315     7,986  
Accrued payroll and benefits   7,291     6,549  
Gift card and loyalty program liability   2,050     2,126  
Current portion of long-term debt   1,396     835  
Current portion of operating lease liabilities   10,919     8,960  
Total current liabilities   43,136     38,582  
Tax receivable agreement liability   64,577     38,893  
Long-term debt, net of current portion   36,694     25,917  
Operating lease liabilities, net of current portion   164,723     128,338  
Total liabilities   309,130     231,730  
Commitments and Contingencies      
Preferred stock, par value $0.00001 per share; 20,000,000 shares authorized, no shares issued or outstanding as of September 30, 2026 or December 31, 2025, respectively   —     —  
Class A common stock, par value $0.00001 per share; 500,000,000 shares authorized, 22,994,301 and 17,478,452 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively   —     —  
Class B common stock, par value $0.00001 per share, 200,000,000 shares authorized, 22,269,956 and 10,916,155 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively   —     —  
Class C common stock, par value $0.00001 per share, 50,000,000 shares authorized, 4,884,984 and 21,661,200 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively   —     —  
Additional paid-in capital   62,898     45,735  
Retained earnings (Accumulated deficit)   3,071     (60 )
Total shareholders’ equity attributable to Black Rock Coffee Bar, Inc.   65,969     45,675  
Noncontrolling interest   55,227     59,031  
Total shareholders’ equity   121,196     104,706  
Total liabilities and shareholders’ equity $ 430,326   $ 336,436  
       
       

BLACK ROCK COFFEE BAR, INC.

Summary Cash Flow Data

(in thousands; unaudited)

         

    Nine Months Ended
September 30,
  Change
Summary of Cash Flows     2026       2025     $   %
Net cash provided by (used in) operating activities   $ 29,119     $ (2,914 )   $ 32,033     1,099.3 %
Net cash used in investing activities     (52,968 )     (23,184 )     (29,784 )   128.5 %
Net cash provided by financing activities     9,061       48,517       (39,456 )   (81.3)%
Net increase (decrease) in cash and cash equivalents   $ (14,788 )   $ 22,419     $ (37,207 )   (166.0)%
                 

Key Performance Measures

($ in thousands; unaudited)

         

  Three Months Ended
September 30,
      Nine Months Ended
September 30,
   
    2026       2025     Change     2026       2025     Change
Total Stores (End of Period)   211       169       42       211       169       42  
Net New Store Openings   11       11       0       30       20       10  
Same Store Sales Growth(1)   5.8 %     10.8 %   (5.0)%     5.1 %     10.3 %   (5.2)%
Average Unit Volume $ 1,296     $ 1,260     $ 36     $ 1,296     $ 1,260     $ 36  
Store revenue $ 66,684     $ 51,410     $ 15,274     $ 185,001     $ 146,520     $ 38,481  
Income (loss) from operations(2) $ 2,799     $ (6,407 )   $ 9,206     $ 9,577     $ (889 )   $ 10,466  
Income (loss) from operations margin(2)   4.2 %   (12.4)%     16.6 %     5.2 %   (0.6)%     5.8 %
Store-Level Profit(3) $ 19,256     $ 15,226     $ 4,030     $ 54,670     $ 42,767     $ 11,903  
Store-Level Profit Margin(3)   28.9 %     29.6 %   (0.7) %     29.6 %     29.2 %     0.4 %
Net income (loss)(2) $ 2,653     $ (16,175 )   $ 18,828     $ 7,670     $ (18,120 )   $ 25,790  
Net income (loss) margin(2)   4.0 %   (31.4)%     35.4 %     4.1 %   (12.4)%     16.5 %
Adjusted EBITDA(3) $ 8,451     $ 6,922     $ 1,529     $ 25,307     $ 20,985     $ 4,322  
Adjusted EBITDA Margin(3)   12.7 %     13.4 %   (0.7)%     13.7 %     14.3 %   (0.6)%
Total store operating weeks(4)   2,687       2,108       579       7,554       6,067       1,487  
                       

(1) Same Store Sales Growth reflects the change in year-over-year sales for the comparable store base, which we define as stores open for 18 months or longer.
(2) The Company does not consider income (loss) from operations, income (loss) from operations margin, net income (loss) or net income (loss) margin to be key performance measures but has included such metrics in this table to provide the most directly comparable GAAP metric to Store-Level Profit, Store-Level Profit Margin, Adjusted EBITDA and Adjusted EBITDA Margin.
(3) See “Non-GAAP Financial Measures” for a discussion of Store-Level Profit, Store-Level Profit Margin, Adjusted EBITDA and Adjusted EBITDA margin and a reconciliation of each measure to its most directly comparable GAAP measure.
(4) Total store operating weeks are calculated based on the number of operating days for the store base and dividing by 7. Our store base is defined as stores open as of the period end date. Management uses this metric as an indicator of our overall financial health, growth and future expansion prospects.
   

Supplemental Reconciliation of U.S. GAAP Actuals to Non-GAAP Actuals

Following are the reconciliations of the most comparable GAAP financial measures to non-GAAP financial measures. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP, and reconciliations from U.S. GAAP to Non-GAAP measures should be carefully evaluated. Please refer to “Non-GAAP Financial Measures” in this press release for a detailed explanation of the adjustments made to the comparable U.S. GAAP measures, the ways management uses the non-GAAP measures, and the reasons why management believes the non-GAAP measures provide useful information for investors.

  Three Months Ended
September 30,
($ in thousands; unaudited)   2026       2025  
Net income (loss) $ 2,653     $ (16,175 )
Non-GAAP Adjustments:      
Interest expense, net   685       2,871  
Income tax expense (benefit)   (670 )     31  
Depreciation and amortization   4,259       3,030  
Transaction costs(1)   —       9,056  
Capital restructuring costs(2)   —       6,866  
Equity-based compensation   1,254       868  
TRA remeasurements   131       —  
Certain litigation defense costs, net(3)   139       273  
Other costs(4)   —       102  
Adjusted EBITDA $ 8,451     $ 6,922  
Net income (loss) margin   4.0 %   (31.4)%
Adjusted EBITDA Margin   12.7 %     13.4 %
       

(1) Includes non-recurring professional service fees and executive compensation related to our IPO.
(2) For the three months ended September 30, 2025, includes the forgiveness of our related party note receivable (refer to Note 12 in the unaudited condensed consolidated financial statements included in the Form 10-Q for the quarterly period ended September 30, 2026) along with a debt extinguishment charge related to the payoff of our Prior Credit Facility.
(3) For the three months ended September 30, 2026, includes litigation expense relating to the defense of our securities class action lawsuit and other legal costs associated with certain litigation matters that we do not consider indicative of our ongoing operating performance. For the three months ended September 30, 2025, includes legal costs associated with certain litigation matters that we do not consider indicative of our ongoing operating performance.
(4) Non-recurring professional service costs.
   

  Nine Months Ended September 30,
($ in thousands; unaudited)   2026       2025  
Net income (loss) $ 7,670     $ (18,120 )
Non-GAAP Adjustments:      
Interest expense, net   1,632       9,028  
Income tax expense (benefit)   (466 )     253  
Depreciation and amortization   11,644       8,856  
Transaction costs(1)   —       11,641  
Capital restructuring costs(2)   —       7,937  
Equity-based compensation   3,581       868  
TRA remeasurements   739       —  
Certain litigation defense costs, net(3)   371       235  
Other costs(4)   136       287  
Adjusted EBITDA $ 25,307     $ 20,985  
Net income (loss) margin   4.1 %   (12.4)%
Adjusted EBITDA Margin   13.7 %     14.3 %
       

(1) Includes non-recurring professional service fees and executive compensation related to our IPO.
(2) For the nine months ended September 30, 2025, includes the forgiveness of our related party note receivable (refer to Note 12 in the unaudited condensed consolidated financial statements included in the Form 10-Q for the quarterly period ended September 30, 2026) along with a debt extinguishment charge related to the payoff of our Prior Credit Facility and fees incurred in connection with the redemption of our Series A.
(3) For the nine months ended September 30, 2026, includes litigation expense relating to the defense of our securities class action lawsuit and other legal costs associated with certain litigation matters that we do not consider indicative of our ongoing operating performance. For the nine months ended September 30, 2025, includes legal costs associated with certain litigation matters that we do not consider indicative of our ongoing operating performance, offset by insurance proceeds.
(4) Non-recurring professional service costs.
   

 

  Three Months Ended September 30,
($ in thousands; unaudited)   2026       2025  
Income (loss) from operations $ 2,799     $ (6,407 )
Other   (71 )     (58 )
Selling, general and administrative expenses   10,340       17,158  
Depreciation and amortization   4,259       3,030  
Pre-opening costs   1,929       1,503  
Store-Level Profit $ 19,256     $ 15,226  
Income (loss) from operations margin   4.2 %   (12.4)%
Store-Level Profit Margin   28.9 %     29.6 %
       

  Nine Months Ended September 30,
($ in thousands; unaudited)   2026       2025  
Income (loss) from operations $ 9,577     $ (889 )
Other   (207 )     (162 )
Selling, general and administrative expenses   29,387       31,898  
Depreciation and amortization   11,644       8,856  
Pre-opening costs   4,269       3,064  
Store-Level Profit $ 54,670     $ 42,767  
Income (loss) from operations margin   5.2 %   (0.6)%
Store-Level Profit Margin   29.6 %     29.2 %
       

  Three Months Ended September 30,
($ in thousands; unaudited)   2026       2025  
Selling, general and administrative expenses $ 10,340     $ 17,158  
Non-GAAP Adjustments:      
Transaction costs(1)   —       (9,056 )
Equity-based compensation   (1,254 )     (868 )
Certain litigation defense costs, net(2)   (139 )     (273 )
Other costs(3)   —       (102 )
Adjusted Selling, General, and Administrative Expenses $ 8,947     $ 6,859  
Selling, general and administrative expenses margin   15.5 %     33.3 %
Adjusted Selling, General, and Administrative Expenses Margin   13.4 %     13.3 %
       

(1) Includes non-recurring professional service fees and executive compensation related to our IPO.
(2) For the three months ended September 30, 2026, includes litigation expense relating to the defense of our securities class action lawsuit and other legal costs associated with certain litigation matters that we do not consider indicative of our ongoing operating performance. For the three months ended September 30, 2025, includes legal costs associated with certain litigation matters that we do not consider indicative of our ongoing operating performance.
(3) Non-recurring professional service costs.
   

  Nine Months Ended September 30,
($ in thousands; unaudited)   2026       2025  
Selling, general and administrative expenses $ 29,387     $ 31,898  
Non-GAAP Adjustments:      
Transaction costs(1)   —       (11,641 )
Equity-based compensation   (3,581 )     (868 )
Certain litigation defense costs, net(2)   (371 )     (235 )
Other costs(3)   (136 )     (287 )
Adjusted Selling, General, and Administrative Expenses $ 25,299     $ 18,867  
Selling, general and administrative expenses margin   15.9 %     21.7 %
Adjusted Selling, General, and Administrative Expenses Margin   13.7 %     12.9 %
       

(1) Includes non-recurring professional service fees and executive compensation related to our IPO.
(2) For the nine months ended September 30, 2026, includes litigation expense relating to the defense of our securities class action lawsuit and other legal costs associated with certain litigation matters that we do not consider indicative of our ongoing operating performance. For the nine months ended September 30, 2025, includes legal costs associated with certain litigation matters that we do not consider indicative of our ongoing operating performance, offset by insurance proceeds.
(3) Non-recurring professional service costs.
   

Investor Contact:
Will MacIntosh
[email protected]
(541) 208-1860



QumulusAI Reports Third Quarter 2026 Results

QumulusAI Reports Third Quarter 2026 Results

Quarterly revenue reaches $14.8 million, doubling sequentially for the second straight quarter; cumulative signed customer contract value surpasses $500 million.

ATLANTA–(BUSINESS WIRE)–
QumulusAI (Nasdaq: QMLS), a neocloud infrastructure provider purpose-built for the AI computing era, today reported financial results for the third quarter ended September 30, 2026.

“Revenue doubled again this quarter, and remaining performance obligations grew to $515.0 million from $173.1 million at the end of the second quarter. That’s the model doing its job: we sell the capacity before we energize it, we deploy into pockets of existing power, and we bring it online in months, not years,” said Michael Maniscalco, CEO of QumulusAI. “And the third quarter is still early in that ramp. We had compute coming online throughout the quarter, and into the fourth, so much of it hasn’t yet billed for a full period.”

Third Quarter 2026 Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended September 30, 2025.

  • Revenue of $14.8 million, an increase of $11.7 million, or 376%, from $3.1 million. Compute power revenue grew to $14.1 million, or approximately 96% of total revenue, from $1.4 million, or approximately 47% of total revenue.

  • Operating loss of $41.6 million, compared to $2.8 million. The increase reflects a $13.4 million increase in depreciation and amortization tied to expanded HPC (High-Performance Computing) infrastructure, as well as higher general and administrative costs associated with public company readiness, including $26.4 million related to shares of common stock issued for professional services in connection with the company’s direct listing, and headcount growth.

  • Net loss of $14.4 million, compared to a net loss of $9.5 million. The current period includes $32.3 million of non-cash gains from changes in the fair value of the convertible note, the related option and the warrant liability; the prior-year period included a $4.8 million non-cash loss from the change in fair value of the warrant liability.

  • Adjusted EBITDA of $3.7 million, our first positive quarter, compared to a loss of $0.6 million, driven by growth in compute revenue.

Recent Corporate Developments

  • Active capacity has reached 8 MW.

  • Cumulative signed customer contract value surpassed $500 million, reaching $528.7 million.

  • Signed $240.9 million in new three-year take-or-pay agreements, covering more than 2,000 NVIDIA Blackwell B300 GPUs across two dedicated clusters.

  • Put the $71.9 million, three-year Blackwell agreement fully into production, with every GPU under the agreement billing within three months of signing.

  • Contracted 1.2 MW in Denver, ready for service in Q1.

  • Contracted 0.5 MW in Columbia, South Carolina, ready for service in December 2026.

Business Outlook

QumulusAI will provide forward-looking guidance in connection with this quarterly earnings announcement on its earnings conference call and webcast.

Webcast and Conference Call

QumulusAI will host a conference call and webcast today at 5:00 p.m. Eastern Time to discuss third quarter 2026 results. The live webcast, together with this release and supplemental materials, is available at investors.qumulusai.com. A replay will be available on the same site following the call.

Non-GAAP Financial Measures

To supplement its condensed consolidated financial statements, which are prepared and presented in accordance with generally accepted accounting principles in the United States (“GAAP”), the company presents Adjusted EBITDA, a non-GAAP financial measure. QumulusAI’s reasons for use of this measure and reconciliation of this non-GAAP financial measure to the most directly comparable GAAP measure and other information are included at the end of this release. Adjusted EBITDA has limitations as an analytical tool and should not be considered in isolation or as a substitute for net income (loss) or any other measure prepared in accordance with GAAP.

About QumulusAI

QumulusAI is a distributed AI cloud platform that delivers accelerated access to high-performance GPU compute. Through an inference-first, demand-led deployment model across a network of data center sites, QumulusAI brings compute closer to customer demand, helping AI teams and enterprises scale production AI workloads with speed, flexibility and control. By combining rapid deployment with flexible private cloud infrastructure, QumulusAI gives customers a faster, more adaptable path beyond the capacity constraints of traditional centralized and hyperscale cloud models. Learn more at QumulusAI.com.

Follow us on LinkedIn and X @QumulusAI.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the value and term of the company’s signed customer contracts and the revenue the company expects to realize from them; the company’s continued ability to deploy, sell, and bring online capacity on its anticipated timeline, the revenue the company expects to recognize in future periods from compute capacity brought online during and after the third quarter; and the expected timing on which contracted capacity will be ready for service including any related contingencies. Words such as “anticipate,” “believe,” “estimate,” “expect,” “guidance,” “intend,” “can,” “may,” “on track,” “plan,” “project,” “target,” “will” and similar expressions are intended to identify forward-looking statements. These statements are based on management’s current expectations and assumptions as of the date of this release and are subject to risks and uncertainties that could cause actual results to differ materially, including, among others, the company’s dependence on a limited number of large customers; the availability and cost of power, network connectivity and specialized hardware such as graphics processing units; the company’s substantial capital requirements and access to financing; competition and rapid technological change in the high-performance computing and AI markets; the company’s limited operating history and history of net losses; and those described in the “Risk Factors” section of the company’s registration statement on Form S-1, as amended (File No. 333-292514), filed with the U.S. Securities and Exchange Commission (SEC), and the company’s quarterly report on Form 10-Q for the quarter ended September 30, 2026, as such factors may be updated in the company’s subsequent filings with the SEC. QumulusAI undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by applicable law.

 

 

QUMULUSAI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

September 30, 2026

 

December 31, 2025

 

(unaudited)

 

 

ASSETS

 

 

 

Current assets:

 

 

 

Cash

$

21,909,713

 

 

$

11,712,493

 

Restricted cash

 

9,225,679

 

 

 

—

 

Accounts receivable, net of allowance for credit losses of $321,047 and $2,263 as of September 30, 2026 and December 31, 2025, respectively

 

30,647,719

 

 

 

57,889

 

Deposits on power equipment – current

 

2,137,972

 

 

 

7,238,383

 

Prepaid expenses and other current assets

 

4,288,244

 

 

 

1,134,851

 

Total current assets

 

68,209,327

 

 

 

20,143,616

 

Property and equipment, net

 

138,629,171

 

 

 

12,502,886

 

Operating right-of-use assets, net

 

1,345,047

 

 

 

1,438,970

 

Finance right-of-use assets, net

 

133,044,741

 

 

 

6,996,077

 

Equity method investments

 

—

 

 

 

4,227,130

 

Investment in equity securities

 

1,082,500

 

 

 

—

 

Deposits on power equipment

 

4,285,885

 

 

 

6,384,258

 

Goodwill

 

31,416,827

 

 

 

31,416,827

 

Intangible assets, net

 

7,224,902

 

 

 

7,268,513

 

Other assets

 

8,823,952

 

 

 

1,356,216

 

Total assets

$

394,062,352

 

 

$

91,734,493

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

7,843,065

 

 

$

1,248,175

 

Dividend payable

 

359,188

 

 

 

359,188

 

Accrued expenses and other current liabilities

 

7,299,193

 

 

 

2,833,337

 

Deferred revenue – current portion

 

33,174,971

 

 

 

—

 

Current portion of notes payable

 

14,862,667

 

 

 

1,684,554

 

Current portion of notes payable – related party

 

2,000,000

 

 

 

3,848,915

 

Current portion of USD.AI protocol loans

 

12,214,906

 

 

 

—

 

Operating lease liabilities – current portion

 

109,557

 

 

 

97,463

 

Finance lease liabilities – current portion

 

39,136,857

 

 

 

1,645,069

 

Deferred tax liability

 

274,554

 

 

 

423,381

 

Total current liabilities

 

117,274,958

 

 

 

12,140,082

 

Long-term notes payable, net of current portion

 

44,245,099

 

 

 

6,241,948

 

Operating lease liabilities, net of current portion

 

1,430,559

 

 

 

1,497,549

 

Finance lease liabilities, net of current portion

 

83,353,330

 

 

 

5,179,828

 

Warrant liability

 

828,232

 

 

 

1,382,955

 

Deferred revenue, net of current portion

 

45,822,451

 

 

 

—

 

Additional convertible notes option liability

 

22,183,450

 

 

 

—

 

USD.AI protocol loans, net of current portion

 

20,319,360

 

 

 

—

 

Convertible note payable

 

32,040,000

 

 

 

—

 

Other non-current liabilities

 

1,313,364

 

 

 

—

 

Total long-term liabilities

 

251,535,845

 

 

 

14,302,280

 

Total liabilities

 

368,810,803

 

 

 

26,442,362

 

 

 

 

 

Shareholders’ Equity

 

 

 

Preferred stock – no par value; 100,000,000 and zero shares authorized as of September 30, 2026 and December 31, 2025, respectively; zero shares issued and outstanding as of September 30, 2026 and December 31, 2025

 

—

 

 

 

—

 

Common stock – no par value; 1,000,000,000 and 500,000,000 shares authorized as of September 30, 2026 and December 31, 2025, respectively; 34,699,038 and 31,367,559 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively

 

135,611,986

 

 

 

93,400,180

 

Additional paid-in capital

 

11,307,803

 

 

 

6,318,290

 

Accumulated deficit

 

(124,247,844

)

 

 

(37,546,254

)

Total shareholders’ equity attributable to QumulusAI shareholders

 

22,671,945

 

 

 

62,172,216

 

Non-controlling interests

 

2,579,604

 

 

 

3,119,915

 

Total shareholders’ equity

 

25,251,549

 

 

 

65,292,131

 

Total liabilities and shareholders’ equity

$

394,062,352

 

 

$

91,734,493

 

 

QUMULUSAI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2026

 

 

 

2025

 

 

 

2026

 

 

 

2025

 

Revenue

 

 

 

 

 

 

 

Revenue from cryptocurrency mining

$

262,995

 

 

$

211,765

 

 

$

1,042,055

 

 

$

507,604

 

Revenue from mining hosting services

 

365,854

 

 

 

1,445,669

 

 

 

2,008,059

 

 

 

4,794,821

 

Revenue from compute power

 

14,126,265

 

 

 

1,443,351

 

 

 

21,837,723

 

 

 

2,755,051

 

Total revenue

 

14,755,114

 

 

 

3,100,785

 

 

 

24,887,837

 

 

 

8,057,476

 

 

 

 

 

 

 

 

 

Costs and expenses

 

 

 

 

 

 

 

Cost of revenue (exclusive of depreciation and amortization)

 

4,161,145

 

 

 

1,643,980

 

 

 

8,539,344

 

 

 

4,245,448

 

General and administrative expenses

 

35,671,537

 

 

 

2,638,965

 

 

 

43,921,812

 

 

 

6,081,954

 

Sales and marketing expenses

 

1,605,602

 

 

 

147,471

 

 

 

2,758,174

 

 

 

238,055

 

Depreciation and amortization expense

 

14,872,738

 

 

 

1,425,735

 

 

 

24,421,737

 

 

 

3,358,079

 

Total costs and expenses

 

56,311,022

 

 

 

5,856,151

 

 

 

79,641,067

 

 

 

13,923,536

 

 

 

 

 

 

 

 

 

Operating loss

 

(41,555,908

)

 

 

(2,755,366

)

 

 

(54,753,230

)

 

 

(5,866,060

)

 

 

 

 

 

 

 

 

Other income (expenses)

 

 

 

 

 

 

 

Income from equity method investments

 

—

 

 

 

179,617

 

 

 

21,994

 

 

 

1,043,937

 

Gain on sale of equity method investments

 

162,785

 

 

 

—

 

 

 

12,732,446

 

 

 

—

 

Gain on remeasurement of investment in TCM

 

—

 

 

 

—

 

 

 

—

 

 

 

14,549,536

 

Change in fair value of warrant liability

 

2,140,561

 

 

 

(4,844,713

)

 

 

554,723

 

 

 

(5,536,816

)

Change in fair value of digital assets

 

—

 

 

 

43,935

 

 

 

—

 

 

 

81,919

 

Change in fair value of convertible note

 

13,650,058

 

 

 

—

 

 

 

16,030,058

 

 

 

—

 

Change in fair value of additional convertible notes option

 

16,537,550

 

 

 

—

 

 

 

20,388,400

 

 

 

—

 

Gain on sale or disposal of property and equipment

 

—

 

 

 

462

 

 

 

36,298

 

 

 

462

 

Loss on settlement of lease liability

 

—

 

 

 

(692,837

)

 

 

—

 

 

 

(692,837

)

Loss on issuance of convertible note

 

—

 

 

 

—

 

 

 

(73,881,850

)

 

 

—

 

Loss on extinguishment of debt

 

—

 

 

 

(883,667

)

 

 

—

 

 

 

(1,037,501

)

Other income (expense), net

 

27,704

 

 

 

(2,183

)

 

 

(160,046

)

 

 

24,771

 

Interest expense, net

 

(5,369,084

)

 

 

(509,866

)

 

 

(7,953,108

)

 

 

(1,450,812

)

Total other income (expenses), net

 

27,149,574

 

 

 

(6,709,252

)

 

 

(32,231,085

)

 

 

6,982,659

 

 

 

 

 

 

 

 

 

Income (loss) before income tax expense

 

(14,406,334

)

 

 

(9,464,618

)

 

 

(86,984,315

)

 

 

1,116,599

 

 

 

 

 

 

 

 

 

Income tax expense (benefit)

 

36,237

 

 

 

(349

)

 

 

(148,827

)

 

 

284,771

 

 

 

 

 

 

 

 

 

Net income (loss)

$

(14,442,571

)

 

$

(9,464,269

)

 

$

(86,835,488

)

 

$

831,828

 

 

 

 

 

 

 

 

 

Less: deemed dividend on conversion of preferred stock

 

—

 

 

 

89,386,947

 

 

 

—

 

 

 

89,386,947

 

 

 

 

 

 

 

 

 

Less: net income (loss) in non-controlling interests

 

16,813

 

 

 

—

 

 

 

(133,898

)

 

 

—

 

 

 

 

 

 

 

 

 

Net loss attributable to common shareholders

$

(14,459,384

)

 

$

(98,851,216

)

 

$

(86,701,590

)

 

$

(88,555,119

)

 

 

 

 

 

 

 

 

Net loss per share attributable to common shareholders, basic and diluted

$

(0.43

)

 

$

(5.34

)

 

$

(2.68

)

 

$

(5.36

)

 

 

 

 

 

 

 

 

Weighted-average common stock outstanding, basic and diluted

 

33,516,738

 

 

 

18,503,757

 

 

 

32,299,039

 

 

 

16,512,498

 

 

QUMULUSAI, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

 

Nine Months Ended September 30,

 

 

2026

 

 

 

2025

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

Net income (loss)

$

(86,835,488

)

 

$

831,828

 

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

Depreciation and amortization expense

 

10,585,870

 

 

 

2,554,911

 

Amortization of right-of-use assets

 

13,929,789

 

 

 

882,733

 

Amortization of loan origination costs

 

186,740

 

 

 

23,513

 

Amortization of discount on convertible note

 

—

 

 

 

135,334

 

Provision for credit losses

 

318,784

 

 

 

—

 

Amortization of premium on loan receivable

 

—

 

 

 

(16,281

)

Non-cash interest expense

 

—

 

 

 

6,418

 

Recovery of credit losses

 

—

 

 

 

(36,921

)

Interest expense under finance lease obligations

 

5,149,195

 

 

 

268,356

 

Income from equity method investments

 

(21,994

)

 

 

(1,043,937

)

Gain on sale of equity method investments

 

(12,732,446

)

 

 

—

 

Gain on remeasurement of investment in TCM

 

—

 

 

 

(14,549,536

)

Change in fair value of warrant liability

 

(554,723

)

 

 

5,536,816

 

Change in fair value of digital assets

 

—

 

 

 

(81,919

)

Change in fair value of convertible note

 

(16,030,058

)

 

 

—

 

Change in fair value of additional convertible notes option

 

(20,388,400

)

 

 

—

 

Change in deferred taxes

 

(148,827

)

 

 

284,771

 

Stock-based compensation

 

4,170,708

 

 

 

799,823

 

Issuance of common stock for services

 

26,412,529

 

 

 

—

 

Issuance of warrants for services

 

626,293

 

 

 

69,663

 

Issuance of warrants as consideration payable to customer

 

192,512

 

 

 

—

 

Noncash revenue recognized from receipt of equity securities

 

(82,500

)

 

 

—

 

Gain on sale or disposal of property and equipment

 

(36,298

)

 

 

(462

)

Loss on issuance of convertible note

 

73,881,850

 

 

 

—

 

Loss on extinguishment of debt

 

—

 

 

 

1,037,501

 

Loss on settlement of lease liability

 

—

 

 

 

692,837

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

 

(30,908,614

)

 

 

8,764

 

Due from related party

 

—

 

 

 

82,213

 

Prepaid expenses and other current assets

 

(3,198,434

)

 

 

(207,498

)

Other assets

 

(1,467,885

)

 

 

—

 

Proceeds from sale of digital assets

 

102,746

 

 

 

3,045,949

 

Mining of digital assets

 

(102,746

)

 

 

(2,876,300

)

Accounts payable

 

6,594,890

 

 

 

508,549

 

Accrued expenses

 

4,465,856

 

 

 

114,685

 

Deferred revenue

 

78,997,422

 

 

 

—

 

Operating lease liabilities

 

(54,896

)

 

 

(43,940

)

Intangible assets

 

(89,112

)

 

 

(7,200

)

Due to related party

 

—

 

 

 

(547,484

)

Other non-current liabilities

 

1,313,364

 

 

 

—

 

Net cash provided by (used in) operating activities

 

54,276,127

 

 

 

(2,526,814

)

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

Purchase of property and equipment

 

(137,021,298

)

 

 

(1,226,323

)

Proceeds from sale of property and equipment

 

478,164

 

 

 

—

 

Proceeds from disposal of property and equipment

 

—

 

 

 

4,000

 

Proceeds from collections of loans receivable

 

—

 

 

 

285,654

 

Deposits on power equipment

 

5,274,478

 

 

 

(1,866,454

)

Data center set up costs

 

(5,999,851

)

 

 

—

 

Purchase of equity securities

 

(1,000,000

)

 

 

—

 

Proceeds from sale of U.S. dollar coin

 

—

 

 

 

391,584

 

Proceeds from sale of digital asset reserve

 

—

 

 

 

393,460

 

Cash acquired as part of business acquisition

 

—

 

 

 

2,441,275

 

Dividends paid on common stock

 

—

 

 

 

(36,759

)

Proceeds from sale of equity method investments

 

16,722,407

 

 

 

—

 

Distributions from equity method investments

 

259,163

 

 

 

2,422,000

 

Distributions to joint venture partners

 

(406,413

)

 

 

—

 

Net cash (used in) provided by investing activities

 

(121,693,350

)

 

 

2,808,437

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

Proceeds from sale of common stock, net of issuance costs

 

5,980,834

 

 

 

21,355,080

 

Redemption of preferred stock

 

—

 

 

 

(293,742

)

Repayments on finance lease obligations

 

(27,399,088

)

 

 

(1,289,600

)

Proceeds from convertible note payable

 

28,800,000

 

 

 

—

 

Proceeds from notes payable, net of issuance costs

 

51,378,460

 

 

 

—

 

Proceeds from notes payable – related party

 

—

 

 

 

7,170

 

Proceeds from exercise of warrants

 

27,501

 

 

 

72,659

 

Proceeds from exercise of options

 

—

 

 

 

112,600

 

Proceeds from line of credit, net of issuance costs

 

34,996,018

 

 

 

—

 

Repayments of line of credit

 

(2,570,755

)

 

 

(299,077

)

Repayments of notes payable

 

(2,522,960

)

 

 

(579,999

)

Repayments of notes payable – related party

 

(1,849,888

)

 

 

(722,838

)

Repayments of convertible note payable – related party

 

—

 

 

 

(3,226,548

)

Repayments of convertible notes payable

 

—

 

 

 

(1,150,000

)

Net cash provided by financing activities

 

86,840,122

 

 

 

13,985,705

 

 

 

 

 

NET CHANGE IN CASH AND RESTRICTED CASH

 

19,422,899

 

 

 

14,267,328

 

 

 

 

 

CASH AND RESTRICTED CASH, beginning of period

 

11,712,493

 

 

 

3,970,466

 

 

 

 

 

CASH AND RESTRICTED CASH, end of period

$

31,135,392

 

 

$

18,237,794

 

 

 

 

 

SUPPLEMENTAL CASH FLOW INFORMATION

 

 

 

Cash paid for income taxes

$

—

 

 

$

—

 

Cash paid for interest

$

6,714,464

 

 

$

907,788

 

 

 

 

 

Non-cash financing and investing activities

 

 

 

Issuance of warrants for property and equipment

$

—

 

 

$

104,854

 

Issuance of warrants as offering costs

$

—

 

 

$

135,482

 

Non-cash contribution to equity method investment

$

—

 

 

$

115,210

 

Issuance of common stock for settlement of lease liability

$

—

 

 

$

1,444,300

 

Conversion of preferred stock to common stock

$

—

 

 

$

36,896,276

 

Issuance of Common Stock and Series D Preferred Stock for the acquisition of TCM

$

—

 

 

$

20,250,013

 

Exchange of TCM stock options resulting in issuance of stock options in acquisition

$

—

 

 

$

1,883,956

 

Issuance of preferred stock upon partial conversion of convertible note

$

—

 

 

$

1,711,837

 

Transfer of leased assets to property and equipment upon lease buyout

$

—

 

 

$

1,340,882

 

Issuance of common stock for conversion of convertible notes

$

9,790,942

 

 

$

—

 

Acquisition of right-of-use asset in exchange for lease obligations

$

139,884,530

 

 

$

6,528,526

 

Lease liabilities arising from obtaining right-of-use assets

$

137,915,183

 

 

$

6,787,230

 

Reconciliation of Net Income (Loss) to Adjusted EBITDA (Unaudited)

The accompanying press release refers to Adjusted EBITDA, a non-GAAP financial measure not calculated or presented in accordance with GAAP. This non-GAAP financial measure is supplemental information and in addition to the financial measures presented in the accompanying release that are calculated and presented in accordance with GAAP.

EBITDA is defined as net income (loss) before interest expense, net; income tax expense (benefit); and depreciation and amortization. Adjusted EBITDA is defined as EBITDA further adjusted to exclude stock-based compensation expense, common stock issued for professional services in connection with the direct listing, and gains and losses arising from the issuance, remeasurement, extinguishment or disposition of financial instruments, investments and other assets, and the settlement of lease liabilities. Net income (loss) margin is calculated as net income (loss) divided by revenue, and Adjusted EBITDA margin is calculated as Adjusted EBITDA divided by revenue.

Management uses Adjusted EBITDA to evaluate operating performance, establish budgets and forecasts and make operational decisions. The company believes the measure is useful to investors because it excludes items that management does not consider indicative of the underlying operating performance of the business, and because it facilitates comparison of results across periods.

Adjusted EBITDA has limitations as an analytical tool and should not be considered in isolation or as a substitute for net income (loss) or any other measure prepared in accordance with GAAP. Among other limitations, Adjusted EBITDA excludes depreciation and amortization of assets that are central to the company’s ability to generate revenue, and excludes interest expense and amortization associated with the company’s finance lease obligations, under which the company expects to make payments of approximately $13.0 million during the remainder of 2026 and approximately $53.3 million during 2027. Adjusted EBITDA as defined by the company may not be comparable to similarly titled measures reported by other companies.

 

For the Three Months Ended

September 30,

 

For the Nine Months Ended

September 30,

 

 

2026

 

 

 

2025

 

 

 

2026

 

 

 

2025

 

Net income (loss)

$

(14,442,571

)

 

$

(9,464,269

)

 

$

(86,835,488

)

 

$

831,828

 

 

 

 

 

 

 

 

 

Depreciation and amortization (inclusive of ROU amortization)

 

14,872,738

 

 

 

1,425,735

 

 

 

24,421,737

 

 

 

3,358,079

 

Interest expense, net

 

5,369,084

 

 

 

509,866

 

 

 

7,953,108

 

 

 

1,450,812

 

Income tax expense (benefit)

 

36,237

 

 

 

(349

)

 

 

(148,827

)

 

 

284,771

 

Stock-based compensation

 

3,928,899

 

 

 

549,271

 

 

 

4,170,708

 

 

 

799,823

 

Common stock issued for professional services in connection with the direct listing

 

26,412,529

 

 

 

—

 

 

 

26,412,529

 

 

 

—

 

Change in fair value of warrant liability

 

(2,140,561

)

 

 

4,844,713

 

 

 

(554,723

)

 

 

5,536,816

 

Change in fair value of digital assets

 

—

 

 

 

(43,935

)

 

 

—

 

 

 

(81,919

)

Change in fair value of convertible note

 

(13,650,058

)

 

 

—

 

 

 

(16,030,058

)

 

 

—

 

Change in fair value of additional convertible notes option

 

(16,537,550

)

 

 

—

 

 

 

(20,388,400

)

 

 

—

 

Loss on settlement of lease liability

 

—

 

 

 

692,837

 

 

 

—

 

 

 

692,837

 

Gain on sale of equity method investments

 

(162,785

)

 

 

—

 

 

 

(12,732,446

)

 

 

—

 

Gain on sale or disposal of property and equipment

 

—

 

 

 

(462

)

 

 

(36,298

)

 

 

(462

)

Loss on issuance of convertible note

 

—

 

 

 

—

 

 

 

73,881,850

 

 

 

—

 

Loss on extinguishment of debt

 

—

 

 

 

883,667

 

 

 

—

 

 

 

1,037,501

 

Gain on remeasurement of investment in TCM

 

—

 

 

 

—

 

 

 

—

 

 

 

(14,549,536

)

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

3,685,962

 

 

$

(602,926

)

 

$

113,692

 

 

$

(639,450

)

 

 

 

 

 

 

 

 

Revenue

$

14,755,114

 

 

$

3,100,785

 

 

$

24,887,837

 

 

$

8,057,476

 

Net income (loss) margin

 

(98

)%

 

 

(305

)%

 

 

(349

)%

 

 

10

%

Adjusted EBITDA margin

 

25

%

 

 

(19

)%

 

 

—

%

 

 

(8

)%

 

Investor Contact

[email protected]

Media Contact

[email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Banking Software Mobile/Wireless Networks Professional Services Internet Hardware Data Management Technology Artificial Intelligence Semiconductor Finance Other Technology

MEDIA:

Logo
Logo

B&G Foods Reports Financial Results for Third Quarter 2026

B&G Foods Reports Financial Results for Third Quarter 2026

—Delivers Growth in Net Sales and Base Business Net Sales—

PARSIPPANY, N.J.–(BUSINESS WIRE)–
B&G Foods, Inc. (NYSE: BGS) today announced financial results for the third quarter and first three quarters of 2026. Financial results for the third quarter and first three quarters of 2026 include the impact of the College Inn and Kitchen Basics acquisition, which was completed on March 19, 2026, the Green Giant U.S. frozen divestiture, which was completed on March 2, 2026, and the co-manufacturing agreement the Company entered into on March 2, 2026 with the acquirer of the Green Giant U.S. frozen business.

Summary

 

 

Third Quarter of 2026

 

First Three Quarters of 2026

(In millions, except per share data)

 

 

Change vs.

 

 

 

Change vs.

 

 

Amount

 

Q3 2025

 

Amount

 

First 3Q 2025

Net Sales

 

$

459.8

 

4.7

%

 

$

1,252.0

 

(2.9)

%

Base Business Net Sales (1)

 

$

404.6

 

5.0

%

 

$

1,116.0

 

1.8

%

Diluted EPS

 

$

(0.40)

 

(66.7)

%

 

$

(0.85)

 

(142.9)

%

Adj. Diluted EPS (1)

 

$

0.21

 

40.0

%

 

$

0.36

 

56.5

%

Net Loss

 

$

(32.5)

 

(69.9)

%

 

$

(69.0)

 

(145.9)

%

Adj. Net Income (1)

 

$

17.8

 

51.3

%

 

$

29.5

 

63.1

%

Adj. EBITDA (1)

 

$

81.8

 

16.2

%

 

$

199.9

 

6.6

%

Guidance for Full Year Fiscal 2026

  • Net sales increased to a range of $1.760 billion to $1.800 billion.

  • Adjusted EBITDA increased to a range of $280.0 million to $290.0 million.

  • Adjusted diluted earnings per share reaffirmed at a range of $0.575 to $0.675.

Commenting on the results, Rob Mills, President and Chief Executive Officer of B&G Foods, stated, “Third quarter and year-to-date results reflect encouraging progress across B&G Foods. We generated base business net sales growth of 5.0% in the third quarter and 1.8% year-to-date, while adjusted EBITDA increased $12.4 million, or 6.6%, year-to-date. We are encouraged by this progress and remain focused on building on it.”

“Since becoming CEO, I have spent considerable time engaging with our teams, reviewing our brands and operations, and identifying opportunities to strengthen performance. I have been impressed by the dedication of our employees, the strength of our brands and the potential across our portfolio. We are establishing a more focused and accountable operating approach, with an emphasis on profitable growth, productivity, faster and better decision-making, and disciplined execution.”

“As we look ahead, our priorities are clear: deliver on our 2026 commitments; build a stronger operating foundation for 2027 and beyond; accelerate productivity and cost savings; improve cash generation; and reduce leverage. We are taking deliberate actions to strengthen B&G Foods, improve financial flexibility and position our company for sustainable long-term performance.”

Financial Results for the Third Quarter of 2026

Net sales for the third quarter of 2026 increased $20.5 million, or 4.7%, to $459.8 million from $439.3 million for the third quarter of 2025. The increase was primarily attributable to an increase in base business net sales, three months of net sales for the College Inn and Kitchen Basics brands and three months of net sales from the co-manufacturing agreement the Company entered into with the acquirer of the Green Giant U.S. frozen business, partially offset by the Green Giant U.S. frozen and Le Sueur U.S. divestitures.

Base business net sales for the third quarter of 2026 increased $19.4 million, or 5.0%, to $404.6 million from $385.2 million for the third quarter of 2025. The increase in base business net sales was driven by an increase in volume of $23.6 million, or 6.1% of base business net sales, partially offset by a decrease in net pricing and the impact of product mix of $3.3 million, or 0.9% of base business net sales, and the negative impact of foreign currency of $0.9 million, or 0.2% of base business net sales.

Net sales for the recently acquired College Inn and Kitchen Basics brands contributed $29.0 million to the Company’s net sales for the third quarter of 2026 and net sales of the Company’s Green Giant U.S. frozen co‑manufacturing agreement contributed $26.3 million of net sales in the third quarter of 2026. These net sales were partially offset by the Green Giant U.S. frozen business and the Le Sueur U.S. business, which contributed net sales during the third quarter of 2025 of $51.8 million and $2.3 million, respectively, which the Company divested in the first quarter of 2026 and in fiscal 2025, respectively, and are therefore not part of the Company’s third quarter of 2026 results.

For the third quarter of 2026, gross profit was $108.9 million, or 23.7% of net sales, and adjusted gross profit(1) was $111.2 million, or 24.2% of net sales. For the third quarter of 2025, gross profit was $99.0 million, or 22.5% of net sales, and adjusted gross profit was $98.8 million, or 22.5% of net sales. Gross profit as a percentage of net sales and adjusted gross profit percentage increased primarily due to the acquisition of the higher margin College Inn and Kitchen Basics brands and the divestiture of the lower margin Green Giant U.S. frozen business. Gross profit and adjusted gross profit also increased in part due to increased base business net sales and lower tariff expense, including the effect of certain tariff refunds received from the U.S. government.

Selling, general and administrative expenses increased $6.7 million, or 14.9%, to $51.3 million for the third quarter of 2026 from $44.6 million for the third quarter of 2025. The increase was composed of increases in acquisition/divestiture‑related and non-recurring expenses of $7.9 million, consumer marketing expenses of $0.6 million and warehousing expenses of $0.3 million, partially offset by decreases in selling expenses of $1.1 million and general and administrative expenses of $1.0 million. Expressed as a percentage of net sales, selling, general and administrative expenses increased by 1.0 percentage point to 11.2% for the third quarter of 2026, as compared to 10.2% for the third quarter of 2025.

During the third quarter of 2026, the Company recorded pre-tax, non-cash impairment charges of $40.7 million related to indefinite-lived intangible trademark assets for the B&M and Joan of Arc brands in connection with the Company’s divestiture of those brands during the fourth quarter of 2026.

During the third quarter of 2025, the Company recorded pre-tax, non-cash impairment charges of $26.0 million related to indefinite-lived intangible trademark assets for the Victoria and McCann’s brands.

During the third quarter of 2026, the Company recorded a gain of approximately $1.8 million related to the Green Giant Canada(2) assets held for sale. The gain resulted from a change in the estimated fair value of the Green Giant Canada assets held for sale less the estimated cost to sell those assets. Assets held for sale are remeasured quarterly.

During the third quarter of 2025, the Company completed the Le Sueur U.S. divestiture and recognized a gain on sale of $15.5 million. During the third quarter of 2025, the Company recorded pre-tax, non-cash impairment charges of $27.8 million related to the Green Giant Canada assets held for sale.

Net interest expense increased $7.5 million, or 20.1%, to $44.8 million for the third quarter of 2026 from $37.3 million for the third quarter of 2025. The increase was primarily attributable to an increase in average long-term debt outstanding compared to the third quarter of 2025, the 11.00% interest rate on the Company’s new senior notes due 2031, and a loss on extinguishment of debt of $1.1 million during the third quarter of 2026 compared to a net gain on extinguishment of debt of $0.5 million during the third quarter of 2025.

The Company had a net loss of $32.5 million, or $0.40 per diluted share, for the third quarter of 2026, compared to a net loss of $19.1 million, or $0.24 per diluted share, for the third quarter of 2025.

The Company’s adjusted net income for the third quarter of 2026 was $17.8 million, or $0.21 per adjusted diluted share, compared to adjusted net income of $11.7 million, or $0.15 per adjusted diluted share, for the third quarter of 2025.

Adjusted EBITDA was $81.8 million for the third quarter of 2026 compared to $70.4 million for the third quarter of 2025. Adjusted EBITDA as a percentage of net sales was 17.8% for the third quarter of 2026, compared to 16.0% for the third quarter of 2025.

The increases in adjusted diluted earnings per share, adjusted EBITDA and adjusted EBITDA as a percentage of net sales were primarily attributable to increased base business net sales, the acquisition of the College Inn and Kitchen Basics brands, the divestiture of the Green Giant U.S. frozen business, the commencement of the Green Giant U.S. frozen co-manufacturing business, and lower tariff expenses, including the effect of certain tariff refunds received from the U.S. government.

Financial Results for the First Three Quarters of 2026

Net sales for the first three quarters of 2026 decreased $37.1 million, or 2.9%, to $1,252.0 million from $1,289.1 million for the first three quarters of 2025. The decrease was primarily attributable to the Green Giant U.S. frozen, Le Sueur U.S. and Don Pepino divestitures, partially offset by seven months of net sales from the co‑manufacturing agreement the Company entered into on March 2, 2026 with the acquirer of the Green Giant U.S. frozen business, six-and-a-half months of net sales for the College Inn and Kitchen Basics brands, and an increase in base business net sales.

As a result of the divestiture of the Green Giant U.S. frozen business on March 2, 2026, net sales from the Green Giant U.S. frozen business were $137.5 million lower during the first three quarters of 2026 than during the first three quarters of 2025. Net sales of the Don Pepino and Le Sueur U.S. businesses, which the Company divested in 2025 and are therefore not part of the Company’s first three quarters of 2026 results, were $22.6 million during the first three quarters of 2025. Partially offsetting the impact of these divestitures were seven months of net sales from the Green Giant U.S. frozen co-manufacturing agreement, which contributed $58.7 million of net sales in the first three quarters of 2026, and six-and-a-half months of net sales for the College Inn and Kitchen Basics brands, acquired on March 19, 2026, which contributed $45.1 million to the Company’s net sales for the first three quarters of 2026.

Base business net sales for the first three quarters of 2026 increased $19.7 million, or 1.8%, to $1,116.0 million from $1,096.3 million for the first three quarters of 2025. The increase in base business net sales was driven by an increase in volume of $15.2 million, or 1.4% of base business net sales, an increase in net pricing and the impact of product mix (primarily related to the Spices & Flavor Solutions business unit) of $3.4 million, or 0.3% of base business net sales, and the positive impact of foreign currency of $1.1 million, or 0.1% of base business net sales.

For the first three quarters of 2026, gross profit was $268.5 million or 21.4% of net sales, and adjusted gross profit was $279.4 million, or 22.3% of net sales. For the first three quarters of 2025, gross profit was $276.1 million, or 21.4% of net sales, and adjusted gross profit was $278.5 million, or 21.6% of net sales. Adjusted gross profit percentage increased due to the acquisition of the higher margin College Inn and Kitchen Basics brands, the divestiture of the lower margin Green Giant U.S. frozen business, and lower tariff expenses during the first three quarters of 2026 compared to the first three quarters of 2025, including the effect of certain tariff refunds received from the U.S. government.

Selling, general and administrative expenses increased $1.2 million, or 0.8%, to $142.1 million for the first three quarters of 2026 from $140.9 million for the first three quarters of 2025. The increase was composed of an increase in acquisition/divestiture‑related and non‑recurring expenses of $16.6 million, inclusive of an increase of $1.9 million for disposals and impairments of property, plant and equipment, partially offset by decreases in general and administrative expenses of $7.5 million, warehousing expenses of $4.9 million, selling expenses of $1.8 million and consumer marketing expenses of $1.2 million. Expressed as a percentage of net sales, selling, general and administrative expenses increased by 0.4 percentage points to 11.3% for the first three quarters of 2026, as compared to 10.9% for the first three quarters of 2025.

During the first three quarters of 2026, the Company recorded pre-tax, non-cash impairment charges of $40.7 million related to indefinite-lived intangible trademark assets for the B&M and Joan of Arc brands in connection with the Company’s divestiture of those brands during the fourth quarter of 2026.

During the first three quarters of 2025, the Company recorded pre-tax, non-cash impairment charges of $26.0 million related to indefinite-lived intangible trademark assets for the Victoria and McCann’s brands.

During the first three quarters of 2026, the Company recognized a loss on sale of assets of $36.3 million, primarily related to the divestiture of the Green Giant U.S. frozen business.

During the first three quarters of 2026, the Company recorded a gain of approximately $1.8 million related to the Green Giant Canada assets held for sale. The gain resulted from a change in the estimated fair value of the Green Giant Canada assets held for sale less the estimated cost to sell those assets. Assets held for sale are remeasured quarterly.

During the first three quarters of 2025, the Company recognized a net gain on sale of assets of $2.9 million, which includes a gain on sale of $15.5 million for the Le Sueur U.S. divestiture during the third quarter of 2025 and a loss on sale of $12.6 million for the Don Pepino divestiture during the second quarter of 2025. During the first three quarters of 2025, the Company recorded pre-tax, non-cash impairment charges of $27.8 million related to the Green Giant Canada assets held for sale.

Net interest expense increased $8.3 million, or 7.4%, to $119.1 million for the first three quarters of 2026 from $110.8 million for the first three quarters of 2025. The increase was primarily attributable to an increase in average long‑term debt outstanding during the first three quarters of 2026 compared to the first three quarters of 2025, the 11.00% interest rate on the Company’s new senior notes due 2031, and a loss on extinguishment of debt of $1.1 million during the first three quarters of 2026 compared to a net gain on extinguishment of debt of $2.3 million during the first three quarters of 2025. During the first three quarters of 2026, net interest expense was also negatively impacted in connection with the Company’s debt refinancing because the Company’s 11.00% senior notes due 2031 were issued on June 10, 2026, prior to the redemption of the Company’s 5.25% senior notes due 2027, and therefore during a 24-day period, the Company incurred interest expense on both sets of notes, which was only partially offset by interest earned on the net proceeds of the issuance of the 11.00% senior notes due 2031.

The Company had a net loss of $69.0 million, or $0.85 per diluted share, for the first three quarters of 2026, compared to a net loss of $28.1 million, or $0.35 per diluted share, for the first three quarters of 2025. The Company’s larger net loss for the first three quarters of 2026 as compared to the first three quarters of 2025 was primarily attributable to: the pre-tax, non-cash impairment charges of $40.7 million related to indefinite-lived intangible trademark assets for the B&M and Joan of Arc brands in connection with the Company’s divestiture of those brands during the fourth quarter of 2026, the loss on sale of assets of $36.3 million (primarily related to the divestiture of the Green Giant U.S. frozen business during the first quarter of 2026), and an increase in acquisition/divestiture-related and non‑recurring expenses, partially offset by the gain of approximately $1.8 million related to the Green Giant Canada assets held for sale recorded during the third quarter of 2026 as compared to the pre-tax, non-cash impairment charges of $27.8 million related to the Green Giant Canada assets held for sale during the third quarter of 2025.

The Company’s adjusted net income for the first three quarters of 2026 was $29.5 million, or $0.36 per adjusted diluted share, compared to adjusted net income of $18.1 million, or $0.23 per adjusted diluted share, for the first three quarters of 2025. The increase in adjusted net income and adjusted diluted earnings per share in the first three quarters of 2026 was primarily attributable to the factors described above, and a decrease in depreciation and amortization.

For the first three quarters of 2026, adjusted EBITDA was $199.9 million, an increase of $12.4 million, or 6.6%, compared to $187.5 million for the first three quarters of 2025. Adjusted EBITDA as a percentage of net sales was 16.0% for the first three quarters of 2026, compared to 14.5% for the first three quarters of 2025.

Segment Results(3)

The Company operates in, and reports results by, four business segments (also referred to as business units):

Specialty — includes, among others, the Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma’s, New York Style, Baker’s Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit brands. Specialty also included the Don Pepino and Sclafani brands until the Company’s divestiture of those brands on May 23, 2025 and the B&M and Joan of Arc brands until the Company’s divestiture of those brands on October 13, 2026.

Meals — includes, among others, the Ortega, Cream of Wheat, College Inn,Maple Grove Farms, Las Palmas, Kitchen Basics,Victoria, Mama Mary’s, Spring Tree, Carey’s, McCann’s and Vermont Maid brands.

Frozen & Vegetables — primarily includes (1) the Company’s frozen vegetable manufacturing operations in Mexico which, following the sale of the Company’s Green Giant U.S. frozen business on March 2, 2026, co-manufactures frozen vegetable products for the acquirer of the Company’s Green Giant U.S. frozen business and (2) the Company’s Green Giant and Le Sieur brands in Canada, and included the Company’s Green Giant U.S. frozen and Le Sueur brands in the United States until the Company’s divestitures of those brands on March 2, 2026 and on August 1, 2025, respectively.

Spices & Flavor Solutions — includes, among others, the Dash, Spice Islands, Weber, Ac’cent, Tone’s, Trappey’s, Durkee and Wright’s brands.

Specialty Segment Results

Specialty segment results were as follows (dollars in thousands):

 

 

Third Quarter Ended

 

 

 

 

 

 

 

 

First Three Quarters Ended

 

 

 

 

 

 

 

October 3,

 

September 27,

 

 

 

 

 

 

 

 

October 3,

 

September 27,

 

 

 

 

 

 

 

2026

 

2025

 

 

$ Change

 

 

% Change

 

 

2026

 

2025

 

 

$ Change

 

% Change

Specialty segment net sales

 

$

163,039

 

$

150,526

 

$

12,513

 

 

8.3%

 

 

$

422,740

 

$

419,785

 

$

2,955

 

0.7%

Specialty segment adjusted expenses

 

 

129,151

 

 

112,802

 

 

16,349

 

 

14.5%

 

 

 

339,018

 

 

315,891

 

 

23,127

 

7.3%

Specialty segment adjusted EBITDA

 

$

33,888

 

$

37,724

 

$

(3,836)

 

 

(10.2)%

 

 

$

83,722

 

$

103,894

 

$

(20,172)

 

(19.4)%

The increase in Specialty segment net sales for the third quarter and first three quarters of 2026 was primarily due to increased volumes in the Specialty portfolio, inclusive of increased institutional bulk vegetable oil sales, partially offset by a decrease in net pricing and the impact of product mix. For the first three quarters of 2026, the increase was also partially offset by the divestiture of the Don Pepino business, which generated $5.3 million of net sales in the first three quarters of 2025.

The decrease in Specialty segment adjusted EBITDA for the third quarter and first three quarters of 2026 was primarily due to higher oil input costs for the Crisco brand and increased transportation and logistics costs due to rising diesel fuel prices. For the first three quarters of 2026, a portion of the decrease in Specialty segment adjusted EBITDA was also attributable to the Don Pepino divestiture.

Meals Segment Results

Meals segment results were as follows (dollars in thousands):

 

 

Third Quarter Ended

 

 

 

 

 

 

 

 

First Three Quarters Ended

 

 

 

 

 

 

 

October 3,

 

September 27,

 

 

 

 

 

 

 

 

October 3,

 

September 27,

 

 

 

 

 

 

 

2026

 

2025

 

 

$ Change

 

 

% Change

 

 

2026

 

2025

 

 

$ Change

 

% Change

Meals segment net sales

 

$

140,608

 

$

109,966

 

$

30,642

 

 

27.9%

 

 

$

358,213

 

$

320,187

 

$

38,026

 

11.9%

Meals segment adjusted expenses

 

 

110,830

 

 

86,087

 

 

24,743

 

 

28.7%

 

 

 

282,677

 

 

245,589

 

 

37,088

 

15.1%

Meals segment adjusted EBITDA

 

$

29,778

 

$

23,879

 

$

5,899

 

 

24.7%

 

 

$

75,536

 

$

74,598

 

$

938

 

1.3%

The increase in Meals segment net sales for the third quarter and first three quarters of 2026 was primarily due to the College Inn and Kitchen Basics acquisition, which contributed $29.0 million and $45.1 million of net sales for the third quarter and first three quarters of 2026, respectively, and an increase in net pricing and the impact of product mix, offset in part by lower volumes across the Meals segment in the aggregate for the first three quarters of 2026, after excluding the benefit of the net sales from the College Inn and Kitchen Basics acquisition. Net sales for the third quarter of 2026 were also positively impacted by an increase in volumes across the Meals segment in the aggregate, as well as the positive impact on volumes from the College Inn and Kitchen Basics acquisition.

The increase in Meals segment adjusted EBITDA for the third quarter and first three quarters of 2026 was primarily due to the increase in Meals segment net sales, primarily attributable to the College Inn and Kitchen Basics acquisition and an increase in overall net pricing for the Meals segment, partially offset by, among other things, increases in certain raw material costs, coupled with increased transportation and logistics costs due to rising diesel fuel prices.

Frozen & Vegetables Segment Results

Frozen & Vegetables segment results were as follows (dollars in thousands):

 

 

Third Quarter Ended

 

 

 

 

 

 

 

 

First Three Quarters Ended

 

 

 

 

 

 

 

October 3,

 

September 27,

 

 

 

 

 

 

 

 

October 3,

 

September 27,

 

 

 

 

 

 

 

2026

 

2025

 

 

$ Change

 

 

% Change

 

 

2026

 

2025

 

 

$ Change

 

% Change

Frozen & Vegetables segment net sales

 

$

54,458

 

$

77,398

 

$

(22,940)

 

 

(29.6)%

 

 

$

172,681

 

$

259,506

 

$

(86,825)

 

(33.5)%

Frozen & Vegetables segment adjusted expenses

 

 

48,726

 

 

73,223

 

 

(24,497)

 

 

(33.5)%

 

 

 

163,567

 

 

259,534

 

 

(95,967)

 

(37.0)%

Frozen & Vegetables segment adjusted EBITDA

 

$

5,732

 

$

4,175

 

$

1,557

 

 

37.3%

 

 

$

9,114

 

$

(28)

 

$

9,142

 

NM

The decrease in Frozen & Vegetables segment net sales for the third quarter and first three quarters of 2026 was primarily due to the Green Giant U.S. frozen divestiture (which negatively impacted net sales versus the third quarter and first three quarters of 2025 by $25.6 million and $78.8 million, respectively, net of the positive impact on net sales of the Green Giant U.S. frozen co‑manufacturing agreement of $26.3 million and $58.7 million, respectively), and the Le Sueur U.S. divestiture (which negatively impacted net sales versus the third quarter and first three quarters of 2025 by $2.3 million and $17.4 million, respectively). Net sales for Green Giant Canada(2) increased by $5.0 million, or 21.6%, and $9.8 million, or 13.6%, for the third quarter and first three quarters of 2026, respectively.

The increase in Frozen & Vegetables segment adjusted EBITDA for the third quarter and first three quarters of 2026 was primarily due to the Green Giant U.S. frozen divestiture and the Green Giant U.S. frozen co‑manufacturing agreement.

Spices & Flavor Solutions Segment Results

Spices & Flavor Solutions segment results were as follows (dollars in thousands):

 

 

Third Quarter Ended

 

 

 

 

 

 

 

 

First Three Quarters Ended

 

 

 

 

 

 

 

October 3,

 

September 27,

 

 

 

 

 

 

 

 

October 3,

 

September 27,

 

 

 

 

 

 

 

2026

 

2025

 

 

$ Change

 

 

% Change

 

 

2026

 

2025

 

 

$ Change

 

% Change

Spices & Flavor Solutions segment net sales

 

$

101,677

 

$

101,414

 

$

263

 

 

0.3%

 

 

$

298,359

 

$

289,653

 

$

8,706

 

3.0%

Spices & Flavor Solutions segment adjusted expenses

 

 

68,928

 

 

75,015

 

 

(6,087)

 

 

(8.1)%

 

 

 

204,783

 

 

212,866

 

 

(8,083)

 

(3.8)%

Spices & Flavor Solutions segment adjusted EBITDA

 

$

32,749

 

$

26,399

 

$

6,350

 

 

24.1%

 

 

$

93,576

 

$

76,787

 

$

16,789

 

21.9%

The increase in Spices & Flavor Solutions segment net sales for the third quarter and first three quarters of 2026 was primarily due to strong continued growth in private label and foodservice channels, and a moderate increase in net pricing, partially offset by declines in volumes for certain spice brands.

The increase in Spices & Flavor Solutions segment adjusted EBITDA for the third quarter and first three quarters of 2026 was primarily due to a moderate increase in net pricing, a reduction in input costs for spices relative to the first three quarters of last year, and lower tariff expenses, including the effect of certain tariff refunds received from the U.S. government. The increase was partially offset by increased transportation and logistics costs due to rising diesel fuel prices.

Full Year Fiscal 2026 Guidance

B&G Foods increased its net sales guidance for fiscal 2026 to a range of $1.760 billion to $1.800 billion, increased its adjusted EBITDA guidance to a range of $280.0 million to $290.0 million, and reaffirmed its adjusted diluted earnings per share at a range of $0.575 to $0.675. This guidance (1) includes the expected impact of one fewer reporting week in fiscal 2026 as compared to fiscal 2025, (2) includes the expected impact of the Company’s divestiture of the Green Giant U.S. frozen business, which closed on March 2, 2026, and the Company’s entry into a co-manufacturing agreement with the acquirer of the business, (3) includes the expected impact of the Don Pepino divestiture, which closed on May 23, 2025, (4) includes the expected impact of the Le Sueur U.S. divestiture, which closed on August 1, 2025, (5) includes the expected impact of the College Inn and Kitchen Basics acquisition, which closed on March 19, 2026, (6) includes the expected impact of the B&M and Joan of Arc divestiture, which closed on October 13, 2026, and (7) excludes the potential impact from any divestiture of Green Giant Canada.

B&G Foods provides earnings guidance only on a non-GAAP basis and does not provide a reconciliation of the Company’s forward-looking adjusted EBITDA and adjusted diluted earnings per share guidance to the most directly comparable GAAP financial measures because of the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliations, including adjustments that could be made for deferred taxes; acquisition/divestiture-related expenses, gains and losses (which may include third-party fees and expenses, integration, restructuring and consolidation expenses, amortization of acquired inventory fair value step-up and gains and losses on the sale of certain assets); gains and losses on extinguishment of debt; impairment of assets held for sale; impairment of intangible assets; non-recurring expenses, gains and losses; and other charges reflected in the Company’s reconciliation of historic non-GAAP financial measures, the amounts of which, based on past experience, could be material. For additional information regarding B&G Foods’ non-GAAP financial measures, see “About Non-GAAP Financial Measures and Items Affecting Comparability” below.

Conference Call

B&G Foods will hold a conference call at 4:30 p.m. ET today, November 10, 2026 to discuss third quarter 2026 financial results. The live audio webcast of the conference call can be accessed at www.bgfoods.com/investor-relations. A replay of the webcast will be available following the conference call through the same link.

About Non-GAAP Financial Measures and Items Affecting Comparability

“Adjusted net income” (net income (loss) adjusted for certain items that affect comparability), “adjusted diluted earnings per share” (diluted earnings (loss) per share adjusted for certain items that affect comparability), “base business net sales” (net sales excluding (1) the net sales from acquisitions until the net sales from such acquisitions are included in both comparable periods, (2) net sales of discontinued or divested brands, and (3) net sales from the Company’s Green Giant U.S. frozen co-manufacturing agreement until the net sales from the co‑manufacturing agreement are included in both comparable periods), “EBITDA” (net income (loss) before net interest expense, income taxes, and depreciation and amortization), “adjusted EBITDA” (EBITDA as adjusted for cash and non-cash acquisition/divestiture-related expenses, gains and losses (which may include third-party fees and expenses, integration, restructuring and consolidation expenses, amortization of acquired inventory fair value step-up and gains and losses on the sale of certain assets), gains and losses on extinguishment of debt, impairment of assets held for sale, impairment of intangible assets, and non-recurring expenses, gains and losses), “segment adjusted EBITDA” (segment net sales less segment adjusted expenses), “segment adjusted expenses” (primarily includes cost of goods sold and other expenses incurred by the Company’s business segments to run day-to-day operations, excluding unallocated corporate items, depreciation and amortization, acquisition/divestiture-related and non-recurring expenses, impairment of intangible assets, goodwill and assets held for sale, gains and losses on sales of assets, interest expense, and income tax expense or benefit), “adjusted gross profit” (gross profit adjusted for acquisition/divestiture-related expenses and non-recurring expenses included in cost of goods sold) and “adjusted gross profit percentage” (gross profit as a percentage of net sales adjusted for acquisition/divestiture-related expenses and non-recurring expenses included in cost of goods sold) are “non-GAAP financial measures.” A non-GAAP financial measure is a numerical measure of financial performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with generally accepted accounting principles in the United States (GAAP) in B&G Foods’ consolidated balance sheets and related consolidated statements of operations, comprehensive loss, changes in stockholders’ equity and cash flows. Non-GAAP financial measures should not be considered in isolation or as a substitute for the most directly comparable GAAP measures. The Company’s non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

The Company uses non-GAAP financial measures to adjust for certain items that affect comparability. This information is provided in order to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Because the Company cannot predict the timing and amount of these items that affect comparability, management does not consider these items when evaluating the Company’s performance or when making decisions regarding allocation of resources.

Additional information regarding EBITDA, adjusted EBITDA, segment adjusted EBITDA and reconciliations of EBITDA, adjusted EBITDA and segment adjusted EBITDA to net loss and, in the case of EBITDA and adjusted EBITDA, to net cash provided by operating activities, is included below for the third quarter and first three quarters of 2026 and 2025, along with the components of EBITDA, adjusted EBITDA and segment adjusted EBITDA. Also included below are reconciliations of the non-GAAP terms adjusted net income, adjusted diluted earnings per share and base business net sales to the most directly comparable measure calculated and presented in accordance with GAAP in the Company’s consolidated balance sheets and related consolidated statements of operations, comprehensive loss, changes in stockholders’ equity and cash flows.

End Notes

(1)

 

Please see “About Non-GAAP Financial Measures and Items Affecting Comparability” above for the definition of the non-GAAP financial measures “base business net sales,” “adjusted diluted earnings per share,” “adjusted net income,” “EBITDA,” “adjusted EBITDA,” “segment adjusted EBITDA,” “segment adjusted expenses,” “adjusted gross profit” and “adjusted gross profit percentage,” as well as information concerning certain items affecting comparability and reconciliations of the non-GAAP terms to the most comparable GAAP financial measures.

(2)

 

Green Giant Canada refers to the Company’s Green Giant and Le Sieur frozen and shelf-stable vegetable product lines in Canada.

(3)

 

Segment net sales, segment adjusted expenses and segment adjusted EBITDA are the primary measures used by the Company’s chief operating decision maker (CODM) to evaluate segment operating performance and to decide how to allocate resources to segments. The Company’s CODM is the Company’s chief executive officer. Segment adjusted expenses and segment adjusted EBITDA exclude unallocated corporate items, depreciation and amortization, acquisition/divestiture-related and non-recurring expenses, impairment of intangible assets, goodwill, property, plant and equipment, and assets held for sale, gains and losses on sales of assets and sales and disposals of property, plant and equipment, interest expense, and income tax expense or benefit. Unallocated corporate items consist of centrally managed corporate functions, including selling, marketing, procurement, centralized administrative functions, insurance, and other similar expenses not directly tied to segment operating performance. Depreciation and amortization expenses are neither maintained nor available by business segment, as the Company’s manufacturing, warehouse, and distribution activities are centrally managed. These items that are centrally managed at the corporate level, and therefore excluded from the measures of segment adjusted expenses and segment adjusted EBITDA, are reviewed by the CODM. Expenses that are managed centrally but can be attributed to a segment, such as warehousing and transportation expenses, are generally allocated to segments based on net sales.

NM – Not meaningful.

About B&G Foods, Inc.

Based in Parsippany, New Jersey, B&G Foods and its subsidiaries manufacture, sell and distribute high-quality, branded shelf-stable and frozen foods across the United States, Canada and Puerto Rico. With B&G Foods’ diverse portfolio of more than 45 brands you know and love, including B&G, Bear Creek, College Inn, Cream of Wheat, Crisco, Dash, Kitchen Basics, Las Palmas, Mama Mary’s, Maple Grove Farms, New York Style, Ortega, Polaner, Spice Islands and Victoria, there’s a little something for everyone. For more information about B&G Foods and its brands, please visit www.bgfoods.com.

Forward-Looking Statements

Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements.” The forward-looking statements contained in this press release include, without limitation, statements related to B&G Foods’ expectations regarding net sales, adjusted EBITDA and adjusted diluted earnings per share; B&G Foods’ overall expectations for the remainder of fiscal 2026 and beyond; and B&G Foods’ priorities and initiatives relating to its 2026 commitments, operating performance, productivity and cost savings, cash generation, leverage, financial flexibility and sustainable long-term performance. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of B&G Foods to be materially different from the historical results or from any future results expressed or implied by such forward‑looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “expects,” “projects,” “intends,” “anticipates,” “assumes,” “could,” “should,” “estimates,” “potential,” “seek,” “predict,” “may,” “will” or “plans” and similar references to future periods to be uncertain and forward-looking. Factors that may affect actual results include, without limitation: the Company’s substantial leverage, which may impact the Company’s ability, among other things, to fund capital expenditures, working capital needs, dividend payments and acquisitions, and to obtain refinancing or additional financing;the Company’s ability to comply with the ratios or tests under its long-term debt agreements, including the maximum consolidated leverage ratio and minimum consolidated interest coverage ratio under its credit agreement, which may be affected not only by the Company’s operating performance but also by events beyond the Company’s control, including prevailing economic, financial and industry conditions, and changes in interest rates; the effects of international trade disputes, tariffs, quotas, and other import or export restrictions on the Company’s procurement, sales and operations (including recent U.S. tariffs imposed or threatened to be imposed on China, Canada, Mexico and other countries and retaliatory actions taken or threatened to be taken by such countries); the effects of rising costs for and/or decreases in supply of the Company’s commodities, ingredients, packaging, other raw materials, distribution and labor; crude oil prices and their impact on distribution, packaging and energy costs; the Company’s ability to successfully implement sales price increases and cost-saving measures to offset any cost increases; intense competition, changes in consumer preferences, demand for the Company’s products and local economic and market conditions; the Company’s continued ability to promote brand equity successfully, to anticipate and respond to new consumer trends, to develop new products and markets, to broaden brand portfolios in order to compete effectively with lower priced products and in markets that are consolidating at the retail and manufacturing levels and to improve productivity; the ability of the Company and its supply chain partners to continue to operate manufacturing facilities, distribution centers and other work locations without material disruption, and to procure ingredients, packaging and other raw materials when needed despite disruptions in the supply chain or labor shortages; the impact pandemics or disease outbreaks may have on the Company’s business, including among other things, the Company’s supply chain, manufacturing operations or workforce and customer and consumer demand for the Company’s products; the Company’s ability to recruit and retain senior management and a highly skilled and diverse workforce at the Company’s corporate offices, manufacturing facilities and other work locations in a competitive labor market and amid changing employee expectations as to fair compensation, an inclusive and diverse workplace, flexible working and other matters; the risks associated with the possible expansion of the Company’s business through acquisitions or reduction in size through divestitures;the Company’s possible inability to successfully complete divestitures of non-core businesses, including a possible divestiture of the Company’s Green Giant and Le Sieur frozen and shelf-stable businesses in Canada, to sharpen its focus, improve margins, reduce costs and reduce its long‑term debt, and, if completed, the Company’s possible inability to achieve the expected margin improvements, cost savings and debt reduction; the Company’s possible inability to identify new acquisitions or to integrate recent or future acquisitions, including the College Inn and Kitchen Basics acquisition, or the Company’s failure to realize anticipated revenue enhancements, cost savings or other synergies from recent or future acquisitions; the Company’s ability to successfully complete the integration of recent or future acquisitions into the Company’s enterprise resource planning (ERP) system; tax reform and legislation, including the effects of the U.S. Tax Cuts and Jobs Act and the One Big Beautiful Bill Act, and any future tax reform or legislation; the Company’s ability to access the credit markets and the Company’s borrowing costs and credit ratings, which may be influenced by credit markets generally and the credit ratings of the Company’s competitors; unanticipated expenses, including, without limitation, litigation or legal settlement expenses; the effects of currency movements of the Canadian dollar and the Mexican peso as compared to the U.S. dollar; future impairments of the Company’s goodwill, other intangible assets, and tangible assets, such as property, plant, equipment or inventory, which impairments may be triggered if operating results for any of the Company’s brands deteriorate at rates in excess of its current projections, the Company’s market capitalization declines or discount rates change, even if due to macroeconomic factors, or may be triggered by divestitures, if divestiture proceeds are less than the book value of the assets being divested; the Company’s ability to protect information systems against, or effectively respond to, a cybersecurity incident, other disruption or data leak; the Company’s ability to successfully implement the Company’s sustainability initiatives and achieve the Company’s sustainability goals, and changes to environmental laws and regulations; the Company’s ability to successfully adopt and utilize new technologies, such as artificial intelligence, including machine learning and generative artificial intelligence; and other factors that affect the food industry generally, including: recalls if products become adulterated or misbranded, liability if product consumption causes injury, ingredient disclosure and labeling laws and regulations and the possibility that consumers could lose confidence in the safety and quality of certain food products; competitors’ pricing practices and promotional spending levels; fluctuations in the level of the Company’s customers’ inventories and credit and other business risks related to the Company’s customers operating in a challenging economic and competitive environment; and the risks associated with third-party suppliers and co-packers, including the risk that any failure by one or more of the Company’s third-party suppliers or co-packers to comply with food safety or other laws and regulations may disrupt the Company’s supply of raw materials or certain finished goods products or injure the Company’s reputation. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in B&G Foods’ filings with the Securities and Exchange Commission, including under Item 1A, “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and in its subsequent reports on Forms 10-Q and 8-K. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. B&G Foods undertakes no obligation to publicly update or revise any forward‑looking statement, whether as a result of new information, future events or otherwise.

B&G Foods, Inc. and Subsidiaries

Consolidated Balance Sheets

(In thousands, except share and per share data)

(Unaudited)

 

 

October 3,

 

January 3,

 

2026

 

2026

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

61,743

 

$

56,293

Trade accounts receivable, net

 

165,957

 

 

140,699

Inventories

 

424,607

 

 

420,766

Assets held for sale

 

52,911

 

 

51,343

Prepaid expenses and other current assets

 

44,194

 

 

53,380

Income tax receivable

 

23,191

 

 

17,337

Total current assets

 

772,603

 

 

739,818

 

 

 

 

 

 

Property, plant and equipment, net

 

224,440

 

 

253,433

Operating lease right-of-use assets

 

48,256

 

 

50,983

Goodwill

 

548,939

 

 

543,812

Other intangible assets, net

 

1,224,591

 

 

1,190,974

Other assets

 

43,738

 

 

45,890

Deferred income taxes

 

9,742

 

 

9,885

Total assets

$

2,872,309

 

$

2,834,795

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Trade accounts payable

$

164,201

 

$

107,669

Accrued expenses

 

79,674

 

 

78,436

Current portion of operating lease liabilities

 

14,703

 

 

16,697

Current portion of long-term debt

 

4,500

 

 

4,500

Income tax payable

 

857

 

 

343

Dividends payable

 

7,708

 

 

15,196

Total current liabilities

 

271,643

 

 

222,841

 

 

 

 

 

 

Long-term debt, net of current portion

 

2,035,354

 

 

1,945,576

Deferred income taxes

 

164,103

 

 

167,951

Long-term operating lease liabilities, net of current portion

 

36,149

 

 

34,636

Other liabilities

 

10,419

 

 

10,866

Total liabilities

 

2,517,668

 

 

2,381,870

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $0.01 par value per share. Authorized 1,000,000 shares; no shares issued or outstanding

 

—

 

 

—

Common stock, $0.01 par value per share. Authorized 125,000,000 shares; 81,140,774 and 79,977,050 shares issued and outstanding as of October 3, 2026 and January 3, 2026, respectively

 

811

 

 

800

Additional paid-in capital

 

—

 

 

—

Accumulated other comprehensive income

 

9,854

 

 

15,045

Retained earnings

 

343,976

 

 

437,080

Total stockholders’ equity

 

354,641

 

 

452,925

Total liabilities and stockholders’ equity

$

2,872,309

 

$

2,834,795

B&G Foods, Inc. and Subsidiaries

Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

 

 

Third Quarter Ended

 

First Three Quarters Ended

 

October 3,

 

September 27,

 

October 3,

 

September 27,

 

2026

 

2025

 

2026

 

2025

Net sales

$

459,782

 

 

$

439,304

 

 

$

1,251,993

 

 

$

1,289,131

 

Cost of goods sold

 

350,845

 

 

 

340,291

 

 

 

983,532

 

 

 

1,013,049

 

Gross profit

 

108,937

 

 

 

99,013

 

 

 

268,461

 

 

 

276,082

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

51,280

 

 

 

44,615

 

 

 

142,058

 

 

 

140,945

 

Amortization expense

 

4,524

 

 

 

5,083

 

 

 

13,366

 

 

 

15,301

 

Impairment of intangible assets

 

40,700

 

 

 

26,000

 

 

 

40,700

 

 

 

26,000

 

(Gain) loss on sales of assets

 

—

 

 

 

(15,513

)

 

 

36,282

 

 

 

(2,867

)

(Gain) impairment on assets held for sale

 

(1,800

)

 

 

27,800

 

 

 

(1,800

)

 

 

27,800

 

Operating income

 

14,233

 

 

 

11,028

 

 

 

37,855

 

 

 

68,903

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses (income):

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

44,784

 

 

 

37,297

 

 

 

119,086

 

 

 

110,835

 

Other income

 

(1,531

)

 

 

(1,201

)

 

 

(4,568

)

 

 

(3,549

)

Loss before income tax benefit

 

(29,020

)

 

 

(25,068

)

 

 

(76,663

)

 

 

(38,383

)

Income tax expense (benefit)

 

3,494

 

 

 

(5,926

)

 

 

(7,624

)

 

 

(10,304

)

Net loss

$

(32,514

)

 

$

(19,142

)

 

$

(69,039

)

 

$

(28,079

)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

81,189

 

 

 

79,994

 

 

 

80,853

 

 

 

79,675

 

Diluted

 

81,189

 

 

 

79,994

 

 

 

80,853

 

 

 

79,675

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share:

 

 

 

 

 

 

 

 

 

 

 

Basic

$

(0.40

)

 

$

(0.24

)

 

$

(0.85

)

 

$

(0.35

)

Diluted

$

(0.40

)

 

$

(0.24

)

 

$

(0.85

)

 

$

(0.35

)

 

 

 

 

 

 

 

 

 

 

 

 

Cash dividends declared per share

$

0.095

 

 

$

0.190

 

 

$

0.380

 

 

$

0.570

 

B&G Foods, Inc. and Subsidiaries

Segment Net Sales, Segment Adjusted Expenses and Segment Adjusted EBITDA and

Reconciliation of Segment Adjusted EBITDA to Net Loss

(In thousands)

(Unaudited)

 

 

 

Third Quarter Ended

 

First Three Quarters Ended

 

 

October 3,

 

September 27,

 

October 3,

 

September 27,

 

 

2026

 

2025

 

2026

 

2025

Segment net sales:

 

 

 

 

 

 

 

 

 

 

 

 

Specialty

 

$

163,039

 

 

$

150,526

 

 

$

422,740

 

 

$

419,785

 

Meals

 

 

140,608

 

 

 

109,966

 

 

 

358,213

 

 

 

320,187

 

Frozen & Vegetables

 

 

54,458

 

 

 

77,398

 

 

 

172,681

 

 

 

259,506

 

Spices & Flavor Solutions

 

 

101,677

 

 

 

101,414

 

 

 

298,359

 

 

 

289,653

 

Total segment net sales

 

 

459,782

 

 

 

439,304

 

 

 

1,251,993

 

 

 

1,289,131

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment adjusted expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Specialty

 

 

129,151

 

 

 

112,802

 

 

 

339,018

 

 

 

315,891

 

Meals

 

 

110,830

 

 

 

86,087

 

 

 

282,677

 

 

 

245,589

 

Frozen & Vegetables

 

 

48,726

 

 

 

73,223

 

 

 

163,567

 

 

 

259,534

 

Spices & Flavor Solutions

 

 

68,928

 

 

 

75,015

 

 

 

204,783

 

 

 

212,866

 

Total segment adjusted expenses

 

 

357,635

 

 

 

347,127

 

 

 

990,045

 

 

 

1,033,880

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment adjusted EBITDA:

 

 

 

 

 

 

 

 

 

 

 

 

Specialty

 

 

33,888

 

 

 

37,724

 

 

 

83,722

 

 

 

103,894

 

Meals

 

 

29,778

 

 

 

23,879

 

 

 

75,536

 

 

 

74,598

 

Frozen & Vegetables

 

 

5,732

 

 

 

4,175

 

 

 

9,114

 

 

 

(28

)

Spices & Flavor Solutions

 

 

32,749

 

 

 

26,399

 

 

 

93,576

 

 

 

76,787

 

Total segment adjusted EBITDA

 

 

102,147

 

 

 

92,177

 

 

 

261,948

 

 

 

255,251

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unallocated corporate expenses

 

 

20,299

 

 

 

21,770

 

 

 

62,063

 

 

 

67,726

 

Adjusted EBITDA

 

$

81,848

 

 

$

70,407

 

 

$

199,885

 

 

$

187,525

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

$

14,442

 

 

$

16,570

 

 

$

43,947

 

 

$

50,124

 

Acquisition/divestiture-related and non-recurring expenses

 

 

12,620

 

 

 

3,195

 

 

 

32,427

 

 

 

9,993

 

Impairment of intangible assets

 

 

40,700

 

 

 

26,000

 

 

 

40,700

 

 

 

26,000

 

Impairment of property, plant and equipment, net

 

 

—

 

 

 

—

 

 

 

172

 

 

 

2,994

 

(Gain) loss on sales of assets

 

 

—

 

 

 

(15,513

)

 

 

36,282

 

 

 

(2,867

)

Loss on sales and disposals of property, plant and equipment

 

 

122

 

 

 

126

 

 

 

5,734

 

 

 

1,029

 

(Gain) impairment on assets held for sale

 

 

(1,800

)

 

 

27,800

 

 

 

(1,800

)

 

 

27,800

 

Interest expense, net

 

 

44,784

 

 

 

37,297

 

 

 

119,086

 

 

 

110,835

 

Income tax expense (benefit)

 

 

3,494

 

 

 

(5,926

)

 

 

(7,624

)

 

 

(10,304

)

Net loss

 

$

(32,514

)

 

$

(19,142

)

 

$

(69,039

)

 

$

(28,079

)

B&G Foods, Inc. and Subsidiaries

Items Affecting Comparability

Reconciliation of Net Loss to EBITDA and Adjusted EBITDA(1)

(In thousands)

(Unaudited)

 

 

 

Third Quarter Ended

 

First Three Quarters Ended

 

 

October 3,

 

September 27,

 

October 3,

 

September 27,

 

 

2026

 

2025

 

2026

 

2025

Net loss

 

$

(32,514

)

 

$

(19,142

)

 

$

(69,039

)

 

$

(28,079

)

Income tax expense (benefit)

 

 

3,494

 

 

 

(5,926

)

 

 

(7,624

)

 

 

(10,304

)

Interest expense, net(2)(3)(4)

 

 

44,784

 

 

 

37,297

 

 

 

119,086

 

 

 

110,835

 

Depreciation and amortization

 

 

14,442

 

 

 

16,570

 

 

 

43,947

 

 

 

50,124

 

EBITDA(1)

 

 

30,206

 

 

 

28,799

 

 

 

86,370

 

 

 

122,576

 

Acquisition/divestiture-related and non-recurring expenses(5)

 

 

12,620

 

 

 

3,195

 

 

 

32,427

 

 

 

9,993

 

Impairment of intangible assets(6)

 

 

40,700

 

 

 

26,000

 

 

 

40,700

 

 

 

26,000

 

Impairment of property, plant and equipment(7)

 

 

—

 

 

 

—

 

 

 

172

 

 

 

2,994

 

(Gain) loss on sale of assets(8)

 

 

—

 

 

 

(15,513

)

 

 

36,282

 

 

 

(2,867

)

(Gain) impairment on assets held for sale(9)

 

 

(1,800

)

 

 

27,800

 

 

 

(1,800

)

 

 

27,800

 

Loss on sales and disposals of property, plant and equipment(10)

 

 

122

 

 

 

126

 

 

 

5,734

 

 

 

1,029

 

Adjusted EBITDA(1)

 

$

81,848

 

 

$

70,407

 

 

$

199,885

 

 

$

187,525

 

B&G Foods, Inc. and Subsidiaries

Items Affecting Comparability

Reconciliation of Net Cash (Used in) Provided by Operating Activities to EBITDA and Adjusted EBITDA(1)

(In thousands)

(Unaudited)

 

 

 

Third Quarter Ended

 

First Three Quarters Ended

 

 

October 3,

 

September 27,

 

October 3,

 

September 27,

 

 

2026

 

2025

 

2026

 

2025

Net cash (used in) provided by operating activities

 

$

(28,451

)

 

$

(64,618

)

 

$

29,566

 

 

$

5,950

 

Income tax expense (benefit)

 

 

3,494

 

 

 

(5,926

)

 

 

(7,624

)

 

 

(10,304

)

Interest expense, net(2)(3)(4)

 

 

44,784

 

 

 

37,297

 

 

 

119,086

 

 

 

110,835

 

(Loss) gain on extinguishment of debt(2)

 

 

(1,127

)

 

 

681

 

 

 

(1,127

)

 

 

2,754

 

Impairment of intangible assets(6)

 

 

(40,700

)

 

 

(26,000

)

 

 

(40,700

)

 

 

(26,000

)

Impairment of property, plant and equipment(7)

 

 

—

 

 

 

—

 

 

 

(172

)

 

 

(2,994

)

Gain (loss) on sales of assets(8)

 

 

—

 

 

 

15,513

 

 

 

(36,282

)

 

 

2,867

 

Gain (impairment) on assets held for sale(9)

 

 

1,800

 

 

 

(27,800

)

 

 

1,800

 

 

 

(27,800

)

Loss on sales and disposals of property, plant and equipment(10)

 

 

(122

)

 

 

(126

)

 

 

(5,734

)

 

 

(1,029

)

Deferred income taxes

 

 

(3,381

)

 

 

(4,702

)

 

 

3,543

 

 

 

13,801

 

Amortization of deferred debt financing costs and bond discount

 

 

(2,030

)

 

 

(1,782

)

 

 

(5,187

)

 

 

(4,937

)

Share-based compensation expense

 

 

(4,176

)

 

 

(4,050

)

 

 

(9,954

)

 

 

(10,604

)

Changes in assets and liabilities, net of effects of business combinations

 

 

60,115

 

 

 

110,312

 

 

 

39,155

 

 

 

70,037

 

EBITDA(1)

 

 

30,206

 

 

 

28,799

 

 

 

86,370

 

 

 

122,576

 

Acquisition/divestiture-related and non-recurring expenses(5)

 

 

12,620

 

 

 

3,195

 

 

 

32,427

 

 

 

9,993

 

Impairment of intangible assets(6)

 

 

40,700

 

 

 

26,000

 

 

 

40,700

 

 

 

26,000

 

Impairment of property, plant and equipment(7)

 

 

—

 

 

 

—

 

 

 

172

 

 

 

2,994

 

(Gain) loss on sales of assets(8)

 

 

—

 

 

 

(15,513

)

 

 

36,282

 

 

 

(2,867

)

(Gain) impairment on assets held for sale(9)

 

 

(1,800

)

 

 

27,800

 

 

 

(1,800

)

 

 

27,800

 

Loss on sales and disposals of property, plant and equipment(10)

 

 

122

 

 

 

126

 

 

 

5,734

 

 

 

1,029

 

Adjusted EBITDA(1)

 

$

81,848

 

 

$

70,407

 

 

$

199,885

 

 

$

187,525

 

B&G Foods, Inc. and Subsidiaries

Items Affecting Comparability

Reconciliation of Net Loss to Adjusted Net Income and Adjusted Diluted Earnings per Share(11)

(In thousands, except per share data)

(Unaudited)

 

 

 

Third Quarter Ended

 

First Three Quarters Ended

 

 

October 3,

 

September 27,

 

October 3,

 

September 27,

 

 

2026

 

2025

 

2026

 

2025

Net loss

 

$

(32,514

)

 

$

(19,142

)

 

$

(69,039

)

 

$

(28,079

)

Loss (gain) on extinguishment of debt(2)

 

 

1,127

 

 

 

(681

)

 

 

1,127

 

 

 

(2,754

)

Accelerated amortization of deferred debt financing costs(3)

 

 

—

 

 

 

289

 

 

 

—

 

 

 

588

 

Debt financing costs(4)

 

 

—

 

 

 

28

 

 

 

—

 

 

 

28

 

Acquisition/divestiture-related and non-recurring expenses(5)

 

 

12,620

 

 

 

3,195

 

 

 

32,427

 

 

 

9,993

 

Impairment of intangible assets(6)

 

 

40,700

 

 

 

26,000

 

 

 

40,700

 

 

 

26,000

 

Impairment of property, plant and equipment, net(7)

 

 

—

 

 

 

—

 

 

 

172

 

 

 

2,994

 

(Gain) loss on sales of assets(8)

 

 

—

 

 

 

(15,513

)

 

 

36,282

 

 

 

(2,867

)

(Gain) impairment on assets held for sale(9)

 

 

(1,800

)

 

 

27,800

 

 

 

(1,800

)

 

 

27,800

 

Loss on sales and disposals of property, plant and equipment(10)

 

 

122

 

 

 

126

 

 

 

5,734

 

 

 

1,029

 

Tax adjustments(12)

 

 

10,460

 

 

 

(299

)

 

 

11,954

 

 

 

(1,296

)

Tax effects of non-GAAP adjustments(13)

 

 

(12,961

)

 

 

(10,070

)

 

 

(28,083

)

 

 

(15,366

)

Adjusted net income(11)

 

$

17,754

 

 

$

11,733

 

 

$

29,474

 

 

$

18,070

 

Adjusted diluted earnings per share(11)(14)

 

$

0.21

 

 

$

0.15

 

 

$

0.36

 

 

$

0.23

 

__________________________

(1)

 

EBITDA and adjusted EBITDA are non-GAAP financial measures used by management to measure operating performance. A non‑GAAP financial measure is defined as a numerical measure of the Company’s financial performance that excludes or includes amounts so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP in the Company’s consolidated balance sheets and related consolidated statements of operations, comprehensive loss, changes in stockholders’ equity and cash flows. The Company defines EBITDA as net income (loss) before net interest expense, income taxes, and depreciation and amortization. The Company defines adjusted EBITDA as EBITDA adjusted for cash and non‑cash acquisition/divestiture‑related expenses, gains and losses (which may include third-party fees and expenses, integration, restructuring and consolidation expenses, amortization of acquired inventory fair value step-up, and gains and losses on the sale of certain assets); gains and losses on extinguishment of debt; impairment of assets held for sale; impairment of intangible assets; and non-recurring expenses, gains and losses.

 

 

Management believes that it is useful to eliminate these items because it allows management to focus on what it deems to be a more reliable indicator of ongoing operating performance and the Company’s ability to generate cash flow from operations. The Company uses EBITDA and adjusted EBITDA in the Company’s business operations to, among other things, evaluate the Company’s operating performance, develop budgets and measure the Company’s performance against those budgets, determine employee bonuses and evaluate the Company’s cash flows in terms of cash needs. The Company also presents EBITDA and adjusted EBITDA because the Company believes they are useful indicators of the Company’s historical debt capacity and ability to service debt and because covenants in the Company’s credit agreement, the Company’s senior secured notes indenture and the Company’s senior notes indenture contain ratios based on these measures. As a result, reports used by internal management during monthly operating reviews feature the EBITDA and adjusted EBITDA metrics. However, management uses these metrics in conjunction with traditional GAAP operating performance and liquidity measures as part of its overall assessment of the Company’s operating performance, cash needs and ability to service debt, and therefore does not place undue reliance on these measures.

 

 

EBITDA and adjusted EBITDA are not recognized terms under GAAP and do not purport to be alternatives to operating income (loss), net income (loss) or any other GAAP measure as indicators of operating performance. EBITDA and adjusted EBITDA are not measures of cash flows in accordance with GAAP and should not be considered as alternatives to net cash provided by operating activities or any other measure of liquidity determined in accordance with GAAP. EBITDA and adjusted EBITDA do not reflect the Company’s cash requirements for debt service, working capital, capital expenditures, acquisitions, income taxes or dividends. Rather, management believes EBITDA and adjusted EBITDA may provide useful information regarding the Company’s ability to fund these cash requirements. EBITDA and adjusted EBITDA are not complete measures of the Company’s profitability because they do not include certain costs and expenses and gains and losses described above. Because not all companies use identical calculations, the Company’s presentation of EBITDA and adjusted EBITDA may not be comparable to similarly titled measures used by other companies. However, management believes EBITDA and adjusted EBITDA can be useful in evaluating the Company’s performance relative to peer companies because these measures provide users with additional insight into key components of the Company’s results determined in accordance with GAAP.

(2)

 

During the third quarter of 2026, upon the redemption of the Company’s 5.25% senior notes due 2027, the Company recognized a loss on extinguishment of debt of $1.1 million (or $0.9 million, net of tax).

 

 

Net interest expense for the third quarter and first three quarters of 2025 was reduced by $0.5 million (or $0.4 million, net of tax) and $2.3 million (or $1.7 million, net of tax), respectively, as a result of gains on extinguishment of debt related to the Company’s repurchases of $20.0 million and $40.7 million aggregate principal amount, respectively, of its 5.25% senior notes due 2027 in open market purchases during the third quarter and first three quarters of 2025 at discounted repurchase prices, which resulted in pre-tax gains of $0.8 million and $2.9 million, partially offset by the accelerated amortization of deferred debt financing costs of $0.3 million and $0.6 million, respectively, described in footnote (3) below.

(3)

 

Net interest expense for the third quarter and first three quarters of 2025 includes the accelerated amortization of deferred debt financing costs of $0.3 million (or $0.2 million, net of tax) and $0.6 million (or $0.4 million, net of tax), respectively, resulting from the Company’s repurchases of 5.25% senior notes due 2027 described in footnote (2) above.

(4)

 

Debt financing costs of less than $0.1 million for the third quarter and first three quarters of 2025 reflect the portion of debt financing costs incurred in connection with the refinancing of the Company’s senior secured credit facility that is included in net interest expense for the third quarter and first three quarters of 2025.

(5)

 

Acquisition/divestiture-related and non-recurring expenses primarily include acquisition, integration and divestiture-related expenses for prior and potential future acquisitions and divestitures, and non-recurring expenses, including separation expenses primarily relating to the retirement during the third quarter of fiscal 2026 of the Company’s former chief executive officer and workforce reductions in fiscal 2025 and 2026, other organizational restructuring expenses, and amortization of acquisition-related inventory step-up.

(6)

 

During the third quarter of 2026, the Company recorded pre-tax, non-cash impairment charges of $40.7 million (or $30.7 million, net of tax) related to indefinite-lived intangible trademark assets for the B&M and Joan of Arc brands in connection with the Company’s divestiture of those brands.

 

 

During the third quarter of 2025, the Company recorded pre-tax, non-cash impairment charges of $26.0 million (or $19.6 million, net of tax) related to indefinite-lived intangible trademark assets for the Victoria and McCann’s brands.

(7)

 

The Company recorded pre-tax, non-cash impairment charges of $0.2 million (or $0.1 million, net of tax) and $3.0 million (or $2.3 million, net of tax) related to property, plant and equipment during the first three quarters of 2026 and the first three quarters of 2025, respectively.

(8)

 

During the first quarter of 2026, the Company recorded a loss on sale of assets of $36.3 million (or $27.4 million, net of tax), primarily related to the sale of the Green Giant U.S. frozen business.

 

 

During the first three quarters of 2025, the Company recognized a net gain on sale of assets of $2.9 million (or $2.1 million, net of tax), which includes a gain on sale of $15.5 million (or $11.6 million, net of tax) for the Le Sueur U.S. divestiture during the third quarter of 2025 and a loss on sale of $12.6 million (or $9.5 million, net of tax) for the Don Pepino divestiture during the second quarter of 2025.

(9)

 

During the third quarter of 2026, the Company recorded a gain of approximately $1.8 million (or $1.4 million, net of tax) related to the Green Giant Canada assets held for sale. The gain resulted from a change in the estimated fair value of the Green Giant Canada assets held for sale less the estimated cost to sell those assets. Assets held for sale are remeasured quarterly.

 

 

During the third quarter of 2025, the Company reclassified $75.6 million of inventories, $6.3 million of indefinite-lived trademark intangible assets and $3.1 million of finite-lived customer relationship intangible assets related to Green Giant Canada within the Frozen & Vegetables business unit to assets held for sale as of the end of the third quarter of 2025. The Company then measured the assets held for sale at the lower of their carrying value or fair value less the estimated costs to sell, and recorded pre-tax, non-cash impairment charges of $27.8 million (or $21.0 million, net of tax) during the third quarter of 2025.

(10)

 

The Company recorded losses on sales and disposals of property, plant and equipment of $0.1 million and $5.7 million (or $4.3 million, net of tax) during the third quarter and first three quarters of 2026, respectively, and $0.1 million and $1.0 million (or $0.8 million, net of tax) during the third quarter and first three quarters of 2025, respectively.

(11)

 

Adjusted net income and adjusted diluted earnings per share are non-GAAP financial measures used by management to measure operating performance. The Company defines adjusted net income and adjusted diluted earnings per share as net income (loss) and diluted earnings (loss) per share adjusted for certain items that affect comparability. These non-GAAP financial measures reflect adjustments to net income (loss) and diluted earnings (loss) per share to eliminate the items identified in the reconciliation above. This information is provided in order to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Because the Company cannot predict the timing and amount of these items, management does not consider these items when evaluating the Company’s performance or when making decisions regarding allocation of resources.

(12)

 

During the first three quarters of 2026, the Company recorded a net discrete tax expense of $12.0 million, primarily related to Section 163(j) of the Internal Revenue Code of 1986 (IRC) adjustments and stock-based compensation, partially offset by tax benefits related to a return-to-provision adjustment in Mexico and miscellaneous tax true-ups.

 

 

During the first three quarters of 2025, the Company recorded a net discrete tax benefit of $1.3 million, primarily related to a pre-transition loss under Section 987 of the IRC, representing the cumulative unrecognized foreign exchange loss related to its primary operating subsidiary in Canada, partially offset by tax expense related to stock-based compensation and rate changes.

(13)

 

Represents the tax effects of the non-GAAP adjustments listed above, assuming a tax rate of approximately 24.5%.

(14)

 

The Company was in a net loss position for the third quarter and first three quarters of 2026 and the third quarter and first three quarters of 2025, therefore there are no potentially dilutive share-based compensation awards included in the calculation of diluted weighted average shares outstanding for those periods, as their effect would have been antidilutive. However, given that the adjustments described above resulted in adjusted net income for those periods, the dilutive impact of potentially dilutive share-based compensation awards is being included in the calculation of adjusted diluted weighted average shares outstanding and, therefore, in the calculation of adjusted diluted earnings per share for those periods.

B&G Foods, Inc. and Subsidiaries

Items Affecting Comparability

Reconciliation of Net Sales to Base Business Net Sales(1)

(In thousands)

(Unaudited)

 

 

 

Third Quarter Ended

 

First Three Quarters Ended

 

 

October 3,

 

September 27,

 

October 3,

 

September 27,

 

 

2026

 

2025

 

2026

 

2025

Net sales

 

$

459,782

 

 

$

439,304

 

 

$

1,251,993

 

 

$

1,289,131

 

Net sales from acquisitions(2)

 

 

(29,014

)

 

 

—

 

 

 

(45,118

)

 

 

—

 

Net sales from discontinued or divested brands(3)

 

 

86

 

 

 

(54,134

)

 

 

(32,176

)

 

 

(192,783

)

Net sales from Green Giant U.S. frozen co-manufacturing agreement(4)

 

 

(26,257

)

 

 

—

 

 

 

(58,719

)

 

 

—

 

Base business net sales(1)

 

$

404,597

 

 

$

385,170

 

 

$

1,115,980

 

 

$

1,096,348

 

__________________________

(1)

 

Base business net sales is a non-GAAP financial measure used by management to measure operating performance. The Company defines base business net sales as the Company’s net sales excluding (1) the net sales of acquisitions until the net sales from such acquisitions are included in both comparable periods, (2) net sales of discontinued or divested brands, and (3) net sales from the Company’s Green Giant U.S. frozen co-manufacturing agreement until the net sales from the co-manufacturing agreement are included in both comparable periods. The portion of current period net sales attributable to recent acquisitions for which there is no corresponding period in the comparable period of the prior year is excluded. For each acquisition, the excluded period starts at the beginning of the most recent fiscal period being compared and ends on the first anniversary of the acquisition date. For discontinued or divested brands, the entire amount of net sales is excluded from each fiscal period being compared. The Company has included this financial measure because management believes it provides useful and comparable trend information regarding the results of the Company’s business without the effect of the timing of acquisitions and the effect of discontinued or divested brands.

(2)

 

For the third quarter and first three quarters of 2026, reflects net sales from the College Inn and Kitchen Basics acquisition, for which there is no comparable period of net sales during the third quarter and first three quarters of 2025. The College Inn and Kitchen Basics acquisition was completed on March 19, 2026.

(3)

 

For the third quarter and first three quarters of 2026, reflects net sales of the Green Giant U.S. frozen vegetable brand through the date of the divestiture. For the third quarter and first three quarters of 2025, reflects net sales of the Green Giant U.S. frozen vegetable brand, which was divested on March 2, 2026, and net sales of the Le Sueur U.S. shelf-stable vegetable brand, which was divested on August 1, 2025. For the first three quarters of 2025, also reflects net sales of the Don Pepino and Sclafani brands, which were divested on May 23, 2025.

(4)

 

For the third quarter and first three quarters of 2026, reflects net sales of the Company’s co-manufacturing agreement with the acquirer of the Green Giant U.S. frozen business pursuant to which the Company is continuing to produce for the acquirer certain Green Giant frozen vegetable products at its frozen vegetable manufacturing facility in Irapuato, Mexico, which was not included as part of the Green Giant U.S. frozen divestiture and for which there is no comparable period of net sales during the third quarter and first three quarters of 2025.

B&G Foods, Inc. and Subsidiaries

Items Affecting Comparability

Reconciliation of Gross Profit to Adjusted Gross Profit and

Gross Profit as a Percentage of Net Sales to Adjusted Gross Profit Percentage(1)

(In thousands, except percentages)

(Unaudited)

 

 

 

Third Quarter Ended

 

First Three Quarters Ended

 

 

October 3,

 

September 27,

 

October 3,

 

September 27,

 

 

2026

 

2025

 

2026

 

2025

Gross profit

 

$

108,937

 

 

$

99,013

 

 

$

268,461

 

 

$

276,082

 

Acquisition/divestiture-related expenses and non-recurring expenses included in cost of goods sold(2)

 

 

2,234

 

 

 

(184

)

 

 

10,947

 

 

 

2,422

 

Adjusted gross profit(1)

 

$

111,171

 

 

$

98,829

 

 

$

279,408

 

 

$

278,504

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit as a percentage of net sales

 

 

23.7

%

 

 

22.5

%

 

 

21.4

%

 

 

21.4

%

Acquisition/divestiture-related expenses and non-recurring expenses included in cost of goods sold as a percentage of net sales

 

 

0.5

%

 

 

0.0

%

 

 

0.9

%

 

 

0.2

%

Adjusted gross profit percentage(1)

 

 

24.2

%

 

 

22.5

%

 

 

22.3

%

 

 

21.6

%

__________________________

(1)

 

Adjusted gross profit and adjusted gross profit percentage are non-GAAP financial measures used by management to measure operating performance. The Company defines adjusted gross profit as gross profit adjusted for acquisition/divestiture-related expenses and non-recurring expenses included in cost of goods sold, and adjusted gross profit percentage as gross profit as a percentage of net sales adjusted for acquisition/divestiture-related expenses and non-recurring expenses included in cost of goods sold. These non-GAAP financial measures reflect adjustments to gross profit and gross profit as a percentage of net sales to eliminate the items identified in the reconciliation above. This information is provided in order to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Because the Company cannot predict the timing and amount of these items, management does not consider these items when evaluating the Company’s performance or when making decisions regarding allocation of resources.

(2)

 

Acquisition/divestiture-related expenses and non-recurring expenses included in cost of goods sold primarily include acquisition, integration and divestiture-related expenses for prior and potential future acquisitions and divestitures, including for the College Inn and Kitchen Basics acquisition, the Green Giant U.S. frozen divestiture and the possible Green Giant Canada divestiture, and non‑recurring expenses, including separation expenses primarily relating to workforce reductions in fiscal 2025 and 2026 and amortization of acquisition-related inventory step-up.

 

Investor Relations:

ICR, Inc.

Anna Kate Heller

[email protected]

Media Relations:

ICR, Inc.

Matt Lindberg

[email protected]

KEYWORDS: New Jersey United States North America

INDUSTRY KEYWORDS: Food/Beverage Manufacturing Retail Supermarket Packaging

MEDIA:

Seer Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Revenue Guidance

REDWOOD CITY, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended September 30, 2026.

Seer reported third-quarter revenue of $4.0 million, compared with $3.1 million in the second quarter of 2026, and ended the quarter with approximately $198.1 million in cash, cash equivalents and investments. Seer also updated its full-year 2026 revenue guidance to a range of $13.5 million to $14.5 million.

“This quarter, our customers continued to demonstrate what Proteograph makes possible, from new discoveries in population-scale research to emerging applications in AI, while established customers returned to purchase consumables and new pharmaceutical customers adopted the platform,” said Omid Farokhzad, Chair and Chief Executive Officer. “Proteograph fundamentally expands the biology researchers can see with mass spectrometry. Our focus is to translate that differentiated value into sustained revenue growth by expanding sample volume within customer accounts and building relationships that support repeat use. With a strong balance sheet and growing evidence of the platform’s value, I remain confident in Seer’s opportunity and committed to building long-term value for our shareholders.”

Recent Business and Corporate Highlights

  • Established customers continued to purchase consumables, including accounts with purchases across multiple consecutive quarters. Several new large pharmaceutical customers purchased instruments and consumables this year, supporting opportunities for larger studies and broader use within customer accounts.
  • Announced on October 29 that the Special Committee of Seer’s Board of Directors completed its review and Seer will remain an independent public company, reinforcing the Company’s continued commitment to innovation, service and customer support.
  • Announced on November 5 that, following Nanomics Biotechnology Co., Ltd.’s withdrawal from defending the U.S. International Trade Commission (“ITC”) investigation brought by Seer and Brigham and Women’s Hospital, the ITC’s investigative staff recommended granting the full exclusion and cease-and-desist orders requested. The Commission’s final determination remains pending and is expected by year-end.

Scientific Highlights

  • Publications, preprints and reviews describing research conducted using Proteograph reached 116, up from 95 at the last quarterly update, highlighting the discoveries researchers are advancing across a broad range of applications.
  • PRECISE-SG100K investigators presented preliminary findings at HUPO 2026 from 9,658 plasma samples. Using Proteograph with Thermo Fisher’s Orbitrap Astral mass spectrometer, they quantified approximately 8,800 protein groups across the study and 88,000 peptides per sample.
  • Proteograph’s nanoparticle enrichment substantially expands the plasma proteome available for discovery. Published studies and customer presentations using matched plasma samples have repeatedly shown that conventional mass spectrometry workflows without Proteograph achieve approximately 10–15% of the protein coverage achieved with Proteograph. The Proteograph makes thousands of additional proteins accessible for biological investigation.
  • PRECISE investigators identified more than 4,200 proteins with significant associations between nearby genetic variation and protein abundance, or cis-pQTLs. They reported 2,762 genetic–protein associations not previously reported across 12 reference studies and linked proteins to 71 health-related traits, illustrating the discovery potential of deep proteomics at population scale.
  • In an independent study published in Clinical Proteomics, CHA University researchers compared seven plasma preparation approaches. Proteograph XT delivered the greatest coverage, averaging approximately 6,060 proteins per sample, and the lowest rate of missing protein measurements, at 1.9%.
  • Korea University Professors Sang-Won Lee and Jaewoo Kang presented preliminary findings from more than 5,500 plasma samples at ASMS and HUPO 2026. Their ID-Free AI Proteomics approach used identified and unidentified spectral signals generated with Proteograph and mass spectrometry, improving overall cancer-classification performance compared with models using identified-peptide features alone.

Third Quarter 2026 Financial Results

Revenue was $4.0 million for the third quarter of 2026, compared with $3.1 million in the second quarter of 2026 and $4.1 million in the third quarter of 2025. Revenue decreased 3% from the prior-year period. Product revenue was $2.8 million, consisting of sales of Proteograph instruments and consumable kits. Service revenue was $1.1 million, related party revenue was $0.1 million, and other revenue was approximately $67,000.

Gross profit was $1.9 million and gross margin was 47% for the third quarter of 2026.

Operating expenses were $16.5 million for the third quarter of 2026, including $1.2 million in stock-based compensation, compared with $21.5 million for the corresponding prior-year period, including $3.6 million in stock-based compensation. Operating expenses decreased 23%, primarily reflecting lower employee compensation expenses, including stock-based compensation.

Net loss was $13.7 million for the third quarter of 2026, compared with $18.2 million for the corresponding prior-year period.

For the nine months ended September 30, 2026, net cash used in operating activities was approximately $34.5 million. After deducting approximately $311,000 of net purchases of property and equipment, free cash flow was approximately negative $34.8 million. Free cash flow is a non-GAAP financial measure, defined as net cash used in operating activities less net purchases of property and equipment.

Cash, cash equivalents and investments were approximately $198.1 million as of September 30, 2026.

Capital Allocation

Through September 30, 2026, Seer had repurchased approximately 13.5 million Class A common shares at a weighted average price of $1.85 per share, using approximately $25 million of the combined $50 million authorized by the Board in May 2024 and February 2026. Approximately $25 million remained available under those authorizations. During the third quarter, the Company repurchased approximately 61,000 shares at a weighted-average price of $1.64 per share.

Seer’s capital allocation approach combines investment in commercial adoption and product innovation with disciplined spending and share repurchases. Based on its current operating plan, the Company believes it has sufficient capital to reach cash flow breakeven.

2026 Guidance

Seer now expects full-year 2026 revenue to be in the range of $13.5 million to $14.5 million, compared with the prior range of $16 million to $18 million. Continued pressure on academic and government funding has extended sales cycles, and several late-stage opportunities are now expected to close later than planned.

Webcast Information

Seer will host a conference call to discuss the third quarter 2026 financial results on Tuesday, November 10, 2026, at 1:30 pm Pacific Time / 4:30 pm Eastern Time. A webcast of the conference call can be accessed at https://investor.seer.bio. The webcast will be archived and available for replay for at least 90 days after the event.

About Seer, Inc.

Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with scale, speed, precision and reproducibility previously unattainable. Seer’s Proteograph® Product Suite integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables and advanced analytical software to overcome the limitations of traditional proteomic methods. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.

For more information, please email us at [email protected].

Forward Looking Statements

This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are based on Seer’s beliefs and assumptions and on information currently available to it on the date of this press release. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause Seer’s actual results, performance, or achievements to be materially different from those expressed or implied by the forward-looking statements. These statements include but are not limited to statements regarding Seer’s revenue guidance; the adoption and use of Seer’s products; expansion within customer accounts, sample volumes, repeat purchases and revenue growth; anticipated sample shipments under customer agreements; the potential applications of proteomic data in AI-driven research; capital allocation, share repurchases and the sufficiency of capital to reach cash flow breakeven under the current operating plan; and the enforcement of intellectual property rights, including the expected timing and outcome of the ITC proceeding. These and other risks are described more fully in Seer’s filings with the Securities and Exchange Commission (“SEC”) and other documents that Seer subsequently files with the SEC from time to time. Except to the extent required by law, Seer undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Media Contact:

Patrick Schmidt
[email protected]

Investor Contact:

Marissa Bych
[email protected]

SEER, INC.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited)
(in thousands, except share and per share amounts)
 
  Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
  2026     2025     2026     2025  
Revenue:                      
Product $ 2,760     $ 2,756     $ 7,193     $ 8,372  
Service   1,064       913       2,283       2,913  
Related party   90       300       146       761  
Other   67       152       254       331  
Total revenue   3,981       4,121       9,876       12,377  
Cost of revenue:                      
Product   1,411       1,327       3,817       3,868  
Service   392       335       909       1,261  
Related party   82       85       88       224  
Other   217       264       695       742  
Total cost of revenue   2,102       2,011       5,509       6,095  
Gross profit   1,879       2,110       4,367       6,282  
Operating expenses:                      
Research and development   6,439       10,797       23,454       34,132  
Selling, general and administrative   10,107       10,659       29,677       32,757  
Total operating expenses   16,546       21,456       53,131       66,889  
Loss from operations   (14,667 )     (19,346 )     (48,764 )     (60,607 )
Other income (expense):                      
Interest income   1,961       2,765       6,238       8,974  
Loss on equity method investment   (1,392 )     (1,419 )     (5,208 )     (4,835 )
Other income (expense)   365       (210 )     284       (965 )
Total other income   934       1,136       1,314       3,174  
Loss before provision for income taxes   (13,733 )     (18,210 )     (47,450 )     (57,433 )
Provision for income taxes   5       24       24       173  
Net loss $ (13,738 )   $ (18,234 )   $ (47,474 )   $ (57,606 )
Other comprehensive loss:                      
Unrealized gain (loss) on available-for-sale securities   (410 )     124       (1,205 )     295  
Comprehensive loss $ (14,148 )   $ (18,110 )   $ (48,679 )   $ (57,311 )
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.25 )   $ (0.32 )   $ (0.85 )   $ (0.99 )
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted   55,562,071       56,312,290       55,572,439       57,928,898  



SEER, INC.

Condensed Consolidated Balance Sheets

(Unaudited)


(in thousands, except share and per share amounts)
 
    September 30,

2026
    December 31,

2025
 
ASSETS            
Current assets:            
Cash and cash equivalents   $ 29,316     $ 47,285  
Short-term investments     126,581       138,612  
Accounts receivable, net     2,717       4,282  
Related party receivables     146       300  
Other receivables     964       1,370  
Inventory     6,396       7,795  
Prepaid expenses and other current assets     1,777       1,890  
Total current assets     167,897       201,534  
Long-term investments     42,190       54,686  
Operating lease right-of-use assets     18,663       20,488  
Property and equipment, net     11,031       14,754  
Restricted cash     524       524  
Other assets     1,494       4,097  
Total assets   $ 241,799     $ 296,083  
LIABILITIES AND STOCKHOLDERS’ EQUITY            
Current liabilities:            
Accounts payable   $ 2,583     $ 5,611  
Accrued expenses     4,070       7,135  
Deferred revenue     482       341  
Operating lease liabilities, current     2,786       2,575  
Other current liabilities     21       29  
Total current liabilities     9,942       15,691  
Operating lease liabilities, net of current portion     18,956       21,077  
Other noncurrent liabilities     10       8  
Total liabilities     28,908       36,776  
Commitments and contingencies            
Stockholders’ equity:            
Preferred stock, $0.00001 par value; 5,000,000 shares authorized as of September 30, 2026 and December 31, 2025; zero shares issued and outstanding as of September 30, 2026 and December 31, 2025     —       —  
Class A common stock, $0.00001 par value; 94,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 55,809,767 and 56,219,599 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively     1       1  
Class B common stock, $0.00001 par value; 134,268 shares authorized as of September 30, 2026 and December 31, 2025; zero shares issued and outstanding as of September 30, 2026 and December 31, 2025     —       —  
Additional paid-in capital     727,082       724,819  
Accumulated other comprehensive gain (loss)     (746 )     459  
Accumulated deficit     (513,446 )     (465,972 )
Total stockholders’ equity     212,891       259,307  
Total liabilities and stockholders’ equity   $ 241,799     $ 296,083  



Airgain® Reports Third Quarter 2026 Financial Results

Airgain® Reports Third Quarter 2026 Financial Results

Q3 highlighted by strong sequential growth and continued momentum across enterprise IoT

SAN DIEGO–(BUSINESS WIRE)–Airgain, Inc. (NASDAQ: AIRG), a leading provider of advanced wireless connectivity solutions, today reported financial results for the third quarter ended September 30, 2026.

“Airgain delivered another strong quarter of progress, with revenue increasing 12% quarter-over-quarter and 9% year-over-year, driven by continued momentum in our enterprise IoT business,” said Jacob Suen, President and CEO of Airgain. “Our results reflect growing demand across established industrial applications, along with new opportunities in areas such as AI data center infrastructure. We are also making progress across AirgainConnect and Lighthouse as we continue expanding our portfolio of integrated wireless connectivity solutions. While near-term supply constraints continue to affect portions of our business, we remain focused on sustaining enterprise IoT momentum, converting opportunities across our growth platforms into revenue, and driving continued improvements in profitability.”

Third Quarter 2026 and Recent Operational Highlights

  • Introduced Airgain RF Intelligence, an AI-powered platform with the aim to accelerate antenna design and unlock new market opportunities for Airgain’s existing antenna portfolio.

  • Secured two IoT design wins supporting AI data center infrastructure, expanding the use of Airgain’s NimbeLink® embedded cellular modems in electrical energy monitoring and intelligent rack-level power management, with initial revenue expected in 2027.

  • Demonstrated the effectiveness of Lighthouse™ 5G Intelligent Node in a Southern California residential community, improving cellular performance across all five measured locations, including achieving approximately 140 Mbps in an area where usable cellular data service was previously unavailable.

  • Expanded AirgainConnect® engagement across public safety and critical field operations, leveraging its relationship with FirstNet®, Built with AT&T, including participation in the 2026 Vision FirstNet Users Summit.

  • Appointed wireless industry veteran Stephan Memmen to the Board of Directors, bringing more than three decades of industry, operating, and strategic experience to support Airgain’s continued growth.

Third Quarter 2026 Financial Highlights

GAAP

  • Sales of $15.3 million

  • GAAP gross margin of 41.8%

  • GAAP operating expenses of $6.9 million

  • GAAP net loss of $0.6 million or $(0.04) per share

Non-GAAP

  • Non-GAAP gross margin of 42.4%

  • Non-GAAP operating expenses of $6.0 million

  • Non-GAAP net income of $0.5 million or $0.04 per share

  • Adjusted EBITDA of $0.6 million

Third Quarter 2026 Financial Results

Sales for the third quarter of 2026 were $15.3 million, compared to $13.7 million in the second quarter of 2026 and $14.0 million in the third quarter of 2025. Third quarter 2026 sales consisted of $10.0 million from the enterprise market, $4.4 million from the consumer market, and $0.9 million from the automotive market. Sequentially, sales increased $1.6 million or 11.7%. Enterprise sales increased $3.3 million, driven by higher IoT modem shipments. Consumer sales decreased $1.4 million, driven by lower antenna shipments to cable and mobile network operators. Automotive sales decreased $0.3 million, driven by lower aftermarket antenna and vehicle gateway shipments. Compared to the third quarter of 2025, sales increased $1.3 million, or 9.3%, reflecting a $3.1 million increase in enterprise revenue and a $0.4 million increase in automotive revenue, partially offset by a $2.2 million decrease in consumer revenue.

GAAP gross profit for the third quarter of 2026 was $6.4 million, compared to $5.8 million for the second quarter of 2026 and $6.1 million for the same quarter a year ago. Non-GAAP gross profit for the third quarter of 2026 was $6.5 million, compared to $6.0 million for the second quarter of 2026 and $6.2 million for the same quarter a year ago (see note regarding “Use of Non-GAAP Financial Measures” below for further discussion of this non-GAAP measure).

GAAP gross margin for the third quarter of 2026 was 41.8%, compared to 42.3% for the second quarter of 2026 and 43.6% for the same quarter a year ago. The sequential decline primarily reflected an unfavorable shift in customer and product mix, driven by higher sales of lower-margin enterprise IoT products and reduced sales of higher-margin consumer products. Non-GAAP gross margin for the third quarter of 2026 was 42.4% compared to 43.6% for the second quarter of 2026 and 44.4% for the same quarter a year ago (see note regarding “Use of Non-GAAP Financial Measures” below for further discussion of this non-GAAP measure).

GAAP operating expenses for the third quarter of 2026 were $6.9 million, compared to $7.5 million for the second quarter of 2026 and $7.1 million for the same quarter a year ago. The sequential decrease was primarily due to the absence of severance expenses incurred in the second quarter, partially offset by higher employee-related expenses. Operating expenses decreased from the same quarter a year ago, primarily due to lower amortization of intangible assets, partially offset by higher employee-related expenses. Non-GAAP operating expenses for the third quarter of 2026 were $6.0 million, compared to $5.7 million in the second quarter of 2026 and $6.1 million for the same quarter a year ago (see note regarding “Use of Non-GAAP Financial Measures” below for further discussion of this non-GAAP measure).

GAAP net loss for the third quarter of 2026 was $0.6 million or ($0.04) per share (based on 13.1 million shares), compared to $1.7 million or ($0.13) per share (based on 12.8 million shares), for the second quarter of 2026 and $1.0 million, or ($0.08) per share (based on 11.8 million shares), for the same quarter a year ago. Non-GAAP net income for the third quarter of 2026 was $0.5 million, or $0.04 per share (based on 13.4 million diluted shares), compared to $0.3 million, or $0.02 per share (based on 13.2 million shares), for the second quarter of 2026 and $0.1 million, or $0.01 per share (based on 11.9 million shares), for the same quarter a year ago (see note regarding “Use of Non-GAAP Financial Measures” below for further discussion of this non-GAAP measure).

Adjusted EBITDA for the third quarter of 2026 was $0.6 million, compared to $0.4 million for the second quarter of 2026 and $0.3 million for the same quarter a year ago (see note regarding “Use of Non-GAAP Financial Measures” below for further discussion of this non-GAAP measure).

Fourth Quarter 2026 Financial Outlook

GAAP

  • Sales are expected to be in the range of $15.5 million and $17.5 million, or $16.5 million at the midpoint

  • GAAP gross margin is expected to be in the range of 39.2% to 42.2%

  • GAAP operating expense is expected to be approximately $7.0 million

  • GAAP net loss per share is expected to be $(0.02) per share at the midpoint

Non-GAAP

  • Non-GAAP gross margin is expected to be in the range of 40.0% to 43.0%

  • Non-GAAP operating expense is expected to be approximately $6.2 million

  • Non-GAAP net income per share is expected to be $0.05 at the midpoint

  • Adjusted EBITDA is expected to be $0.8 million at the midpoint

The Company’s financial outlook for the three months ending December 31, 2026, including reconciliations of GAAP to non-GAAP measures can be found at the end of this press release.

Conference Call

Management will hold a conference call today, November 10, 2026, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss financial results for the third quarter ended September 30, 2026.

Management will host the presentation, followed by a question-and-answer period.

Dial-In: 877-407-2988 or 201-389-0923 or Call Me

Confirmation #: 13763234

The conference call will be broadcast simultaneously and be available for replay via the investor section of the company’s website at investors.airgain.com.

For webcast access, please follow the web address below to register for the conference call.

Registration: Here

A replay of the webcast will be available via the registration link after 8:00 p.m. Eastern Time until November 10, 2027.

About Airgain, Inc.

Headquartered in San Diego, California, Airgain, Inc. (NASDAQ: AIRG) is a leading provider of advanced wireless connectivity solutions that drive cutting-edge innovation in 5G technology. We are committed to delivering high-performance, cost-effective, and energy-efficient wireless solutions that enable rapid market deployment. Our mission is to connect the world through integrated, innovative, and optimized wireless solutions. Our diverse product portfolio serves three primary markets: enterprise, automotive, and consumer. For more information, visit airgain.com, or follow us on LinkedIn and X.

Airgain, AirgainConnect, and the Airgain logo are trademarks or registered trademarks of Airgain, Inc. All other trademarks are the property of their respective owner.

Forward-Looking Statements

Airgain cautions you that statements in this press release that are not a description of historical facts are forward-looking statements. These statements are based on the company’s current beliefs and expectations. These forward-looking statements include statements regarding our expectations about our pipeline, and timing for production units and shipments and future revenue, the potential for RF Intelligence to accelerate antenna design and unlock new opportunities, the leverage in our model and scalability of revenue, market opportunities and momentum thereto, the size of potential opportunities from design wins, and our fourth quarter 2026 financial outlook. The inclusion of forward-looking statements should not be regarded as a representation by Airgain that any of our plans will be achieved. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in our business, including, without limitation: the market for our products is developing and may not develop as we expect; our operating results may fluctuate significantly, including based on seasonal factors, which makes future operating results difficult to predict and could cause our operating results to fall below expectations or guidance; supply constraints on our contract manufacturers’ and our customers’ ability to obtain necessary components in our respective supply chains, including with respect to memory semiconductors which suppliers may redirect toward higher-margin AI applications, may delay our volume ramp timelines, increase our costs and negatively affect our sales and operating results; risks associated with the performance of our products, including bundled solutions with third-party products, and technologies; our products are subject to intense competition, and competitive pressures from existing and new companies may harm our business, sales, growth rates, and market share; emerging satellite-to-device connectivity technologies may reduce demand for terrestrial wireless solutions or require significant engineering investment to address hybrid connectivity requirements; the potential for partnerships, strategic alliances and advisors to not meet expectations; risks associated with quality and timing in manufacturing our products and our reliance on third-party manufacturers; we may not be able to maintain strategic collaborations under which our bundled solutions are offered; overall global supply shortages, including with respect to memory chips, and logistics delays within the supply chain that our products are used in, and uncertainty regarding tariffs and trade policies and their potential impact, as well as in each case, their adverse effect on general U.S. and global economic conditions and financial markets, and, ultimately, our sales and operating results; any rise in interest rates and inflation may adversely impact our margins, the supply chain and our customers’ sales, which may negatively affect our sales and operating results; our future success depends on our ability to develop and successfully introduce new and enhanced products for the wireless market that meet the needs of our customers, including our ability to transition to provide a more diverse solutions capability; we sell to customers who are price conscious, and a few customers represent a significant portion of our sales, and if we lose any of these customers, our sales could decrease significantly; we rely on a limited number of contract manufacturers to produce and ship all of our products, and our contract manufacturers rely on a single or limited number of suppliers for some components of our products and channel partners to sell and support our products, and the failure to manage our relationships with these parties successfully or a failure of these parties to perform could adversely affect our ability to market and sell our products; if we cannot protect our intellectual property rights, our competitive position could be harmed or we could incur significant expenses to enforce our rights; and other risks described in our prior press releases and in our filings with the Securities and Exchange Commission (SEC), including under the heading “Risk Factors” in our Annual Report on Form 10-K and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and we undertake no obligation to revise or update this press release to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Note Regarding Use of Non-GAAP Financial Measures

To supplement our financial statements presented in accordance with U.S. generally accepted accounting principles (GAAP), this earnings release and the accompanying tables and the related earnings conference call contain certain non-GAAP financial measures, including adjusted earnings before interest, taxes, depreciation, amortization (Adjusted EBITDA), non-GAAP net income (loss) attributable to common stockholders (non-GAAP net income (loss)), non-GAAP net income (loss) per (basic or diluted) share (non-GAAP EPS), non-GAAP operating expense, non-GAAP gross profit and non-GAAP gross margin. We believe these financial measures provide useful information to investors with which to analyze our operating trends and performance.

In computing Adjusted EBITDA, non-GAAP net income (loss), and non-GAAP EPS, we exclude stock-based compensation expense, which represents non-cash charges for the fair value of stock awards; interest income, net of interest expense offset by other expense, depreciation and amortization, workforce reduction severance and exit costs, and provision (benefit) for income taxes. In computing non-GAAP operating expense, we exclude stock-based compensation expense, amortization of intangibles, workforce reduction severance, and exit costs. In computing non-GAAP gross profit and non-GAAP gross margin, we exclude stock-based compensation expense, and amortization of intangible assets. Because of varying available valuation methodologies, subjective assumptions, and the variety of equity instruments that can impact a company’s non-cash operating expenses; we believe that providing non-GAAP financial measures that exclude non-cash expense allows for meaningful comparisons between our core business operating results and those of other companies, as well as providing us with an important tool for financial and operational decision making and for evaluating our own core business operating results over different periods of time. Management considers these types of expenses and adjustments, to a great extent, to be unpredictable and dependent on a considerable number of factors that are outside of our control and are not necessarily reflective of operational performance during a period.

Our non-GAAP measures may not provide information that is directly comparable to that provided by other companies in our industry, as other companies in our industry may calculate non-GAAP financial results differently, particularly related to non-recurring, unusual items. Our Adjusted EBITDA, non-GAAP net income (loss), non-GAAP EPS, non-GAAP operating expense, non-GAAP gross profit and non-GAAP gross margin are not measurements of financial performance under GAAP and should not be considered as an alternative to operating or net income or as an indication of operating performance or any other measure of performance derived in accordance with GAAP. We do not consider these non-GAAP measures to be a substitute for, or superior to, the information provided by GAAP financial results. Reconciliations with specific adjustments to GAAP results and outlooks are provided at the end of this release.

 

Airgain, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except par value)

(unaudited)

 

 

 

September 30, 2026

 

December 31, 2025

 

 

(Unaudited)

 

 

Assets

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

7,710

 

 

$

7,358

 

Trade accounts receivable, net

 

 

13,884

 

 

 

12,775

 

Inventories

 

 

4,943

 

 

 

3,580

 

Prepaid expenses

 

 

1,144

 

 

 

868

 

Other current assets

 

 

483

 

 

 

1,177

 

Total current assets

 

 

28,164

 

 

 

25,758

 

Property and equipment, net

 

 

1,259

 

 

 

1,696

 

Operating lease right-of-use assets

 

 

3,468

 

 

 

4,166

 

Goodwill

 

 

10,845

 

 

 

10,845

 

Intangible assets, net

 

 

2,529

 

 

 

2,787

 

Other assets

 

 

108

 

 

 

85

 

Total assets

 

$

46,373

 

 

$

45,337

 

Liabilities and stockholders’ equity

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

6,788

 

 

$

9,214

 

Accrued compensation

 

 

1,091

 

 

 

1,157

 

Accrued liabilities and other

 

 

4,610

 

 

 

1,790

 

Short-term lease liabilities

 

 

903

 

 

 

821

 

Total current liabilities

 

 

13,392

 

 

 

12,982

 

Deferred tax liability

 

 

192

 

 

 

186

 

Long-term lease liabilities

 

 

3,113

 

 

 

3,880

 

Total liabilities

 

 

16,697

 

 

 

17,048

 

Commitments and contingencies

 

 

 

 

Stockholders’ equity:

 

 

 

 

Common stock and additional paid-in capital, par value $0.0001, 200,000 shares authorized; 13,755 shares issued and 13,214 shares outstanding at September 30, 2026; and 12,666 shares issued and 12,125 shares outstanding at December 31, 2025.

 

 

132,849

 

 

 

127,292

 

Treasury stock, at cost: 541 shares at September 30, 2026 and December 31, 2025.

 

 

(5,364

)

 

 

(5,364

)

Accumulated deficit

 

 

(97,821

)

 

 

(93,635

)

Accumulated other comprehensive income (loss)

 

 

12

 

 

 

(4

)

Total stockholders’ equity

 

 

29,676

 

 

 

28,289

 

Total liabilities and stockholders’ equity

 

$

46,373

 

 

$

45,337

 

 

Airgain, Inc.

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

(unaudited)

 

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

 

2026

 

 

 

2025

 

 

 

2026

 

 

 

2025

 

Sales

 

$

15,324

 

 

$

14,018

 

 

$

40,533

 

 

$

39,654

 

Cost of goods sold

 

 

8,913

 

 

 

7,907

 

 

 

23,360

 

 

 

22,544

 

Gross profit

 

 

6,411

 

 

 

6,111

 

 

 

17,173

 

 

 

17,110

 

Operating expenses:

 

 

 

 

 

 

 

 

Research and development

 

 

2,119

 

 

 

2,141

 

 

 

7,249

 

 

 

7,192

 

Sales and marketing

 

 

2,112

 

 

 

2,144

 

 

 

6,564

 

 

 

7,027

 

General and administrative

 

 

2,636

 

 

 

2,793

 

 

 

7,614

 

 

 

8,954

 

Total operating expenses

 

 

6,867

 

 

 

7,078

 

 

 

21,427

 

 

 

23,173

 

Loss from operations

 

 

(456

)

 

 

(967

)

 

 

(4,254

)

 

 

(6,063

)

Other income (expense):

 

 

 

 

 

 

 

 

Gain on business acquisition

 

 

—

 

 

 

—

 

 

 

340

 

 

 

—

 

Employee retention credit refund

 

 

—

 

 

 

—

 

 

 

—

 

 

 

1,989

 

Interest income, net

 

 

13

 

 

 

13

 

 

 

45

 

 

 

334

 

Other expense, net

 

 

(155

)

 

 

—

 

 

 

(288

)

 

 

(197

)

Total other (expense) income, net

 

 

(142

)

 

 

13

 

 

 

97

 

 

 

2,126

 

Loss before income taxes

 

 

(598

)

 

 

(954

)

 

 

(4,157

)

 

 

(3,937

)

Income tax (benefit) expense

 

 

(15

)

 

 

10

 

 

 

29

 

 

 

48

 

Net loss

 

$

(583

)

 

$

(964

)

 

$

(4,186

)

 

$

(3,985

)

Net loss per share:

 

 

 

 

 

 

 

 

Basic

 

$

(0.04

)

 

$

(0.08

)

 

$

(0.33

)

 

$

(0.34

)

Diluted

 

$

(0.04

)

 

$

(0.08

)

 

$

(0.33

)

 

$

(0.34

)

Weighted average shares used in calculating loss per share:

 

 

 

 

 

 

 

 

Basic

 

 

13,141

 

 

 

11,791

 

 

 

12,767

 

 

 

11,782

 

Diluted

 

 

13,141

 

 

 

11,791

 

 

 

12,767

 

 

 

11,782

 

 

Airgain, Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

 

 

Nine months ended September 30,

 

 

 

2026

 

 

 

2025

 

Cash flows from operating activities:

 

 

 

 

Net loss

 

$

(4,186

)

 

$

(3,985

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

Depreciation

 

 

274

 

 

 

339

 

Loss on disposal of property and equipment

 

 

279

 

 

 

—

 

Amortization of intangible assets

 

 

686

 

 

 

2,415

 

Gain on business acquisition

 

 

(340

)

 

 

—

 

Stock-based compensation

 

 

2,314

 

 

 

1,890

 

Deferred tax liability

 

 

6

 

 

 

(1

)

Changes in operating assets and liabilities:

 

 

 

 

Trade accounts receivable

 

 

(1,109

)

 

 

(1,214

)

Inventories

 

 

(1,363

)

 

 

291

 

Prepaid expenses and other current assets

 

 

417

 

 

 

93

 

Other assets

 

 

(21

)

 

 

(1

)

Accounts payable

 

 

(2,426

)

 

 

(1,575

)

Accrued compensation

 

 

(31

)

 

 

(881

)

Accrued liabilities and other

 

 

2,789

 

 

 

813

 

Lease liabilities

 

 

13

 

 

 

509

 

Net cash used in operating activities

 

 

(2,698

)

 

 

(1,307

)

Cash flows from investing activities:

 

 

 

 

Purchases of property and equipment

 

 

(117

)

 

 

(65

)

Purchase of intellectual property

 

 

(88

)

 

 

(223

)

Net cash used in investing activities

 

 

(205

)

 

 

(288

)

Cash flows from financing activities:

 

 

 

 

Proceeds from at-the-market common stock offering, net of offering costs

 

 

1,836

 

 

 

—

 

Payments for withholding taxes related to net share settlement of equity awards

 

 

—

 

 

 

(191

)

Proceeds from employee stock purchase and option exercises

 

 

1,403

 

 

 

375

 

Net cash provided by financing activities

 

 

3,239

 

 

 

184

 

 

 

 

 

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 

16

 

 

 

(8

)

 

 

 

 

 

Net increase (decrease) in cash, cash equivalents and restricted cash

 

 

352

 

 

 

(1,419

)

Cash, cash equivalents, and restricted cash; beginning of period

 

 

7,413

 

 

 

8,565

 

Cash, cash equivalents, and restricted cash; end of period

 

$

7,765

 

 

$

7,146

 

Supplemental disclosure of non-cash investing and financing activities:

 

 

 

 

Operating lease liabilities resulting from right-of-use assets

 

$

191

 

 

$

716

 

Derecognition of right-of-use assets and lease liabilities due to lease termination

 

$

—

 

 

$

796

 

Accrual of property and equipment

 

$

—

 

 

$

14

 

Cash, cash equivalents, and restricted cash:

 

 

 

 

Cash and cash equivalents

 

$

7,710

 

 

$

7,091

 

Restricted cash included in other assets

 

$

55

 

 

$

55

 

Total cash, cash equivalents, and restricted cash

 

$

7,765

 

 

$

7,146

 

 

Airgain, Inc.

(in thousands)

(unaudited)

 

Sales by Target Market

 

 

 

Three months ended

 

Nine months ended September 30,

 

 

September 30, 2026

 

June 30, 2026

 

September 30, 2025

 

2026

 

2025

Enterprise

 

$

9,974

 

$

6,730

 

$

6,870

 

$

21,656

 

$

18,363

Consumer

 

 

4,386

 

 

5,800

 

 

6,658

 

 

15,800

 

 

18,709

Automotive

 

 

964

 

 

1,168

 

 

490

 

 

3,077

 

 

2,582

Total sales

 

$

15,324

 

$

13,698

 

$

14,018

 

$

40,533

 

$

39,654

 

Reconciliation of GAAP to Non-GAAP Gross Profit

 

 

Three months ended

 

Nine months ended September 30,

 

September 30, 2026

 

June 30, 2026

 

September 30, 2025

 

2026

 

2025

Gross profit

$

6,411

 

 

$

5,789

 

$

6,111

 

$

17,173

 

$

17,110

Stock-based compensation

 

(10

)

 

 

37

 

 

18

 

 

52

 

 

130

Amortization of intangible assets

 

89

 

 

 

91

 

 

88

 

 

270

 

 

266

Severance and exit costs

 

—

 

 

 

21

 

 

—

 

 

21

 

 

—

Acquisition and integration costs

 

—

 

 

 

35

 

 

—

 

 

35

 

 

—

Non-GAAP gross profit

$

6,490

 

 

$

5,973

 

$

6,217

 

$

17,551

 

$

17,506

Reconciliation of GAAP to Non-GAAP Gross Margin

 

 

Three months ended

 

Nine months ended September 30,

 

September 30, 2026

 

June 30, 2026

 

September 30, 2025

 

2026

 

2025

Gross margin

41.8

%

 

42.3

%

 

43.6

%

 

42.4

%

 

43.1

%

Stock-based compensation

—

 

 

0.3

%

 

0.2

%

 

0.1

%

 

0.3

%

Amortization of intangible assets

0.6

%

 

0.7

%

 

0.6

%

 

0.6

%

 

0.7

%

Severance and exit costs

—

 

 

0.1

%

 

—

 

 

0.1

%

 

—

 

Acquisition and integration costs

—

 

 

0.2

%

 

—

 

 

0.1

%

 

—

 

Non-GAAP gross margin

42.4

%

 

43.6

%

 

44.4

%

 

43.3

%

 

44.1

%

Reconciliation of GAAP to Non-GAAP Operating Expenses

 

 

Three months ended

 

Nine months ended September 30,

 

September 30, 2026

 

June 30, 2026

 

September 30, 2025

 

 

2026

 

 

 

2025

 

Operating expenses

$

6,867

 

 

$

7,474

 

 

$

7,078

 

 

$

21,427

 

 

$

23,173

 

Stock-based compensation expense

 

(722

)

 

 

(858

)

 

 

(362

)

 

 

(2,262

)

 

 

(1,760

)

Amortization of intangible assets

 

(146

)

 

 

(144

)

 

 

(654

)

 

 

(416

)

 

 

(1,960

)

Severance and exit costs

 

—

 

 

 

(569

)

 

 

6

 

 

 

(569

)

 

 

(280

)

Acquisition and integration costs

 

—

 

 

 

(214

)

 

 

—

 

 

 

(388

)

 

 

—

 

Non-GAAP operating expenses

$

5,999

 

 

$

5,689

 

 

$

6,068

 

 

$

17,792

 

 

$

19,173

 

 

Airgain, Inc.

(in thousands, except per share data)

(unaudited)

Reconciliation of GAAP to Non-GAAP Net Income (Loss)

 

 

Three months ended

 

Nine months ended September 30,

 

September 30, 2026

 

June 30, 2026

 

September 30, 2025

 

 

2026

 

 

 

2025

 

Net loss

$

(583

)

 

$

(1,706

)

 

$

(964

)

 

$

(4,186

)

 

$

(3,985

)

Employee retention credit

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,989

)

Stock-based compensation expense

 

712

 

 

 

895

 

 

 

380

 

 

 

2,314

 

 

 

1,890

 

Amortization of intangible assets

 

235

 

 

 

235

 

 

 

742

 

 

 

686

 

 

 

2,226

 

Severance and exit costs

 

—

 

 

 

590

 

 

 

(6

)

 

 

590

 

 

 

280

 

Gain on business acquisition

 

—

 

 

 

—

 

 

 

—

 

 

 

(340

)

 

 

—

 

Acquisition and integration costs

 

—

 

 

 

249

 

 

 

—

 

 

 

423

 

 

 

—

 

Other expense (income), net

 

142

 

 

 

49

 

 

 

(15

)

 

 

243

 

 

 

(158

)

Income tax (benefit) expense

 

(15

)

 

 

(28

)

 

 

10

 

 

 

29

 

 

 

48

 

Non-GAAP net income (loss) attributable to common stockholders

$

491

 

 

$

284

 

 

$

147

 

 

$

(241

)

 

$

(1,688

)

Non-GAAP net income (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

$

0.04

 

 

$

0.02

 

 

$

0.01

 

 

$

(0.02

)

 

$

(0.14

)

Diluted

$

0.04

 

 

$

0.02

 

 

$

0.01

 

 

$

(0.02

)

 

$

(0.14

)

Weighted average shares used in calculating non-GAAP net income (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

13,141

 

 

 

12,841

 

 

 

11,791

 

 

 

12,767

 

 

 

11,782

 

Diluted

 

13,359

 

 

 

13,189

 

 

 

11,941

 

 

 

12,767

 

 

 

11,782

 

 

Reconciliation of Net Loss to Adjusted EBITDA

 

 

Three months ended

 

Nine months ended September 30,

 

September 30, 2026

 

June 30, 2026

 

September 30, 2025

 

 

2026

 

 

 

2025

 

Net loss

$

(583

)

 

$

(1,706

)

 

$

(964

)

 

$

(4,186

)

 

$

(3,985

)

Employee retention credit

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,989

)

Stock-based compensation expense

 

712

 

 

 

895

 

 

 

380

 

 

 

2,314

 

 

 

1,890

 

Depreciation and amortization

 

314

 

 

 

331

 

 

 

845

 

 

 

960

 

 

 

2,565

 

Severance and exit costs

 

—

 

 

 

590

 

 

 

(6

)

 

 

590

 

 

 

280

 

Gain on business acquisition

 

—

 

 

 

—

 

 

 

—

 

 

 

(340

)

 

 

—

 

Acquisition and integration costs

 

—

 

 

 

249

 

 

 

—

 

 

 

423

 

 

 

—

 

Other expense (income), net

 

142

 

 

 

49

 

 

 

(15

)

 

 

243

 

 

 

(158

)

Income tax (benefit) expense

 

(15

)

 

 

(28

)

 

 

10

 

 

 

29

 

 

 

48

 

Adjusted EBITDA

$

570

 

 

$

380

 

 

$

250

 

 

$

33

 

 

$

(1,349

)

 

Q4-2026 Financial Outlook

 

 

 

 

 

 

 

Reconciliations of GAAP to Non-GAAP Gross Margin, Operating Expense, Net Income (Loss), EPS and to Adjusted EBITDA

For the Three Months Ended December 31, 2026

(dollars in millions, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Margin Reconciliation:

 

 

 

Operating Expense Reconciliation:

 

 

GAAP gross margin

 

 

40.7

%

 

GAAP operating expenses

 

$

7.0

 

Stock-based compensation

 

 

0.2

%

 

Stock-based compensation

 

 

(0.7

)

Amortization

 

 

0.6

%

 

Amortization

 

 

(0.1

)

Non-GAAP gross margin

 

 

41.5

%

 

Non-GAAP operating expenses

 

$

6.2

 

 

 

 

 

 

 

 

Net Income (Loss) Reconciliation

 

 

 

Net Income (Loss) per Share Reconciliation(1):

 

 

GAAP net income (loss)

 

$

(0.3

)

 

GAAP net income (loss) per share

 

$

(0.02

)

Stock-based compensation

 

 

0.7

 

 

Stock-based compensation

 

 

0.05

 

Amortization

 

 

0.3

 

 

Amortization

 

 

0.02

 

Non-GAAP net income

 

$

0.7

 

 

Non-GAAP net income per share

 

$

0.05

 

 

 

 

 

 

 

 

Adjusted EBITDA Reconciliation

 

 

 

 

 

 

GAAP net income (loss)

 

$

(0.3

)

 

 

 

 

Stock-based compensation

 

 

0.7

 

 

 

 

 

Depreciation and amortization

 

 

0.4

 

 

 

 

 

Adjusted EBITDA

 

$

0.8

 

 

 

 

 

 

 

 

 

 

 

 

(1) Amounts are based on 13.2 million basic and 13.4 million diluted weighted average shares outstanding.

 

Airgain Contact

Michael Elbaz

Chief Financial Officer

[email protected]

Airgain Investor Contact

Matt Glover

Gateway Group, Inc.

+1 949 574 3860

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: IOT (Internet of Things) Technology Telecommunications Mobile/Wireless 5G Artificial Intelligence Internet

MEDIA:

Astera Labs Announces Upcoming Financial Conference Participation

SAN JOSE, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) — Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced its participation in the following financial conferences:

  • BMO Technology and Innovation Leaders Conference on Nov. 12th in New York. Astera Labs’ presentation is scheduled for 9:15 am ET.
  • Raymond James 2026 TMT & Consumer Conference on Dec. 8th in New York. Astera Labs’ presentation is scheduled for 9:20 am ET.
  • Barclays 24th Annual Global Technology Conference on Dec. 9th in San Francisco. Astera Labs’ presentation is scheduled for 2:00 pm PT.
  • Needham Growth Conference on Jan. 12th in New York. Astera Labs’ presentation time will be available on the investor relations website.

Webcasts of these sessions will be available on Astera Labs’ investor relations website at https://ir.asteralabs.com

About Astera Labs

Astera Labs (Nasdaq: ALAB) provides rack-scale AI infrastructure through purpose-built connectivity solutions. By collaborating with hyperscalers and ecosystem partners, Astera Labs enables organizations to unlock the full potential of modern AI. Astera Labs’ Intelligent Connectivity Platform integrates CXL®, Ethernet, NVLink Fusion, PCIe®, and UALink™ semiconductor-based technologies with the company’s COSMOS software suite to unify diverse components into cohesive, flexible systems that deliver end-to-end scale-up and scale-out connectivity. The company’s custom connectivity solutions business complements its standards-based portfolio, enabling customers to deploy tailored architectures to meet their unique infrastructure requirements. Discover more at www.asteralabs.com.

IR CONTACT: Leslie Green
[email protected]



Beachbody (BODi) Reports Third Quarter Financial Results

Beachbody (BODi) Reports Third Quarter Financial Results

Net Income and Operating Income Reported for Fifth Consecutive Quarter

Net Income and Adjusted EBITDA Exceed High End of Guidance

Revenue Within Guidance

Twelfth Consecutive Quarter of Positive Adjusted EBITDA

EL SEGUNDO, Calif.–(BUSINESS WIRE)–
The Beachbody Company, Inc. (NASDAQ: BODi) (“BODi” or the “Company”), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, today announced financial results for its third quarter ended September 30, 2026.

“Net income and adjusted EBITDA exceeded the high end of our guidance and revenue met expectations as we continue to transform our business model,” said Carl Daikeler, co-founder and BODi’s Chief Executive Officer. “As the proactive wellness company delivering nutrition, supplements and proven fitness programs that help people take control of their health, we are executing on our omni-channel strategy to place our iconic brands wherever shoppers are. Our innovation pipeline is strong and we expect to continue to benefit from our compelling digital fitness content along with our premium nutritional products as consumers increasingly focus on complete wellness solutions.”

“Our third quarter results mark our twelfth consecutive quarter of positive Adjusted EBITDA and our fifth consecutive quarter of double-digit Adjusted EBITDA margins, reflecting the operating discipline we have built into this company,” said Mark Goldston, BODi’s Executive Chairman. “Additional cost efficiencies are lowering our breakeven point even further and our multi-channel distribution strategy is gaining traction as we bring on new partners and expand our rollout across retail, DTC and Amazon. Our focus on the wellness category, under the BODi Wellness umbrella, significantly broadens our total addressable market and we are well positioned to capitalize on this massive opportunity.”

Third Quarter 2026 Results

  • Total revenue was $45.2 million compared to $59.9 million in the prior year period.

    • Digital revenue was $27.8 million compared to $36.4 million in the prior year period and digital subscriptions totaled 0.69 million in the third quarter.

    • Nutrition and Other revenue was $17.4 million compared to $23.5 million in the prior year period and nutritional subscriptions totaled 0.06 million in the third quarter.

  • Gross margin was 70.7% compared to 74.6% in the prior year period.

  • Total operating expenses were $30.7 million compared to $39.7 million in the prior year period.

  • Operating income decreased by $3.7 million to $1.3 million, the Company’s fifth consecutive quarter of operating income, compared to $5.0 million in the prior year period.

  • Net income was $3.3 million, the Company’s fifth consecutive quarter of net income, compared to $3.6 million in the prior year period.

  • Adjusted EBITDA1 was $6.4 million compared to $9.5 million in the prior year period.

  • Adjusted net income1 was $0.6 million compared to $4.3 million in the prior year period.

  • Cash used in operating activities for the nine months ended September 30, 2026 was $10.1 million compared to cash provided by operating activities of $16.8 million in the prior year period, and cash provided by investing activities was $0.4 million compared to cash used in investing activities of $3.7 million in the prior year period. Free cash flow1 was $(12.1) million compared to $13.1 million in the prior year period.

1Definitions of (1) Adjusted EBITDA, (2) adjusted net income (loss), (3) free cash flow and (4) net cash position, and reconciliations to the comparable GAAP metrics, are at the end of this release.

Key Operational and Business Metrics

 

 

For the Three Months Ended

September 30,

 

For the Nine Months Ended

September 30,

 

 

2026

2025

Change v 2025

 

2026

2025

Change v 2025

 

 

 

 

 

 

 

 

 

Digital Subscriptions (in millions)

 

0.69

0.90

(23.3%)

 

0.69

0.90

(23.3%)

Nutritional Subscriptions (in millions)

 

0.06

0.07

(14.3%)

 

0.06

0.07

(14.3%)

Total Subscriptions (in millions)

 

0.75

0.97

(22.7%)

 

0.75

0.97

(22.7%)

 

 

 

 

 

 

 

 

 

Average Digital Retention

 

95.4%

96.9%

(150bps)

 

95.8%

96.9%

(110bps)

Total Streams (in millions)

 

13.3

17.6

(24.4%)

 

46.4

56.4

(17.8%)

DAU/MAU

 

31.4%

32.0%

(60bps)

 

32.1%

32.0%

10bps

 

 

 

 

 

 

 

 

 

Connected Fitness Units Delivered (in thousands)

 

—

—

—%

 

—

1.5

(100.0%)

 

 

 

 

 

 

 

 

 

Digital

 

$27.8

$36.4

(23.5%)

 

$92.6

$119.0

(22.2%)

Nutrition & Other

 

$17.4

$23.5

(26.1%)

 

$56.5

$76.3

(25.9%)

Connected Fitness

 

$—

$—

—%

 

$—

$0.9

(100.0%)

Revenue (in millions)

 

$45.2

$59.9

(24.5%)

 

$149.1

$196.2

(24.0%)

Net Income (loss) (in millions)

 

$3.3

$3.6

(8.1%)

 

$7.0

($8.1)

NM

Adjusted Net Income (loss) (in millions)

 

$0.6

$4.3

(84.9%)

 

$4.0

($3.6)

NM

Adjusted EBITDA (in millions)

 

$6.4

$9.5

(32.6%)

 

$21.0

$17.9

17.3%

 

 

 

 

 

 

 

 

 

NM: Not Meaningful

Outlookfor The Fourth Quarter of 2026

 

 

Outlook For Quarter Ending December 31, 2026

 

 

 

Low

 

High

 

(in millions)

 

 

 

 

 

Revenue

 

$

38

 

$

42

 

 

 

 

 

 

 

Net Income (Loss)(1)(2)

 

$

(2

)

$

1

 

Adjustments – Restructuring(2)

 

$

3

 

$

3

 

Adjusted Net Income(1)

 

$

1

 

$

4

 

 

 

 

 

 

 

Net Income (Loss)(1)(2)

 

$

(2

)

$

1

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

Depreciation

 

$

1

 

$

1

 

Amortization of Content Assets

 

$

2

 

$

2

 

Interest Expense

 

$

1

 

$

1

 

Equity-Based Compensation

 

$

1

 

$

1

 

Other (restructuring, income tax, interest income)

 

$

3

 

$

3

 

Total Adjustments

 

$

8

 

$

8

 

 

 

 

 

 

 

Adjusted EBITDA

 

$

6

 

$

9

 

 

 

 

 

 

 

(1)A reconciliation between the outlook of net income (loss) and the outlook for adjusted net income has only been provided for restructuring expenses expected in the fourth quarter of 2026 and has not been provided for other adjustments given the inability to forecast certain reconciling items without unreasonable efforts. In particular the outlook for net income (loss) and adjusted net income does not include the change in fair value of warrant liabilities as that is significantly impacted by the change in the Company’s stock price which cannot be estimated and other potential reconciling items such as impairment of goodwill that are not normal, recurring operating activities that cannot be reasonably forecasted.

(2) The outlook for the fourth quarter of 2026 net income (loss) includes restructuring expense of $3 million which is an adjustment to determine adjusted net income.

Conference Call and Webcast Information

BODi will host a conference call at 5:00pm ET on Tuesday, November 10, 2026, to discuss its financial results and matters other than past results, such as guidance. To participate in the live call, please dial (833) 461-5787 (U.S. & Canada) and provide the conference identification number: 705307026. The conference call will also be available to interested parties through a live webcast at https://investors.thebeachbodycompany.com/.

After the conference call, a webcast replay will remain available on the investor relations section of the Company’s website for one year.

About BODi and The Beachbody Company, Inc.

BODi is the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out. With nearly three decades of experience, BODi, formerly Beachbody, has evolved from a leader in home fitness into a comprehensive health and fitness ecosystem designed to help people achieve their goals and lead healthier, more fulfilling lives. Anchored by science-backed nutrition solutions like Shakeology and supported by its portfolio of proven fitness and habit-building programs, including P90X and INSANITY, BODi is creating a more accessible and effective path to long-term health. Since its inception, BODi has supported more than 30 million customers in achieving lasting results. The company continues to innovate across nutrition and digital fitness to deliver simple, proven solutions for modern lifestyles. For more information, please visit TheBeachBodyCompany.com.

Safe Harbor Statement

This press release of The Beachbody Company, Inc. (“we,” “us,” “our,” and similar terms) contains “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are statements other than statements of historical facts and statements in future tense. These statements include but are not limited to, statements regarding our future performance and our market opportunity, including expected financial results for the third quarter and full year, our business strategy, our plans, and our objectives and future operations.

Forward-looking statements are based upon various estimates and assumptions, as well as information known to us as of the date hereof, and are subject to risks and uncertainties. Accordingly, actual results could differ materially due to a variety of factors, including: our ability to effectively compete in the fitness and nutrition industries; our ability to successfully acquire and integrate new operations; our reliance on a few key products; market conditions and global and economic factors beyond our control; intense competition and competitive pressures from other companies worldwide in the industries in which we operate; and litigation and the ability to adequately protect our intellectual property rights. You can identify these statements by the use of terminology such as “believe”, “plans”, “expect”, “will”, “should,” “could”, “estimate”, “anticipate” or similar forward-looking terms. You should not rely on these forward-looking statements as they involve risks and uncertainties that may cause actual results to vary materially from the forward-looking statements. For more information regarding the risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements, as well as risks relating to our business in general, we refer you to the “Risk Factors” section of our Securities and Exchange Commission (SEC) filings, including those risks and uncertainties included in the Form 10-K filed with the SEC on March 10, 2026 and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K, which are available on the Investor Relations page of our website at https://investors.thebeachbodycompany.com and on the SEC’s website at www.sec.gov.

All forward-looking statements contained herein are based on information available to us as of the date hereof and you should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance, or achievements. We undertake no obligation to update any of these forward-looking statements for any reason after the date of this press release or to conform these statements to actual results or revised expectations, except as required by law. Undue reliance should not be placed on forward-looking statements.

 

The Beachbody Company, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

 
 

 

 

September 30,

 

December 31,

 

 

 

2026

 

 

 

2025

 

 

 

(unaudited)

 

 

Assets

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents (restricted cash of zero and $0.1 million at September 30, 2026 and December 31, 2025, respectively)

 

$

27,529

 

 

$

39,017

 

Restricted short-term investments

 

 

1,750

 

 

 

4,250

 

Inventory

 

 

14,435

 

 

 

9,410

 

Prepaid expenses

 

 

4,490

 

 

 

6,823

 

Other current assets

 

 

2,700

 

 

 

4,338

 

Total current assets

 

 

50,904

 

 

 

63,838

 

Property and equipment, net

 

 

5,122

 

 

 

8,523

 

Content assets, net

 

 

5,775

 

 

 

6,292

 

Goodwill

 

 

65,166

 

 

 

65,166

 

Right-of-use assets, net

 

 

1,019

 

 

 

1,625

 

Other assets

 

 

1,061

 

 

 

1,591

 

Total assets

 

$

129,047

 

 

$

147,035

 

Liabilities and Stockholders’ Equity

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

5,802

 

 

$

5,304

 

Accrued expenses

 

 

11,822

 

 

 

18,408

 

Deferred revenue

 

 

42,962

 

 

 

56,866

 

Current portion of lease liabilities

 

 

650

 

 

 

1,036

 

Current portion of debt

 

 

2,700

 

 

 

1,062

 

Other current liabilities

 

 

755

 

 

 

3,920

 

Total current liabilities

 

 

64,691

 

 

 

86,596

 

Long-term debt

 

 

20,193

 

 

 

22,564

 

Long-term lease liabilities, net

 

 

418

 

 

 

738

 

Other liabilities

 

 

1,433

 

 

 

5,817

 

Total liabilities

 

 

86,735

 

 

 

115,715

 

Stockholders’ equity:

 

 

 

 

Preferred stock, $0.0001 par value; 100,000,000 shares

authorized, none issued and outstanding at September 30, 2026

and December 31, 2025

 

 

—

 

 

 

—

 

Common stock, $0.0001 par value, 1,900,000,000 shares

authorized (1,600,000,000 Class A, 200,000,000 Class X and

100,000,000 Class C);

 

 

 

 

Class A: 4,575,156 and 4,450,721 shares issued and

outstanding at September 30, 2026 and December 31,

2025, respectively;

 

 

1

 

 

 

1

 

Class X: 2,729,003 shares issued and outstanding

at September 30, 2026 and December 31, 2025,

respectively;

 

 

1

 

 

 

1

 

Class C: no shares issued and outstanding at

September 30, 2026 and December 31, 2025

 

 

—

 

 

 

—

 

Additional paid-in capital

 

 

681,772

 

 

 

677,743

 

Accumulated deficit

 

 

(639,427

)

 

 

(646,378

)

Accumulated other comprehensive loss

 

 

(35

)

 

 

(47

)

Total stockholders’ equity

 

 

42,312

 

 

 

31,320

 

Total liabilities and stockholders’ equity

 

$

129,047

 

 

$

147,035

 

 

The Beachbody Company, Inc.

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except per share data)

 
 

 

 

Three months ended

September 30,

 

Nine months ended

September 30,

 

 

 

2026

 

 

 

2025

 

 

 

2026

 

 

 

2025

 

 

 

 

 

 

 

 

 

 

Revenue:

 

 

 

 

 

 

 

 

Digital

 

$

27,832

 

 

$

36,390

 

 

$

92,552

 

 

$

118,994

 

Nutrition and other

 

 

17,353

 

 

 

23,497

 

 

 

56,530

 

 

 

76,322

 

Connected fitness

 

 

—

 

 

 

—

 

 

 

—

 

 

 

875

 

Total revenue

 

 

45,185

 

 

 

59,887

 

 

 

149,082

 

 

 

196,191

 

Cost of revenue:

 

 

 

 

 

 

 

 

Digital

 

 

3,806

 

 

 

4,348

 

 

 

12,066

 

 

 

15,452

 

Nutrition and other

 

 

9,413

 

 

 

10,890

 

 

 

30,305

 

 

 

36,081

 

Connected fitness

 

 

—

 

 

 

—

 

 

 

—

 

 

 

2,222

 

Total cost of revenue

 

 

13,219

 

 

 

15,238

 

 

 

42,371

 

 

 

53,755

 

Gross profit

 

 

31,966

 

 

 

44,649

 

 

 

106,711

 

 

 

142,436

 

Operating expenses:

 

 

 

 

 

 

 

 

Selling and marketing

 

 

11,549

 

 

 

19,130

 

 

 

45,942

 

 

 

75,628

 

Enterprise technology and development

 

 

10,193

 

 

 

10,406

 

 

 

29,484

 

 

 

33,613

 

General and administrative

 

 

8,913

 

 

 

10,139

 

 

 

25,192

 

 

 

33,367

 

Restructuring

 

 

—

 

 

 

(12

)

 

 

—

 

 

 

2,480

 

Total operating expenses

 

 

30,655

 

 

 

39,663

 

 

 

100,618

 

 

 

145,088

 

Operating income (loss)

 

 

1,311

 

 

 

4,986

 

 

 

6,093

 

 

 

(2,652

)

Other income (expense):

 

 

 

 

 

 

 

 

Loss on debt extinguishment

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(2,166

)

Change in fair value of warrant liabilities

 

 

2,685

 

 

 

(762

)

 

 

3,013

 

 

 

107

 

Interest expense

 

 

(1,047

)

 

 

(1,056

)

 

 

(3,070

)

 

 

(3,889

)

Other income, net

 

 

323

 

 

 

352

 

 

 

1,056

 

 

 

618

 

Income (loss) before income taxes

 

 

3,272

 

 

 

3,520

 

 

 

7,092

 

 

 

(7,982

)

Income tax (provision) benefit

 

 

9

 

 

 

49

 

 

 

(141

)

 

 

(97

)

Net income (loss)

 

$

3,281

 

 

$

3,569

 

 

$

6,951

 

 

$

(8,079

)

 

 

 

 

 

 

 

 

 

Net income (loss) per common share, basic (1)

 

$

0.45

 

 

$

0.51

 

 

$

0.96

 

 

$

(1.16

)

Net income (loss) per common share, diluted (1)

 

$

0.38

 

 

$

0.51

 

 

$

0.86

 

 

$

(1.16

)

Weighted-average common shares outstanding, basic

 

 

7,219

 

 

 

6,999

 

 

 

7,172

 

 

 

6,945

 

Weighted-average common shares outstanding, diluted

 

 

7,418

 

 

 

7,046

 

 

 

7,415

 

 

 

6,945

 

 

(1) In computing basic and diluted net income per common share, net income is reduced by the amount of undistributed net income allocated to participating securities other than common shares, as required under the two-class method. In computing the diluted net income per share, net income is adjusted for the change in fair value of warrant liabilities for warrants that are dilutive.

 

The Beachbody Company, Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

 
 

 

 

Nine months ended September 30,

 

 

 

2026

 

 

 

2025

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

Net income (loss)

 

$

6,951

 

 

$

(8,079

)

Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:

 

 

 

 

Depreciation and amortization expense

 

 

5,602

 

 

 

6,789

 

Amortization of content assets

 

 

3,793

 

 

 

6,945

 

Provision for inventory

 

 

1,087

 

 

 

1,256

 

Change in fair value of warrant liabilities

 

 

(3,013

)

 

 

(107

)

Equity-based compensation

 

 

4,280

 

 

 

4,744

 

Amortization of debt issuance costs

 

 

596

 

 

 

1,280

 

Paid-in-kind interest expense

 

 

—

 

 

 

218

 

Loss on debt extinguishment

 

 

—

 

 

 

2,166

 

Change in lease assets

 

 

606

 

 

 

1,161

 

Changes in operating assets and liabilities:

 

 

 

 

Inventory

 

 

(6,112

)

 

 

3,899

 

Content assets

 

 

(3,276

)

 

 

(2,294

)

Prepaid expenses

 

 

2,333

 

 

 

4,718

 

Other assets

 

 

2,273

 

 

 

23,378

 

Accounts payable

 

 

381

 

 

 

(5,234

)

Accrued expenses

 

 

(6,572

)

 

 

(1,844

)

Deferred revenue

 

 

(15,058

)

 

 

(17,434

)

Other liabilities

 

 

(3,942

)

 

 

(4,795

)

Net cash (used in) provided by operating activities

 

 

(10,071

)

 

 

16,767

 

Cash flows from investing activities:

 

 

 

 

Purchase of property and equipment

 

 

(2,075

)

 

 

(3,698

)

Maturity of restricted short-term investments

 

 

2,500

 

 

 

—

 

Net cash provided by (used in) investing activities

 

 

425

 

 

 

(3,698

)

Cash flows from financing activities:

 

 

 

 

Proceeds from exercise of stock options

 

 

112

 

 

 

67

 

Debt borrowings

 

 

—

 

 

 

25,000

 

Debt repayments

 

 

(579

)

 

 

(22,582

)

Proceeds from issuance of common shares in the Employee Stock Purchase Plan

 

 

95

 

 

 

78

 

Tax withholding payments for vesting of restricted stock

 

 

(458

)

 

 

(271

)

Payment of debt issuance costs

 

 

(750

)

 

 

(1,781

)

Net cash (used in) provided by financing activities

 

 

(1,580

)

 

 

511

 

Effect of exchange rates on cash, cash equivalents, and restricted cash

 

 

(262

)

 

 

182

 

Net (decrease) increase in cash, cash equivalents, and restricted cash

 

 

(11,488

)

 

 

13,762

 

Cash, cash equivalents and restricted cash, beginning of period

 

 

39,017

 

 

 

20,187

 

Cash, cash equivalents, and restricted cash, end of period

 

$

27,529

 

 

$

33,949

 

Supplemental disclosure of cash flow information:

 

 

 

 

Cash paid during the period for interest

 

$

2,462

 

 

$

1,758

 

Cash received during the period for US Federal income taxes

 

 

—

 

 

 

(324

)

Cash paid during the period for Texas GMT income taxes

 

 

69

 

 

 

73

 

Cash (received) paid during the period for UK income taxes

 

 

—

 

 

 

24

 

Cash paid during the period for Canada income taxes

 

 

16

 

 

 

26

 

Cash paid during the period for income taxes from other jurisdictions

 

 

13

 

 

 

22

 

Supplemental disclosure of noncash investing activities:

 

 

 

 

Property and equipment acquired but not yet paid for

 

$

405

 

 

$

359

 

 
 

The Beachbody Company, Inc.

Non GAAP Information

Adjusted EBITDA

We use Adjusted EBITDA, which is a non-GAAP performance measure, to supplement our results presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). We believe Adjusted EBITDA is useful in evaluating our operating performance, as it is similar to measures reported by our public competitors and is regularly used by security analysts, institutional investors, and other interested parties in analyzing operating performance and prospects. Adjusted EBITDA is not intended to be a substitute for any GAAP financial measure and, as calculated, may not be comparable to other similarly titled measures of performance of other companies in other industries or within the same industry.

We define and calculate Adjusted EBITDA as net income (loss) adjusted for depreciation and amortization, amortization of capitalized cloud computing implementation costs, amortization of content assets, interest expense, income tax provision, equity-based compensation, restructuring costs, and other items that are not normal, recurring, operating expenses necessary to operate the Company’s business as described in the reconciliation below.

We include this non-GAAP financial measure because it is used by management to evaluate BODi’s core operating performance and trends and to make strategic decisions regarding the allocation of capital and new investments. Adjusted EBITDA excludes certain expenses that are required in accordance with GAAP because they are non-cash (for example, in the case of depreciation and amortization and equity-based compensation) or are not related to our underlying business performance (for example, in the case of restructuring costs, interest income and expense).

The table below presents our Adjusted EBITDA reconciled to our net income (loss), the closest GAAP measure, for the periods indicated:

 

 

Three months ended September 30,

 

Nine months ended September 30,

(in thousands)

 

 

2026

 

 

 

2025

 

 

 

2026

 

 

 

2025

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

3,281

 

 

$

3,569

 

 

$

6,951

 

 

$

(8,079

)

Adjusted for:

 

 

 

 

 

 

 

 

Loss on debt extinguishment (1)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

2,166

 

Depreciation and amortization

 

 

1,428

 

 

 

1,879

 

 

 

5,602

 

 

 

6,789

 

Amortization of capitalized cloud computing implementation costs

 

 

534

 

 

 

37

 

 

 

918

 

 

 

112

 

Amortization of content assets

 

 

1,124

 

 

 

1,927

 

 

 

3,793

 

 

 

6,945

 

Interest expense

 

 

1,047

 

 

 

1,056

 

 

 

3,070

 

 

 

3,889

 

Income tax (benefit) provision

 

 

(9

)

 

 

(49

)

 

 

141

 

 

 

97

 

Equity-based compensation (2)

 

 

1,877

 

 

 

1,003

 

 

 

4,280

 

 

 

4,744

 

Restructuring (3)

 

 

—

 

 

 

(12

)

 

 

—

 

 

 

2,480

 

Change in fair value of warrant liabilities

 

 

(2,685

)

 

 

762

 

 

 

(3,013

)

 

 

(107

)

Non-operating (4)

 

 

(243

)

 

 

(628

)

 

 

(778

)

 

 

(1,147

)

Adjusted EBITDA

 

$

6,354

 

 

$

9,544

 

 

$

20,964

 

 

$

17,889

 

1

The nine months ended September 30, 2025 represents the loss related to the $17.3 million debt extinguishment that the Company made on May 13, 2025.

2

Includes benefits due to the modification of stock awards of approximately zero and $0.9 million for the three and nine months ended September 30, 2025, respectively.

3

Includes post-Pivot restructuring expenses, primarily termination benefits, of approximately zero and $2.5 million for the three and nine months ended September 30, 2025.

4

Primarily includes interest income.

 

Adjusted Net Income (Loss)

We use adjusted net income (loss), which is a non-GAAP performance measure, to supplement our results presented in accordance with GAAP. We believe adjusted net income (loss) is useful in evaluating our operating performance, as it is similar to measures reported by our public competitors and is regularly used by security analysts, institutional investors, and other interested parties in analyzing operating performance and prospects. Adjusted net income (loss) is not intended to be a substitute for any GAAP financial measure and, as calculated, may not be comparable to other similarly titled measures of performance of other companies in other industries or within the same industry.

We define and calculate adjusted net income (loss) as net income (loss) adjusted for impairment of goodwill, restructuring costs, the change in fair value of warrant liabilities, and other items that are not normal, recurring operating activities necessary to operate the Company’s business, and the tax impact of the adjustments as described in the reconciliation below.

We include this non-GAAP financial measure because it is used by management to evaluate BODi’s core operating performance and trends and to make strategic decisions regarding the allocation of capital and new investments. Adjusted net income (loss) excludes certain expenses that are required in accordance with GAAP because they are non-cash (for example, in the case of impairment of goodwill and the change in fair value of warrant liabilities) or are not related to our underlying business performance (for example, in the case of restructuring costs).

The table below presents our adjusted net income (loss) reconciled to our net income (loss), the closest GAAP measure, for the periods indicated:

 

 

Three Months Ended September 30,

 

Nine months ended September 30,

(in thousands)

 

 

2026

 

 

 

2025

 

 

 

2026

 

 

 

2025

 

Net income (loss)

 

$

3,281

 

 

$

3,569

 

 

$

6,951

 

 

$

(8,079

)

Adjusted for:

 

 

 

 

 

 

 

 

Loss on debt extinguishment (1)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

2,166

 

Restructuring (2)

 

 

—

 

 

 

(12

)

 

 

—

 

 

 

2,480

 

Change in fair value of warrant liabilities

 

 

(2,685

)

 

 

762

 

 

 

(3,013

)

 

 

(107

)

Tax impact of adjustment (3)

 

 

53

 

 

 

(9

)

 

 

60

 

 

 

(55

)

Adjusted net income (loss)

 

$

649

 

 

$

4,310

 

 

$

3,998

 

 

$

(3,595

)

 

(1) The nine months ended September 30, 2025 represents the loss related to the $17.3 million debt extinguishment that the Company made on May 13, 2025.

(2) Includes post-Pivot restructuring expenses, primarily termination benefits, of approximately zero and $2.5 million for the three and nine months ended September 30, 2025.

(3) Tax impact calculated using the annual effective tax rate.

Net Cash Position

We use net cash position, which is a non-GAAP liquidity measure, to supplement our liquidity as presented in accordance with GAAP. We believe that net cash position is useful in viewing our liquidity, as it is similar to measures reported by our public competitors and is regularly used by security analysts, institutional investors, and other interested parties in analyzing liquidity. Net cash position is not intended to be a substitute for GAAP financial measures and, as calculated may not be comparable to other similarly titled measures of liquidity for other companies in other industries or within the same industry.

The table below presents our net cash position, which is our cash and cash equivalents less the debt on our balance sheet for the periods indicated:

 

 

September 30,

 

 

December 31,

(in thousands)

 

2026

 

 

2025

 

 

 

 

 

 

Cash and cash equivalents

 

$

27,529

 

 

$

39,017

Less:

 

 

 

 

 

Current portion of debt

 

 

2,700

 

 

 

1,062

Long-term debt

 

 

20,193

 

 

 

22,564

Net cash position

 

$

4,636

 

 

$

15,391

 

 

 

 

 

 

Free Cash Flow

We use free cash flow, which is a non-GAAP liquidity measure, to supplement our cash provided by (used in) operating activities as presented in accordance with GAAP. We believe that free cash flow is useful in evaluating our liquidity, as it is similar to measures reported by our public competitors and is regularly used by security analysts, institutional investors, and other interested parties in analyzing liquidity. Free cash flow is not intended to be a substitute for GAAP financial measures and, as calculated may not be comparable to other similarly titled measures of liquidity for other companies in other industries or within the same industry.

The table below presents our free cash flow, which is our net cash provided by operating activities less cash used for the purchase of property and equipment for the periods indicated:

 

 

Nine months ended September 30,

(in thousands)

 

 

2026

 

 

2025

 

 

 

 

 

Net cash (used in) provided by operating activities

 

$

(10,071

)

 

$

16,767

Less:

 

 

 

 

Cash used in the purchase of property and equipment

 

 

2,075

 

 

 

3,698

Free cash flow

 

$

(12,146

)

 

$

13,069

 

 

 

 

 

 

Investor Relations

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: General Health Vitamins/Supplements Other Health Health Fitness & Nutrition

MEDIA:

KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDA

KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDA

MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2026.

Third Quarter 2026 and Recent Highlights

  • Net revenues grew 11% over the prior year period to $11.6 million; year to date net revenues grew 17% to $35.4 million

  • Gross profit grew 20% over the prior year period to $7.5 million, driven by gross margin improvement from 60.2% to 65.2%

  • Net income improved by $1.0 million to $0.2 million compared to a net loss of $0.8 million in prior year period

  • Adjusted EBITDA increased to $1.3 million from $0.1 million in the prior year period

  • Signed two new sales and distribution agreements with partners in Europe and Africa, expanding our geographic footprint internationally

  • Revising full-year 2026 revenue guidance to $48.0 – $48.5 million, representing year-over-year growth of 17% – 18%, compared to the previous guidance range of $47.5 – $48.5 million.

“Total Revenue of $11.6 million represents another quarter of consistent above-market growth for KORU, driven by our recurring patient base,” said Adam Kalbermatten, President and CEO of KORU Medical. “We also delivered positive net income and adjusted EBITDA for the second consecutive quarter, demonstrating the scalability of our business model. As anticipated, our year-over-year revenue growth moderated in the third quarter compared to the first half of 2026, reflecting in part the timing of our entry into a competitive non-tender market in Europe. With that market launch now behind us, we anticipate revenue growth to reaccelerate in the fourth quarter for a strong finish to the year. We are encouraged by our geographic expansion, specialty pharmacy partnerships, and pipeline advancements and plan to continue investing resources in our long-term growth strategy as we move forward.”

2026 Third Quarter Financial Results

 

 

Three Months Ended September 30,

 

Change from Prior Year

 

% of Net Revenues

 

 

2026

 

2025

 

$

 

%

 

2026

 

2025

Net Revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Domestic Core

 

$

8,058,131

 

$

6,122,365

 

$

1,935,766

 

 

31.6

%

 

69.6

%

 

58.9

%

International Core

 

 

3,084,050

 

 

3,695,524

 

 

(611,474

)

 

(16.5

%)

 

26.7

%

 

35.5

%

Total Core

 

 

11,142,181

 

 

9,817,889

 

 

1,324,292

 

 

13.5

%

 

96.3

%

 

94.4

%

Pharma Services and Clinical Trials

 

 

424,374

 

 

584,274

 

 

(159,900

)

 

(27.4

%)

 

3.7

%

 

5.6

%

Total

 

$

11,566,555

 

$

10,402,163

 

$

1,164,392

 

 

11.2

%

 

100

%

 

100

%

Total net revenues increased $1.2 million, or 11.2%, to $11.6 million for the three months ended September 30, 2026, as compared to $10.4 million in the prior year period.

Domestic core revenues were $8.1 million, an increase of $1.9 million, or 31.6%, compared to the prior-year period. Approximately $1.2 million of the increase reflected lower orders from a U.S. distributor in the third quarter of 2025, when the distributor purchased a portion of its KORU products through one of our international distributors and reduced its inventory levels. The remaining increase was primarily driven by higher pump and consumable volumes, new patient starts, and market share gains within existing accounts.

International core revenues were $3.1 million, a decrease of 16.5% compared to the prior-year period. The decrease primarily reflected a higher prior-year comparison base, which included shipments to a distributor in a strategic market in anticipation of demand associated with conversions from vials to prefilled products, as well as purchases by an international distributor for subsequent resale in the U.S. The decrease was partially offset by growth in new patient starts within existing international markets.

As discussed above, purchases through the international distributor for resale in the U.S. affected the geographic mix of Core revenues in the prior-year period and, consequently, the year-over-year comparisons of Domestic and International Core revenues.

Pharma services and clinical trials net revenues were $0.4 million, a decrease of 27.4% compared to the prior-year period, primarily reflecting lower purchases of products for use in a customer’s clinical trial program.

Gross profit increased $1.3 million, or 20.5%, to $7.5 million in the three months ended September 30, 2026, as compared to $6.3 million in the prior year period, primarily driven by gross margin and volume growth. Gross margin increased to 65.2% for the three months ended September 30, 2026, as compared to 60.2% in the prior year period, primarily driven by lower manufacturing costs, higher than average selling prices from our geographical customer mix and lower tariff costs driven by tariff related rebates.

Total operating expenses increased $0.2 million, or 3.2%, to $7.4 million for the third quarter of 2026 primarily driven by an increase of $0.3 million in research and development. The increase in research and development expenses was primarily due to higher salary and stock compensation related to headcount additions, including employees added in connection with our technology asset acquisition.

Net income increased $1.0 million to $0.2 million or $0.00 per diluted share for the third quarter of 2026, compared to a net loss of ($0.8) million, or ($0.02) per diluted share, for the prior year period. Adjusted EBITDA for the quarter was $1.3 million, or $0.02 per adjusted diluted share versus $0.1 million or $0.00 per adjusted diluted share in the prior year period. A reconciliation of adjusted EBITDA to the most directly comparable GAAP measures is provided at the end of this press release.

Cash and cash equivalents were $7.4 million as of September 30, 2026, reflecting cash usage of $0.9 million in the third quarter of 2026.

Updated 2026 Guidance

  • Revising full-year 2026 revenue guidance to $48.0 – $48.5 million, representing year-over-year growth of 17% – 18%, compared to the previous guidance range of $47.5 – $48.5 million.

  • Revising full year 2026 gross margin to be between 63 – 64%, from prior range of 62 – 64%

  • Reiterating positive adjusted EBITDA for the full year

  • Raising year-end cash balance to be greater than $8.0 million, from prior guidance of greater than $7.5 million

Conference Call and Webcast Details

The Company will host a live conference call and webcast to discuss these results and provide a corporate update on Tuesday, November 10, 2026, at 4:30 PM ET.

To participate in the call, please dial (877) 407-0784 (domestic) or (201) 689-8560 (international). The live webcast will be available on the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website.

Non-GAAP Measures

This press release includes the non-GAAP financial measures “adjusted diluted EPS” and “adjusted EBITDA” that are not in accordance with, nor an alternate to, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. These non-GAAP measures are not based on any comprehensive set of accounting rules or principles. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. They are limited in value because they exclude charges that have a material effect on KORU Medical’s reported results and, therefore, should not be relied upon as the sole financial measures to evaluate the Company’s financial results. Non-GAAP financial measures are meant to supplement, and to be viewed in conjunction with GAAP financial results. Reconciliations of the Company’s non-GAAP measures are included at the end of this press release.

About KORU Medical Systems

KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The Freedom Syringe Infusion System (the “Freedom System”) currently includes the Freedom60® and FreedomEDGE® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HigH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Pharma Service and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit www.korumedical.com.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. All statements that are not historical fact are forward-looking statements, including, but not limited to, anticipated revenue growth in the fourth quarter and financial guidance and expected operating performance for fiscal 2026. Forward-looking statements discuss the Company’s current expectations and projections relating to its financial position, results of operations, plans, objectives, future performance, and business. Forward-looking statements can be identified by words such as “anticipate”, “potential”, “guidance”, and “expect”. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties that could cause actual results to differ from the results predicted include, among others, ability to adapt new technology, uncertainties associated with inflation, tariffs, war and other geopolitical conflicts, customer ordering patterns, availability and costs of raw materials and labor and our ability to recover such costs, future operating results, growth of new patient starts and the Ig market, our compliance with Food and Drug Administration and foreign authority regulations and the outcome of regulatory audits, introduction and adoption of competitive products, acceptance of and demand for new and existing products, ability to penetrate new markets, success in enforcing and obtaining patents, reimbursement related risks, government regulation of the home health care industry, success of our research and development effort, expanding the market of the Freedom System, demand in the SCIg market, availability of sufficient capital if or when needed, dependence on key personnel, the impact of recent accounting pronouncements, and those risks and uncertainties included under the captions “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, which is on file with the SEC and available on our website at www.korumedical.com/investors and on the SEC website at www.sec.gov. All information provided in this release and in the attachments is as of November 10, 2026. Undue reliance should not be placed on the forward-looking statements in this press release, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

KORU MEDICAL SYSTEMS, INC.

BALANCE SHEETS

 

 

 

 

 

 

 

September 30,

 

December 31,

 

 

2026

 

2025

 

 

(UNAUDITED)

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS

 

 

 

 

 

 

Cash and cash equivalents

 

$

7,364,200

 

 

$

8,872,212

 

Accounts receivable, net

 

 

6,382,020

 

 

 

5,972,252

 

Inventory, net

 

 

4,691,949

 

 

 

3,678,131

 

Other receivables

 

 

601,294

 

 

 

557,653

 

Prepaid expenses and other current assets

 

 

1,097,918

 

 

 

908,542

 

TOTAL CURRENT ASSETS

 

 

20,137,381

 

 

 

19,988,790

 

Property and equipment, net

 

 

4,004,237

 

 

 

4,471,386

 

Intangible assets, net of accumulated amortization of $572,949 and $527,949 as of September 30, 2026 and December 31, 2025, respectively

 

 

1,683,726

 

 

 

684,841

 

Capitalized software development costs, net

 

 

206,863

 

 

 

 

Operating lease right-of-use assets

 

 

2,653,308

 

 

 

2,956,192

 

Other assets

 

 

98,970

 

 

 

98,970

 

TOTAL ASSETS

 

$

28,784,485

 

 

$

28,200,179

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

Accounts payable

 

$

1,875,343

 

 

$

2,267,473

 

Accrued expenses

 

 

3,418,114

 

 

 

4,828,830

 

Note payable

 

 

332,479

 

 

 

–

 

Other liabilities

 

 

18,468

 

 

 

27,722

 

Accrued payroll and related taxes

 

 

578,261

 

 

 

531,972

 

Finance lease liability

 

 

130,257

 

 

 

124,913

 

Operating lease liability

 

 

438,712

 

 

 

413,448

 

TOTAL CURRENT LIABILITIES

 

 

6,791,634

 

 

 

8,194,358

 

Finance lease liability, net of current portion

 

 

51,572

 

 

 

78,675

 

Operating lease liability, net of current portion

 

 

2,546,190

 

 

 

2,879,224

 

TOTAL LIABILITIES

 

 

9,389,396

 

 

 

11,152,257

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

Common stock, $0.01 par value, 75,000,000 shares authorized, 50,375,678 and 49,790,934 shares issued 46,375,176 and 46,370,432 shares outstanding as of September 30, 2026, and December 31, 2025, respectively

 

 

503,757

 

 

 

497,909

 

Additional paid-in capital

 

 

57,650,483

 

 

 

52,449,339

 

Treasury stock, 4,018,526 and 3,438,526 shares as of September 30, 2026 and December 31, 2025, respectively, at cost

 

 

(6,405,793

)

 

 

(3,882,494

)

Accumulated deficit

 

 

(32,353,358

)

 

 

(32,016,832

)

TOTAL STOCKHOLDERS’ EQUITY

 

 

19,395,089

 

 

 

17,047,922

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

 

$

28,784,485

 

 

$

28,200,179

 

KORU MEDICAL SYSTEMS, INC.

STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

 

2026

 

 

 

2025

 

 

 

2026

 

 

 

2025

 

 

 

 

 

 

 

 

 

 

NET REVENUES

 

$

11,566,555

 

 

$

10,402,163

 

 

$

35,376,599

 

 

$

30,232,038

 

Cost of goods sold

 

 

4,020,471

 

 

 

4,137,592

 

 

 

12,752,917

 

 

 

11,445,362

 

Gross Profit

 

 

7,546,084

 

 

 

6,264,571

 

 

 

22,623,682

 

 

 

18,786,676

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

5,867,903

 

 

 

5,994,661

 

 

 

18,235,907

 

 

 

17,338,183

 

Research and development

 

 

1,281,040

 

 

 

933,107

 

 

 

3,821,004

 

 

 

3,242,505

 

Depreciation and amortization

 

 

210,023

 

 

 

204,482

 

 

 

617,585

 

 

 

631,326

 

Total Operating Expenses

 

 

7,358,966

 

 

 

7,132,250

 

 

 

22,674,496

 

 

 

21,212,014

 

 

 

 

 

 

 

 

 

 

Net Operating Income /(Loss)

 

 

187,118

 

 

 

(867,679

)

 

 

(50,814

)

 

 

(2,425,338

)

 

 

 

 

 

 

 

 

 

Non-Operating Income/(Expense)

 

 

 

 

 

 

 

 

Gain/(Loss) on currency exchange

 

 

(11,752

)

 

 

11,790

 

 

 

(57,246

)

 

 

61,571

 

Gain/(Loss) on disposal of fixed assets, net

 

 

(1

)

 

 

3,206

 

 

 

(406,269

)

 

 

3,205

 

Interest income, net

 

 

60,738

 

 

 

74,567

 

 

 

201,603

 

 

 

226,698

 

TOTAL OTHER (EXPENSE)/INCOME

 

 

48,985

 

 

 

89,563

 

 

 

(261,912

)

 

 

291,474

 

 

 

 

 

 

 

 

 

 

INCOME / (LOSS) BEFORE INCOME TAXES

236,103

 

(778,116

)

 

(312,726

)

 

(2,133,864

)

 

 

 

 

 

 

 

 

 

Income Tax Benefit (Expense)

 

 

(18,000

)

 

 

150

 

 

 

(23,800

)

 

 

(17,206

)

 

 

 

 

 

 

 

 

 

NET INCOME/(LOSS)

 

 

218,103

 

 

 

(777,966

)

 

 

(336,526

)

 

 

(2,151,070

)

 

 

 

 

 

 

 

 

 

NET INCOME / (LOSS) PER SHARE

 

 

 

 

 

 

 

 

Basic

 

$

0.00

 

 

 

(0.02

)

 

 

(0.01

)

 

 

(0.05

)

Diluted

 

$

0.00

 

 

 

(0.02

)

 

 

(0.01

)

 

 

(0.05

)

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

 

 

 

 

 

 

 

 

Basic

 

 

46,239,985

 

 

 

46,238,819

 

 

 

46,229,137

 

 

 

46,140,347

 

Diluted

 

 

46,731,836

 

 

 

46,238,819

 

 

 

46,229,137

 

 

 

46,140,347

 

KORU MEDICAL SYSTEMS, INC.

STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

 

 

Nine Months Ended

 

September 30,

September 30,

 

 

2026

 

 

2025

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

Net Loss

$

(336,526

)

$

(2,151,070

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

Stock-based compensation expense and warrant expense

 

2,067,152

 

 

1,740,727

 

Depreciation and amortization

 

617,585

 

 

631,326

 

Loss on disposal of fixed assets

 

406,269

 

 

–

 

Loss on write-off of intangible assets

 

21,890

 

 

–

 

Non-cash leasing charges

 

(6,007

)

 

–

 

Changes in operating assets and liabilities:

 

 

Decrease/(Increase) in accounts receivable

 

(409,768

)

 

390,139

 

Decrease/(Increase) in other receivables

 

(43,641

)

 

38,151

 

Decrease/(Increase) in inventory

 

(1,013,818

)

 

(1,608,041

)

Decrease/(Increase) in prepaid expenses and other assets

 

(189,376

)

 

(224,063

)

Increase/(Decrease) in accounts payable

 

(392,131

)

 

222,193

 

Increase/(Decrease) in accrued payroll and related taxes

 

46,289

 

 

(355,335

)

Increase/(Decrease) in other liabilities

 

(9,255

)

 

(26,377

)

Increase/(Decrease) in accrued expenses

 

(1,410,717

)

 

709,999

 

NET CASH FLOWS FROM OPERATING ACTIVITIES

 

(652,054

)

 

(632,351

)

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

Purchases of property and equipment

 

(422,289

)

 

(524,735

)

Purchases of intangible assets

 

(571,804

)

 

(3,400

)

Capitalized software development costs

 

(206,863

)

 

–

 

NET CASH FLOWS FROM INVESTING ACTIVITIES

 

(1,200,956

)

 

(528,135

)

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

Proceeds from exercise of employee stock options

 

197,600

 

 

89,025

 

Borrowings from insurance finance indebtedness

 

403,869

 

 

406,751

 

Payments on insurance finance indebtedness

 

(71,390

)

 

(342,972

)

Payments for taxes related to net share settlement of equity awards

 

(81,059

)

 

(27,536

)

Payments on finance lease liability, net of asset

 

(104,022

)

 

(81,710

)

NET CASH FLOWS FROM FINANCING ACTIVITIES

 

344,998

 

 

43,558

 

 

 

 

NET DECREASE IN CASH AND CASH EQUIVALENTS

 

(1,508,012

)

 

(1,116,928

)

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

 

8,872,212

 

 

9,580,947

 

CASH AND CASH EQUIVALENTS, END OF PERIOD

$

7,364,200

 

$

8,464,019

 

 

 

 

Supplemental Information

 

 

Cash paid during the nine months ended September 30 for:

 

 

Interest

$

11,714

 

$

36,690

 

Income Taxes

$

23,800

 

$

17,206

 

Non-cash Financing Activity

 

 

During the nine months ended September 30, 2026, the Company acquired an intangible asset for $961,035, of which $500,000 was settled through the issuance of 125,628 shares of common stock

 

See accompanying Notes to Financial Statements.

 

 

KORU MEDICAL SYSTEMS, INC.

SUPPLEMENTAL INFORMATION

(UNAUDITED)

 

Three Months Ended

Nine Months Ended

Reconciliation of GAAP Net Income /(Loss) to Non-GAAP Adjusted EBITDA:

September 30,

September 30,

 

2026

 

 

2025

 

 

2026

 

 

2025

 

GAAP Net Income (Loss)

 

$

218,103

 

$

(777,966

)

 

$

(336,526

)

$

(2,151,070

)

Depreciation and Amortization

 

210,023

 

 

204,482

 

 

617,585

 

 

631,326

 

Interest (Income), Net

 

 

(60,738

)

 

(74,567

)

 

 

(201,603

)

 

(226,698

)

Tax Expense (Refund)

 

18,000

 

 

(150

)

 

23,800

 

 

17,206

 

Stock-based Compensation Expense

 

 

927,869

 

 

737,398

 

 

 

2,067,152

 

 

1,850,732

 

Adjusted EBITDA

 

$

1,313,257

 

$

89,197

 

 

$

2,170,408

 

$

121,496

 

 

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING:

Basic

 

46,239,985

 

 

46,238,819

 

 

 

46,229,137

 

 

46,140,347

 

Diluted

 

46,731,836

 

 

46,238,819

 

 

 

46,229,137

 

 

46,140,347

 

 
 

Three Months Ended

Nine Months Ended

Reconciliation of Reported Diluted EPS to Non-GAAP Adjusted Diluted EPS:

September 30,

September 30,

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Reported Diluted Earnings Per Share

 

$

0.00

 

$

(0.02

)

 

$

(0.01

)

$

(0.05

)

Stock-based Compensation Expense

 

 

0.02

 

 

0.02

 

 

 

0.04

 

 

0.04

 

Adjusted Diluted Earnings Per Share

 

$

0.02

 

$

(0.00

)

 

$

0.04

 

$

(0.01

)

Reconciliation of Reported Revenue to Normalized Revenue — Q3 2025

($ in millions, rounded)

Revenue Category

Q3 2025 Reported

Normalization Adjustment

Q3 2025 Normalized

Q3 2026 Reported

Reported Y/Y Growth

Normalized Y/Y Growth

Domestic Core

$

6.1

$

1.2

 

$

7.3

$

8.1

31.6

%

10.1

%

International Core

$

3.7

$

(1.2

)

$

2.5

$

3.1

(16.5

%)

23.2

%

Total Core

$

9.8

$

0.0

 

$

9.8

$

11.2

13.5

%

13.5

%

Pharma Services & Clinical Trials

$

0.6

 

—

 

$

0.6

$

0.4

(27.4

%)

(27.4

%)

Total Revenue

$

10.4

$

0.0

 

$

10.4

$

11.6

11.2

%

11.2

%

*Normalization adjustments reflect certain distributor purchasing patterns in Q3 2025 and net to zero at both the Total Core and Total Revenue levels. Revenue amounts are rounded to the nearest $0.1 million, and year-over-year growth rates are calculated using unrounded amounts.

Investor Contact:

Louisa Smith

[email protected]

KEYWORDS: United States North America New Jersey

INDUSTRY KEYWORDS: Oncology Medical Supplies Health Medical Devices Health Technology Pharmaceutical Biotechnology

MEDIA:

Logo
Logo

Supermicro Announces Participation in Upcoming Investor Events

Supermicro Announces Participation in Upcoming Investor Events

SAN JOSE, Calif.–(BUSINESS WIRE)–Super Micro Computer, Inc. (Nasdaq: SMCI), an AI, Enterprise, Storage, and 5G/Edge Total IT Solution Provider featuring Data Center Building Block Solutions® (DCBBS), today announced its participation in the upcoming investor conferences:

Cantor Convergence Conference

Date: November 11, 2026

Location: Miami, FL

1x1s Only

UBS Global Technology and AI Conference

Date: December 1, 2026

Location: Scottsdale, AZ

1x1s Only

Raymond James TMT & Consumer Conference

Date: December 7, 2026

Location: New York, NY

Fireside Chat: 11:20am ET (webcast available)

Barclays Annual Global Technology Conference

Date: December 10, 2026

Location: San Francisco, CA

Fireside Chat: 9:55am PT (webcast available)

About Super Micro Computer, Inc.

Supermicro (NASDAQ: SMCI) is a global leader in Application-Optimized Total IT Solutions. Founded and operating in San Jose, California, Supermicro is committed to delivering first-to-market innovation for Enterprise, Cloud, AI, and 5G Telco/Edge IT Infrastructure. We are a Total IT Solutions provider with server, AI, storage, IoT, switch systems, software, and support services. Supermicro’s motherboard, power, and chassis design expertise further enables our development and production, enabling next-generation innovation from cloud to edge for our global customers. Our products are designed and manufactured in-house (in the US, Taiwan, and the Netherlands), leveraging global operations for scale and efficiency and optimized to improve TCO and reduce environmental impact (Green Computing). The award-winning portfolio of Server Building Block Solutions® allows customers to optimize for their exact workload and application by selecting from a broad family of systems built from our flexible and reusable building blocks that support a comprehensive set of form factors, processors, memory, GPUs, storage, networking, power, and cooling solutions (air-conditioned, free air cooling or liquid cooling).

Supermicro, Server Building Block Solutions, and We Keep IT Green are trademarks and/or registered trademarks of Super Micro Computer, Inc.

All other brands, names, and trademarks are the property of their respective owners.

Investor Relations Contact:

[email protected]

KEYWORDS: United States North America California New York Florida Arizona

INDUSTRY KEYWORDS: Data Management Technology IOT (Internet of Things) Telecommunications Software Artificial Intelligence Networks Internet Mobile/Wireless 5G Hardware

MEDIA:

SenesTech Reports Record Q3 2026 Revenue with 59% Year-Over-Year Growth

Revenue increased 42% sequentially as e-commerce and subscriptions expanded; 

Gross profit reached a record $796,000

SURPRISE, Ariz., Nov. 10, 2026 (GLOBE NEWSWIRE) — SenesTech, Inc. (NASDAQ: SNES), an innovator in rodent control, today announced financial results for the third quarter ended September 30, 2026.

Q3 2026 Financial Highlights

  • Total revenue increased 42% sequentially to a record $1.097 million in Q3 2026, compared to $770,000 in Q2 2026, and increased 59% compared to $690,000 in Q3 2025. This was the second consecutive quarterly revenue record and the first quarter above $1 million, consistent with the preliminary revenue of approximately $1.1 million announced on October 15, 2026.
  • E-commerce revenue increased 52% sequentially and 337% year over year, representing approximately 71% of total Q3 revenue.
  • Subscription revenue increased 53% sequentially and 234% year over year. Combined subscribers across Amazon and the Company’s website increased 72% compared to Q2 2026, strengthening the recurring revenue base.
  • Direct B2B revenue increased 19% sequentially and 2% year over year. Sequential growth was driven by process changes to the Company’s B2B efforts, which drove growth in the pest management, government and commercial verticals.
  • Evolve® revenue increased 67% year over year to $979,000 and represented 89% of product revenue. ContraPest® revenue increased 13% year over year to $118,000, driven by higher refill sales.
  • Gross profit increased 40% to a record $796,000 in Q3 2026, compared to $567,000 in Q2 2026, and increased 84% compared to $433,000 in Q3 2025.
  • Gross margin was 72.6% in Q3 2026, compared to 73.6% in Q2 2026 and 62.8% in Q3 2025.
  • Net loss for Q3 2026 was $2.0 million, compared to $1.8 million in Q2 2026 and $1.3 million in Q3 2025.
  • Adjusted EBITDA loss was $1.4 million in Q3 2026, compared to $1.4 million in Q2 2026 and $1.1 million in Q3 2025.
  • Cash and cash equivalents at the end of the quarter were $4.0 million. Subsequent to the end of the quarter, the Company raised $1.2 million in gross proceeds from the ATM.
  • Net cash used in operating activities declined each quarter in 2026, falling to $1.3 million in Q3 from $1.7 million in Q2 2026 and $1.9 million in Q1 2026.

Recent Operational and Strategic Highlights

  • Amazon Revenue and
    Subscriptions Continue to Grow: Amazon revenue increased each month of Q3, bringing in new customers and expanding the recurring subscription base.
  • B2B Sales Team
    Expanded: The Company added two salespeople, bringing the team under Executive Vice President of Sales Jack Karabees to four, with two additional hires expected by year end. The team is focused on building repeat business across targeted domestic verticals.
  • E-commerce Reach Expanded
    Through Grove Collaborative: SenesTech added Grove Collaborative as a third-party e-commerce channel, bringing Evolve® to an engaged base of consumers focused on sustainability.
  • Assessment and Monitoring Services Launched
    for B2B Customers: In July, SenesTech began offering assessment services to help B2B customers measure rodent activity and understand the scope of an infestation. Customers can choose an assessment performed by SenesTech or deploy the Company’s tracking products themselves, with results analyzed using SenesTech’s internally developed AI tool. These services complement existing implementation and deployment services and are expected to provide an additional revenue opportunity.
  • Municipal Results
    Support Broader Adoption: Chicago’s Wicker Park Bucktown program, which incorporated SenesTech’s assessment services and Evolve® into an integrated pest management approach, reduced average rat activity intensity by 88% over 12 months. Evolve has expanded to six Chicago-area Special Service Areas and wards. In Swampscott, Massachusetts, Evolve Rat, combined with sanitation and waste management improvements, helped reduce measured rodent activity by 43% over six months.
  • Sandstrom Partners Engaged
    to Support Branding and Marketing: SenesTech engaged Sandstrom Partners, a Portland, Oregon, brand development firm whose clients have included Nike, Target and Coca-Cola, as a strategic advisor on marketing and branding. An early priority is helping retain Amazon customers and attract new customers by more clearly communicating how the Company’s rodent birth control products work.

Management Commentary

“SenesTech delivered a milestone third quarter, exceeding $1 million in quarterly revenue for the first time and setting new records for revenue, gross profit and subscription customers,” said Michael Edell, President and Chief Executive Officer of SenesTech. “These results demonstrate the momentum we are building. With e-commerce delivering strong growth and our expanded B2B sales team pursuing new opportunities, we are excited about the foundation we are establishing for continued growth.

“Our e-commerce business continues to lead the way, with revenue increasing 52% sequentially, driven by another record quarter on Amazon. Across Amazon and our website, combined subscription customers increased 72% sequentially, while subscription revenue grew 53%. We are reaching more customers and building ongoing relationships that support repeat purchases, greater revenue visibility and long-term customer value.

“We see direct B2B as the next significant driver of growth alongside our expanding e-commerce business. By expanding the sales team, we have increased our capacity to pursue opportunities across our targeted verticals. Direct B2B revenue increased 19% sequentially, and we believe our growing brand awareness, broader customer adoption and focused sales efforts position us to build on that progress,” Mr. Edell concluded.

“Record gross profit of $796,000 and a gross margin of 72.6% highlight the strength of our business model as revenue scales,” said Tom Chesterman, Chief Financial Officer of SenesTech. “Our focus is on translating this commercial momentum into sustained financial progress. We are also putting our cash to work more efficiently: excluding non-cash items such as stock-based and other non-cash compensation, depreciation and straight-line rent, sales and marketing has grown as a share of operating expenses compared to the third quarter of 2025, while general and administrative spending has declined as a share.”

Use of Non-GAAP Measures

Adjusted EBITDA is a non-GAAP measure and is not intended to be a substitute for those financial measures reported in accordance with GAAP. This measure has been included because management believes that, when considered together with the GAAP figures, it provides meaningful information related to operating performance and liquidity trends. We use these non-GAAP financial measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors concerning our financial performance. These adjustments may be calculated by us differently than other companies that disclose measures with the same or similar terms. See our attached financials for a reconciliation of the non-GAAP measures to the nearest GAAP measure.

Conference Call Details

Date: Tuesday, November 10, 2026.

Time: 5 p.m. ET.

Call-in Information: Interested parties can access the live teleconference by dialing 1-844-308-3351 or 1-412-317-5407.

Webcast: https://app.webinar.net/EM53kOPaJDx

Webcast Replay: Available for 90 days on the Company’s website.

About SenesTech

SenesTech is the leader in rodent birth control and sustainable rodent population management, with a mission to support a healthier environment through the responsible management of animal pest populations. The Company’s Evolve® and ContraPest® fertility control solutions, along with its assessment and monitoring services, target reproduction to help reduce rodent populations. SenesTech serves consumer and professional markets with proven approaches that can be used independently or as part of an integrated pest management (IPM) program.

For more information, visit https://senestech.com/.

Safe Harbor Statement

This press release contains “forward-looking statements” within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, without limitation, statements regarding expected growth in e-commerce, subscription and direct B2B revenue; the planned addition of two salespeople by year end; the anticipated benefits of the Company’s third-party e-commerce relationship with Grove Collaborative; the expansion of municipal adoption of Evolve®; the anticipated benefits of, and revenue opportunity from, the Company’s assessment services; the anticipated benefits of the Company’s engagement of Sandstrom Partners, including improved customer retention and acquisition; and the Company’s ability to use cash more efficiently.

Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as “believe,” “may,” “future,” “plan,” “will,” “should,” “expect,” “anticipate,” “eventually,” “project,” “estimate,” “continuing,” “intend” and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the Company’s ability to sustain revenue growth across its e-commerce and B2B channels; its reliance on Amazon and other third-party platforms; its ability to retain and grow subscribers; the ability of its sales team to generate direct B2B revenue; the continued adoption of its products by municipalities; market acceptance of its assessment services and its ability to deliver them profitably; the effectiveness of its marketing and branding initiatives; the Company’s history of losses and need for additional capital to fund operations; its ability to manage operating expenses and cash; competition; regulatory developments affecting its products, including EPA and state registration requirements; supply chain and manufacturing risks; general economic conditions; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

CONTACT:

Investors: Robert Blum, Lytham Partners, LLC, (602) 889-9700, [email protected]

Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., (928) 779-4143

       
SENESTECH, INC.

BALANCE SHEETS

(In thousands, except share and per share data)
(Unaudited)
       
  September 30,

2026
  December 31, 2025
ASSETS      
Current assets:      
Cash and cash equivalents $ 3,951     $ 7,575  
Short-term investments   —       994  
Accounts receivable, net   247       201  
Inventory   966       994  
Prepaid expenses and other current assets   398       297  
Total current assets   5,562       10,061  
Right to use asset, operating lease   2,211       2,336  
Property and equipment, net   334       410  
Other noncurrent assets   36       36  
Total assets $ 8,143     $ 12,843  
       
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Current liabilities:      
Accounts payable $ 357     $ 183  
Accrued expenses   615       383  
Current portion of operating lease liability   151       139  
Current portion of notes payable   65       61  
Deferred revenue   45       32  
Total current liabilities   1,233       798  
Operating lease liability, less current portion   2,217       2,332  
Notes payable, less current portion   95       145  
Total liabilities   3,545       3,275  
Stockholders’ equity:      
Common stock   5       5  
Additional paid-in capital   152,924       152,043  
Accumulated deficit   (148,331 )     (142,480 )
Total stockholders’ equity   4,598       9,568  
Total liabilities and stockholders’ equity $ 8,143     $ 12,843  
               

SENESTECH, INC.

STATEMENTS OF OPERATIONS

(In thousands, except share and per share data)
(Unaudited)
       
  Three Months Ended

September 30,
  Nine Months Ended

September 30,
  2026   2025   2026   2025
Revenues, net $ 1,097     $ 690     $ 2,360     $ 1,800  
Cost of sales   301       257       659       645  
Gross profit   796       433       1,701       1,155  
Operating expenses:              
Research and development   418       400       1,217       1,245  
Sales and marketing   1,082       425       2,218       1,277  
General and administrative   1,287       955       4,238       3,257  
Total operating expenses   2,787       1,780       7,673       5,779  
Loss from operations   (1,991 )     (1,347 )     (5,972 )     (4,624 )
Interest income, net   35       49       121       45  
Net loss $ (1,956 )   $ (1,298 )   $ (5,851 )   $ (4,579 )
Weighted average shares outstanding — basic and diluted   5,420,899       4,668,009       5,329,923       2,619,841  
Loss per share — basic and diluted $ (0.36 )   $ (0.28 )   $ (1.10 )   $ (1.75 )
                               

SENESTECH, INC.

STATEMENTS OF CASH FLOWS

(In thousands)
(Unaudited)
       
  Three Months Ended September 30,   Nine Months Ended September 30,
  2026   2025   2026   2025
Cash flows from operating activities:              
Net loss $ (1,956 )   $ (1,298 )   $ (5,851 )   $ (4,579 )
Adjustments to reconcile net loss to net cash used in operating activities:              
Stock-based compensation   276       47       481       228  
Depreciation and amortization   32       29       94       103  
Other non-cash expenses, net   7       43       16       87  
Changes in operating assets and liabilities, net   319       (200 )     300       75  
Net cash used in operating activities   (1,322 )     (1,379 )     (4,960 )     (4,086 )
               
Cash flows from investing activities:              
Purchase of held-to-maturity investments   —       (2,964 )     —       (2,964 )
Maturity of held-to-maturity investment   —       —       1,000       —  
Purchase of property and equipment   (18 )     (42 )     (18 )     (125 )
Net cash provided by (used in) investing activities   (18 )     (3,006 )     982       (3,089 )
               
Cash flows from financing activities:              
Proceeds from the exercise of warrants, net   —       5,622       —       10,482  
Proceeds from issuances of common stock, net   227       —       400       2,706  
Repayments of notes payable   (16 )     (14 )     (46 )     (42 )
Net cash provided by financing activities   211       5,608       354       13,146  
               
Increase (decrease) in cash and cash equivalents   (1,129 )     1,223       (3,624 )     5,971  
Cash and cash equivalents, beginning of period   5,080       6,055       7,575       1,307  
Cash and cash equivalents, end of period $ 3,951     $ 7,278     $ 3,951     $ 7,278  
                               

SENESTECH, INC.

Itemized Reconciliation Between Net Loss and Adjusted EBITDA (non-GAAP)

(In thousands)
(Unaudited)
       
  Three Months Ended

September 30,
  Nine Months Ended

September 30,
  2026   2025   2026   2025
Net loss (as reported, GAAP) $ (1,956 )   $ (1,298 )   $ (5,851 )   $ (4,579 )
Non-GAAP adjustments:              
Stock-based and non-cash compensation   524       18       757       299  
Severance costs   —       —       503       27  
One-time legal costs   —       111       217       356  
Interest income, net   (35 )     (49 )     (121 )     (45 )
Depreciation expense   32       29       94       103  
Non-cash operating lease expense   7       49       22       87  
Total non-GAAP adjustments   528       158       1,472       827  
Adjusted EBITDA loss (non-GAAP) $ (1,428 )   $ (1,140 )   $ (4,379 )   $ (3,752 )